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RIASSUNTO  
L’attività biologica di molti farmaci, composti agroalimentari ed aromi e le 
caratteristiche chimico-fisiche di molti polimeri sono direttamente legati alla 
configurazione assoluta dei centri chirali che li caratterizzano. La domanda di prodotti 
otticamente attivi è in continua crescita, e la catalisi asimmetrica è lo strumento 
maggiormente studiato per il loro ottenimento sia in campo accademico che 
industriale.  
Lo scopo di questa tesi è la sintesi di leganti enantiomericamente puri per la sintesi di 
complessi metallici da utilizzare in catalisi asimmetrica. Il lavoro ha previsto la sintesi 
di tre differenti tipologie di leganti, in particolare i capitoli 2 e 3, riportano la sintesi di 
leganti di tipo CNN-pincer e N-Nˈ, ottenuti in entrambe le forme enantiomere grazie 
all’applicazione di metodi chemoenzimatici stereo complementari, mentre il capitolo 4 
riporta la sintesi di leganti di tipo P-N a partire dalla L-prolina e l’attività catalitica dei 
relativi complessi di Pd(II).  
 
LEGANTI CNN-PINCER 
Recentemente, sono stati ottenuti degli ottimi risultati in reazioni di riduzione di 
chetoni prochirali, sia in idrogenazione che in trasferimento di idrogeno, catalizzate da 
complessi di Ru(II) e Os(II) coordinati da leganti CNN-pincer achirali (Figure 1) e da 
fosfine chirali. Negli esempi studiati si sono osservate infatti elevate produttività (TOF 
fino a 105 h-1) e stereoselettività nella formazione degli alcoli chirali prodotti (e.e. fino 
al  99%).  
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FIGURA 1.  
Sulla base di tali risultati si è deciso di estendere questo studio a catalizzatori analoghi, 
in cui il legante pincer fosse chirale otticamente puro. E’ stata messa a punto una 
strategia sintetica che ha permesso di ottenere i leganti amminici in Figura 2 con 
ottimo eccesso enantiomerico ed in entrambe le forme otticamente attive, direttamente 
dai rispettivi alcoli, sintetizzati a loro volta per via chemoenzimatica con e.e. ≥ 99%, 
attraverso due metodi enzimatici: uno basato sulla risoluzione cinetica dinamica 
mediata da lipasi della miscela racema degli alcoli precursori, l’altro sulla riduzione 
asimmetrica mediata da lievito di birra del precursore chetonico.  
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FIGURA 2. 
Con lo scopo di verificare l’effetto di sostituenti arilici diversi in posizione 6 dell’ 
anello piridinico centrale, sono stati sintetizzati dei leganti CNN-pincer caratterizzati 
da gruppi arilici di diverso ingombro sterico (4a e 4b) o recanti in posizione 3,5 e 4 
gruppi con affetti elettronici opposti (4c-h, Figure 3). 
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 FIGURA 3. 
Grazie alla messa a punto di una strategia comune per tutti i nuovi derivati che 
prevede, anche in questo caso, il passaggio attraverso un precursore alcolico ottenuto 
per via chemoenzimatica, i leganti 4a-h sono stati ottenuti con ottimo eccesso 
enantiomerico (e.e. > 90%) 
La coordinazione dei leganti e l’attività catalitica dei complessi di Ru(II) e Os(II) 
ottenuti sono stati studiati dal gruppo del Prof. Baratta e del Prof. Rigo dell’Università 
degli studi di Udine. I complessi dei nuovi leganti CNN-pincer (4, 5 e 4a-h), in 
combinazione con fosfine chirali (Josiphos) hanno dimostrato buona attività ed 
enantioselettività nel catalizzare la reazione di riduzione di chetoni, sia in 
idrogenazione che in trasferimento di idrogeno. 
La strategia sintetica per ottenere i leganti e i risultati relativi alle reazioni di riduzione 
svolte utilizzando i complessi contenenti questi nuovi derivati sono riportati nel 
Capitolo 2. 
 
LEGANTI N-N’ 
Leganti di tipo 2,2’-bipiridina, piridina-imidazolina e 1,10-fenantrolina sono 
notoriamente leganti di elezione per la copolimerizzazione CO/stirene, permettendo di 
ottenere polichetoni stereoregolari e ad alto peso molecolare. Un ulteriore obbiettivo di 
questo lavoro di tesi è stato verificare l’effetto su complessi di Pd(II) dell’introduzione 
di un sostituente in posizione orto all’azoto di uno dei due anelli di un legante bi 
piridina. A questo scopo è stato sintetizzato il nuovo legante 29 (Figura 4), sia in forma 
racema che nelle sue forme otticamente attive a partire dagli alcoli precursori ottenuti 
per via chimica e chemoenzimatica rispettivamente. Anche in tal caso la bioriduzione 
con lievito di birra del precursore chetonico e la risoluzione cinetica dinamica mediata 
da lipasi si sono dimostrati metodi ottimali per l’ottenimento di alcoli secondari con 
alto eccesso enantiomerico (e.e. 99%). È stato inoltre sintetizzato un nuovo legante 
achirale del tipo piridina-triazolo (30) (Figura 4).   
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FIGURA 4. 
L’attività dei complessi di Pd(II) contenenti i nuovi derivati nella reazione di 
copolimerizzazione CO/stirene è stata verificata e confrontata con quella di complessi 
caratterizzati dai già noti leganti 31 e 32. Sorprendentemente, in ogni caso i complessi 
cationici, di formula generale [Pd(N-Nˈ)(CH3)(NCCH3)][PF6], hanno dimostrato 
completa selettività per la reazione di oligomerizzazione CO/stirene, dando prodotti a 
basso peso molecolare caratterizzati da 1-5 unità ripetitive. La formazione di prodotti 
regio- e diasteroisomerici in diversi rapporti denota una dipendenza dalla natura e dalla 
chiralità del legante usato.   
Sono stati inoltre preparati complessi di palladio caratterizzati da un secondo legante 
coordinato di formula generale [Pd(N-Nˈ)2(CH3)][PF6]. Pur non causando variazioni 
nella distribuzione dei prodotti, il loro studio ha permesso di verificare una forte 
dipendenza dalla presenza della seconda molecola di legante nel determinare la 
discriminazione fra le enantiofacce dello stirene durante l’inserzione delle prime unità 
della catena oligomerica. 
LEGANTI P-N 
La chimica dei leganti caratterizzati da differenti gruppi donatori, come fosforo e 
azoto, è in forte espansione grazie alla versatilità di tali sistemi. In particolare leganti 
P-N chirali hanno ottenuto particolare attenzione e sono stati utilizzati in vari 
complessi in catalisi asimmetrica. 
Da un’idea originale del Prof. Castillòn (Università Rovira i Virgili, Tarragona, 
Spagna) sono stati sintetizzati a partire dalla L-prolina i due leganti P-N otticamente 
attivi in Figura 5, che differiscono per la presenza del carbonile sul ponte tra l’atomo di 
azoto legato all’anello piridinico e l’atomo di carbonio dell’anello pirrolidinico. 
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FIGURA 5. 
I leganti 44 e 45 sono caratterizzati da due centri chirali: il carbonio in posizione 2 
dell’anello pentatomico e l’atomo di fosforo, ma in entrambi i casi solo uno dei due 
possibili diasteroisomeri è stato riconosciuto come prodotto. Sono state studiate sia la 
capacità di complessazione di tali leganti al Pd(II) che l’attività dei sistemi ottenuti 
nella reazione di copolimerizzazione CO/stirene. 
I due leganti, dipendentemente dalla loro natura, hanno dimostrato diversa attitudine 
alla formazione di complessi mono- e di-nucleari di palladio. La reazione di 
copolimerizzazione non viene catalizzata da complessi di questo tipo, ma, in 
particolare, il complesso con il legante 44 ha mostrato attività catalitica per la reazione 
di dimerizzazione dello stirene. 
La sintesi dei leganti e dei rispettivi complessi e gli studi catalitici sono stati riportati 
nel Capitolo 4.  
   
 
 
 
 
SUMMARY 
The biological activity of drugs, agrochemicals and flavors as well as the chemical and 
physical characteristics of many polymers are strictly related to the their absolute 
configuration. The demand for optically active products is growing, and asymmetric 
catalysis is one of instruments for their achievement, in both the academic and 
industrial world. 
Aim of this thesis is the synthesis of enantiomerically pure ligands for their application 
in asymmetric catalysis. In particular, the work is focused on the synthesis of three 
different classes of ligands. Chapters 2 and 3 deal with the synthesis of CNN-pincer 
and N-Nˈ ligands respectively, obtained in both enantiomeric forms by 
stereocomplementary chemoenzymatic methods, while Chapter 4 presents the 
synthesis of P-N type ligands obtained from L-proline and the activity of their Pd(II) 
complexes. 
 
CNN-PINCER LIGANDS 
Recently, excellent results were obtained in the reduction of prochiral ketones 
catalyzed by Ru (II) and Os (II) complexes with achiral CNN-pincer (Figure 1) and 
chiral diphosphines, both in asymmetric hydrogenation and transfer hydrogenation 
reactions, with excellent productivity (TOF up to 105 h-1) and enantioselectivities (e.e. 
up to 99% of the chiral alcohol products).  
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FIGURE 1.  
Based on these results, we decided to extend this research on analogous complexes 
with the chiral optically active CNN pincer ligands represented in figure 2, which were 
obtained by a clean SN2 reaction from their optically active alcohol precursors.  
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FIGURE 2. 
The alcohols were synthesized by two enantiocomplementary chemoenzymatic 
methods, based on baker’s yeast bioreduction of the parent prochiral ketone and the 
lipase mediated dynamic resolution of the racemic alcohol substrates. In order to verify 
the effect of substituent at the C-6 of the pyridine ring, CNN-pincer ligands with aryl 
groups differing in the steric (4a and 4b) or and electronic properties (4c-h, Figure 3) 
have been synthesized by analogous strategy, with excellent enantiomeric excess (e.e. 
> 90%). 
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 FIGURE 3. 
The ligands coordination and the catalytic activity of the Ru (II) and Os (II) complexes 
obtained, were studied by Prof. Baratta and Prof. Rigo’s group (University of Udine). 
Complexes stabilized by CNN-pincer ligands (4, 5 and 4a-h), in combination with 
chiral phosphine (Josiphos) showed good activity and enantioselectivity in catalyzing 
the reaction of reduction of ketones, both in transfer hydrogen reaction and asymmetric 
hydrogenation. The synthesis and application of CNN pincer ligands are described in  
Chapter 2. 
 
N-N’LIGANDS 
2,2'-Bipyridine, pyridine-imidazoline and 1,10-phenanthroline derivatives are known 
as ligands of choice for the copolymerization CO/styrene, allowing stereoregular and 
high molecular weight polyketones. A further purpose of this thesis was to investigate 
the effect of an ortho chiral substituent on bipyridine, on the activity of their Pd(II) 
complexes. For this purpose, we have synthesized compounds 29 (Figure 4), in both 
enantiomeric forms, by applying the chemoenzymatic methodologies seen before for 
the 6-arylpyridine pincer ligands for the synthesis of the corresponding optically active 
alcohol precursors, which were obtained in high enantiomeric excesses (e.e. 99%). It 
was also synthesized a new achiral ligand pyridine-triazole (30) (Figure 4). 
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FIGURE 4. 
The activity of the Pd(II) complexes containing the new derivatives was tested in the 
CO/styrene copolymerization reaction, the results obtained were compared with that of 
complexes characterized by already known ligands 31and 32.  
Surprisingly, in each case the cationic complexes, of general formula [Pd(N-
Nˈ)(CH3)(NCCH3)][PF6], showed complete selectivity for the CO/styrene 
oligomerization, giving oligomeric products of 1-5 units. The formation of different 
regio- and diasteroisomeric products was shown to depend on the ligand chirality and 
nature.  
Palladium complexes with a second bipyridine of general formula [Pd(N-
Nˈ)2(CH3)][PF6], have been also prepared. The presence of the second ligand did not 
affect products distribution, but it played a crucial role in determining the enantioface 
discrimination at least for the first units inserted in the oligomeric chain. 
The synthetic strategy for the N-Nˈ ligands, the characterization of the complexes and 
application in catalysis are discussed in Chapter 3. 
 
P-N LIGANDS 
There is an increasing interest in the chemistry of the ligands characterized by different 
donor groups, such as phosphorus and nitrogen, due to the versatility of such systems. 
In particular chiral P-N ligands have received particular attention and were used in 
various complexes for asymmetric synthesis.  
From an original idea of Prof. Castillòn (University of Rovira i Virgili, Tarragona, 
Spain) the synthesis of two optically active P-N ligands in Figure 5, starting from L-
proline, has been developed. 
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FIGURE 5. 
The ligands differ in the presence of the carbonyl group on the bridge connecting the 
nitrogen atom bound to the pyridine ring and the chiral carbon of the pyrrolidine ring: 
In spite of the presence of two chiral centers, the carbon in position 2 of pentatomic 
ring and the phosphorus atom, ligands 44 and 45 formed as a single diasteroisomer. 
Both the coordination to Pd(II) and the activity of the systems obtained in the 
copolymerization reaction of CO/styrene have been investigated.  
Depending on their nature, the two ligands, have shown a different attitude to the 
formation of mono- and di-nuclear palladium complexes. They turned out not to 
catalyze any copolymerization reaction. Instead the complex with the ligand 44 proved 
active in styrene dimerization. The synthesis of ligands and their complexes and 
catalytic studies were reported in Chapter 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Introduction 
 
Chapter 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1.1. ASYMMETRIC CATALYSIS 
Chirality is an intrinsic universal feature of a various level of matter, molecular 
chirality plays a key role in science and technology. Most physiological phenomena 
arise from hightly precise molecular interactions, in which chiral host molecules 
recognize two enantiomeric guests molecules in different ways. There are a lot of 
examples of enantiomer effects which are frequently dramatic: enantiomer often smell 
and taste different and the structural difference between enantiomers can be serious 
with respect to the actions of synthetic drugs. Thus, gaining access to optically pure 
compounds in the developments of pharmaceuticals, agrochemicals and flavors is a 
very significant endeavor. 
Discovery of truly efficient methods to achieve this goal has been a substantial 
challenge for chemists in both academia and industry. Stereoselective conversion of a 
prochiral compound to a chiral product (Asymmetric Reaction), is a very attractive 
approach, practical access to pure enantiomer relied largely on biochemical or 
biological methods. However the scope of such methods using enzymes, cell cultures 
or whole organisms is limited because of the inherent single-hand specificity of 
biocatalyst. On the other hand, a chemical allows for a flexible synthesis of a wide 
array of enantiopure organic substances from achiral precursor. The requirements for 
practical asymmetric synthesis include high stereoselectivity, high rate and 
productivity, atom economy, cost efficiency, operational simplicity, environmental 
friendliness, and low-energy consumption. 
Traditional asymmetric synthesis using a stoichiometric amount of a chiral compound, 
which is convenient for small to medium-scale reaction, is practical only if the 
expensive chiral auxiliary deliberately attached to a substrate or reagent is readily 
recyclable; otherwise it’s a wasteful procedure! 
A general principle of asymmetric catalysis using a chiral organometallic system is to 
provide an ideal way for multiplying molecular chirality (Figure 1). 
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FIGURE 1. Schematic principle of asymmetric catalysis with chiral organometallic catalyst: M = metal; 
A, B = substrate and reactant. 
A small amount of well-designed chiral catalyst can combine A and B, which produces 
the chiral AB compound stereoselectively in a large amount. Of various possibilities, 
the use of chiral organometallic molecular catalyst would be the most powerful 
strategy for this purpose. Asymmetric catalysis is an integrated chemical approach in 
which the maximum chiral efficiency can be obtained only by a combination of 
suitable molecular design with proper reaction conditions. The reaction must proceed 
with high turnover number (TON) and high turnover frequency (TOF), while the 
enantioselectivity range from 50:50 (nonselective) to 100:0 (perfectly selective). 
The chiral ligands that modify intrinsically metal atoms must possess suitable three-
dimensional structure and functionality, to generate sufficient reactivity and the 
desired stereoselectivity. The chiral catalyst can permit kinetically precise 
discrimination among the enantiotopic atoms, groups or faces in chiral molecules.1 
Well-defined chiral transition metal complexes not only decrease the activation energy 
of reactions but also differentiate between diasteromeric transition states. In 
asymmetric catalysis ligands induce asymmetry in a reaction, but not just though steric 
factors, also by generating electronic asymmetry on the metal centre through the 
presence of different donor atoms.2 Playing with steric and electronic properties of the 
ligand is possible to perform a perfect selective environment which give desired 
EE
MXnLm
R
properties to the metal centre and thinking about the virtually unlimited variations of 
the organic ligand, the enormous opportunities for asymmetric catalysis is clear. 
In conclusion to make an efficient transition metal catalyst, the following task are 
generally required: designing and synthesizing chiral ligand; preparing suitable 
substrates, catalyst precursor and metal-ligand complexes; and searching for 
appropriate reaction conditions. The significant challenges on asymmetric catalysis are 
two: discovering new catalytic reactions and inventing effective chiral catalysts. With 
regard to developing new metal-catalyzed reactions, it is important to focus on certain 
reactivity principles and experimental details: for example many inorganic and 
organometallic complexes can be converted to effective catalyst if proper conditions, 
proper ligands, suitable solvents and additives are used. Converting stoichiometric 
transformation into catalytic reactions and developing hightly active catalysts that 
feature broad under mild and simple conditions remain key problem. The combined 
use of organometallic and coordination chemistry has produced a number of new and 
powerful synthetic methods for important classes of compounds in general and for 
optically pure substances in particular. For this purpose complexes with optically 
active ligands have been used, the follow paragraphs report some example of ligands 
used in asymmetric catalysis focusing on the asymmetric reduction of ketones by 
hydrogen transfer or hydrogenation reaction and copolymerization reactions.  
1.2. PINCER LIGANDS 
Since 1970 pincer-type ligands have attracted increasing interest owing to the unusual 
properties of the metal centers imparted by this kind of ligand. The most common type 
of pincer skeleton is an anionic aryl ring ortho,ortho-disubstituted which bond the 
metal via M-C σ-bond; ortho-substituents could be heteroatom as CH2NR2, CH2PR2 or 
CH2SR, which generally coordinate to the metal center too.3 
 
 
             E = CH2NR2,CH2PR2,CH2SR                                                                                                                   
                                                                                                                    
 
FIGURE 2. Generic structure of ECE pincer ligand. 
 
The control of the properties of the metal center by a well-defined ligand system is an 
ultimate goal of inorganic and organometallic chemistry. Chelation, that is, the binding 
of a ligand to a metal through two or more bonds, is a versatile method to realize it. In 
organometallic complexes containing a direct transition metal-carbon bond, chelation 
leads to the formation of metallacycles, which provides an additional stabilization of 
M-C bond.4 “Pincer” ligands have the general formula ECE  and comprise a 
potentially E,C,E terdentate coordinating, monoanionic array, where E is a neutral 
two-electron donor such as N, P, O, S, while C represent the anionic aryl carbon atom. 
Metal complexation with pincer ligands usually occurs with formation of two five-
member metallacycles to afford complexes [MXn(ECE)Lm], this bonding mode forces 
the central aryl group to a conformation which is approximately coplanar with the 
coordination plane of d8 square-planar metal centers (RhI, IrI, NiII, PdII, PtII) or with the 
basal plane of d6 square-pyramidal metal geometries (RuII, RhIII, IrIII). Modification of 
various ligand parameters allows for a refined adjustment of the steric and electronic 
properties of the complexed metal center without changing its bonding pattern 
significantly. In such pincer system the correlation of modification in the ligand with 
the properties of the metal center are exceptionally high: for instance steric influences 
may be varied by changing the size of the donor substituents or by introducing 
functional groups in the benzylic position. Clearly some of these modifications will 
also have electronic effects that are attributed to the type of donor atoms E and the 
electron-withdrawing or –releasing character of their substituents. Fine-tuning of 
electronic properties can also be achieved by further substitutions of the aromatic 
rings.3 
So far, the majority of investigation have been carried out with pincer ligands 
containing nitrogen, phosphorus or sulfur donor group. 
Complexes containing biscyclometalated pincer ligands offer particularly attractive 
possibilities for catalytic applications, since the tailoring of catalytic properties is 
readily achieved: 
1. The terdentate binding mode and the covalent M-C σ bond stabilize the 
catalytically active metal site, preventing efficiently the metal leaching. 
2. The electronic properties are highly sensitive towards modifications in the 
donor array. 
3. The steric requirements around the catalytic site can be modified to 
discriminate against some substrates or to create a chiral pocket for 
asymmetric catalysis. 
Unique characteristics of pincer ligands have attracted extensive research into them 
catalytic uses: Kharasch reactions, Heck reactions, Suzuki coupling, hydrogen transfer 
reactions, Michael reaction and aldol reactions are few examples of catalytic use of 
this system.5 
1.2.1. PINCER LIGANDS IN ASYMMETRIC HYDROGENATION (AH) AND 
ASYMMETRIC TRANSFER HYDROGENATION (ATH) 
Hydrogen (H2) is the simplest molecule and its properties are fully understood. 
Because this clean resource is available in abundance at a very low cost, catalytic 
hydrogenation is a core technology in both research and industry. Nevertheless, the 
ways to manipulate H2 chemically have remained limited. Among all asymmetric 
catalytic methods, asymmetric hydrogenation utilizing molecular hydrogen to reduce 
prochiral olefins, ketones and imines, have become one of the most efficient methods 
for constructing chiral compounds. In particular, there are many successful examples 
in which high enantioselectivities were achieved in asymmetric hydrogenation of 
prochiral ketones to yield optically active secondary alcohols by using chiral Ru, Rh, 
and Ir complexes.6  
An attractive alternative to asymmetric hydrogenation for the production of chiral 
compound, due to its operational simplicity and easy availability of hydrogen sources, 
is the asymmetric transfer hydrogenation of prochiral substrates. 2-Propanol is the 
conventional hydrogen source having favorable properties: it is stable, easy to handle 
(bp 82 °C), nontoxic, environmentally friendly, and inexpensive and dissolves many 
organic compounds. The acetone product is readily removable.7  
An interesting challenge, is the development of new catalytic system active in both 
symmetric hydrogenation and hydrogen transfer.  
With this aim a new class of pincer ligands have been recently developed by the group 
of Prof. P. Rigo8 The novel terdentate complexes of general structure in Figure 3, are 
bound to a diphosphane and an aminomethyl-based CNN pincer and show an 
extremely high efficiency in transfer hydrogenation of diaryl, dialkyl and aryl-alkyl 
ketones. The stability of the complex is assured by the rigid framework build up by the 
association of the robust terdentate pincer and the chelating phosphane, consequently 
catalyst deactivation is significantly retarded.8b 
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FIGURE 3. Example of new catalytic systems containing CNN pincer ligand for AH and ATH. 
Mechanistic aspect of the catalyzed ATH of benzophenone in 2-propanol/NaOH with 
Ru(II) complexes has been studied (Scheme 1).8a 
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SCHEME 1. Catalyst activation in hydrogen transfer mechanism. M = Ru. 
The catalytic species is the Rhutenium hydride formed by the reaction between the 
halide precursor complex and sodium isopropoxide, resulting in a covalent metal 
alkoxide as a reactive intermediate that undergoes a facile β-hydrogen elimination 
reaction affording the active Ru-H species. Hydride complex reacts fast with an 
equimolar amount of benzophenone to give the alkoxide-amine complex through 
insertion of the ketone into Ru-H bond, this species beeing stabilized by an hydrogen 
N···H···O bond interaction. It is worth pointing out that for CNN ligands the presence 
of the primary –NH2 group is crucial in enhancing the activity of the catalyst. 
Subsequent reaction with 2-propanol, which is present in large excess, leads the 
formation of Ru-isopropoxide closing the catalytic cycle.8a When an optically pure 
CNN pincer has been used, a fast enantioselective transfer hydrogenation has been 
observed. The structure of the terdentate pyridine ligand is therefore well suited for a 
modular synthetic approach, which allows for a fine tuning of stereochemical 
properties of CNN complexes. These pincer complexes are efficient catalysts for AH 
and ATH of alkyl aryl ketones. High enantioselectivities (up to 99%) have been 
achieved in ATH with a remarkably high rate (TOF = 105–106 h-1) and low catalyst 
loading (0.005–0.002 mol%). By changing the reaction parameters, these pincer 
complexes also catalyze the AH of ketones (0.02–0.01 mol% of catalyst) with H2 (5 
atm) to give up to 99% e.e. of the alcohol products.  
On account of the remarkably high activity and productivity of these complexes, this 
class of derivatives has a great potential for application in homogeneous asymmetric 
catalysis.8 
 
1.3. N-N LIGANDS 
The range of nitrogen donors is more extensive than that of any other atom. An 
appropriate classification of nitrogen donors can be based on the sp3, sp2 or sp 
hybridization of this atom. Complexes with nitrogen donors containing N-H bond, as 
sp3 type ligands, are generally not suitable for most organometallic reactions because 
H atom on coordinated nitrogen are sufficiently acidic to react with a nucleophile, 
furthermore coordinated nitrogen atom containing nonbonding pairs of electrons are 
suitable to electrophile attacks. The only class of organic nitrogen donors with sp 
hybridization are nitriles, but their main function is as labile ligands that are replaced 
by appropriate reagents. Ligands containing sp2-hybridized nitrogen atoms, 
particularly when N-atom is part of an aromatic system, instead have a very extensive 
coordination chemistry (Figure 4).9 
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FIGURE 4. Some nitrogen-donors with sp2-hybridized N atoms. 
Also for this kind of donors, a much more extensive and useful coordination chemistry 
is possible if they are bi- or terdentate ligands, however the use of such ligands in 
asymmetric catalysis requires the presence of stereogenic substituents.  
M-N bonds are most of σ-type but π interactions are possible with ligand containing 
sp2-hybridized nitrogen donors, and π back-bonded effects, particularly between 
nitrogen heterocycles and metal centers, have been frequently invoked to explain a 
variety of observations. 
Thus the following generalization can be made: 
1. Donor-acceptor bonds formed by nitrogen donors with metal atoms of the 
transition series and the inner series are generally strong and their strength is 
unlikely to show drastic changes if the metal center, but not the ionic charge, is 
changed.  
2. The strength of the M-N bonds will be much less affected by steric effects. 
3. The nitrogen donors, generally, will not be as effective in producing low-spin 
complexes with the consequence that the species produced are less 
thermodynamically stable and more kinetically labile. 
The consequence of this “boundary conditions” are that nitrogen-donor ligands 
forming robust complexes are di-, ter- or multidentate ligands, often macrocycles, with 
sp2-hybridized N-atoms.  
Nitrogen ligands in homogeneous catalysis have received increasing attention in recent 
years. In particular, the use of optically active, chelating, nitrogen-containing ligands 
made many significant contribution to the field of asymmetric catalysis. This important 
peculiarity increase the range of catalytic use which includes asymmetric 
hydrogenation and transfer hydrogenation, asymmetric cyclopropanation, asymmetric 
Dies-Alder reaction, asymmetric aldol condensation and much more.9  
 
1.3.1. NITROGEN LIGANDS IN POLYKETONES SYNTHESIS10 
The copolymerization reaction of carbon monoxide with terminal alkenes (Scheme 2) 
or strained cyclic olefins leads to the synthesis of alternated polyketones, most 
commonly this reaction is homogeneously catalyzed by Pd(II) complexes containing a 
wide array of bidentate ligands including bidentate phosphine donors, bidentate 
nitrogen donors, hybrid phosphorus-nitrogen systems and phosphino-phosphite 
ligands.11 
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SCHEME 2. General catalyzed polyketones synthesis. 
 
During the last two decades, considerable interest has been focused on the synthesis of 
polyketones originating from carbon monoxide with an aromatic alkene, like styrene or 
its substituted derivatives,10,12 this copolymerization reaction requiring the use of 
Pd(II) complexes with N-N chelating ligands to be effectively accomplished.10,11 
Copolymers of general formula [CH(Ar)CH2CO]n show regio- and stereoisomerism 
due to the presence of truly stereogenic centers in the polymer backbone. Depending 
on the regioselectivity of the monomer insertion, primary (1,2 mode) or secondary (2,1 
mode) into the polymer chain, three different arrangements might be possible during 
the polymerization: tail-to-tail, head-to-tail and head-to-head (Figure 5). Styrene 
insertions in palladium complexes usually take place in the 2,1-fashion. 
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FIGURE 5. Regioselectivity of propagation chain during CO/styrene copolymerization. 
The occurrence of the same insertion mode during the chain growth leads only to head-
to-tail units. Moreover, the sequence of absolute configuration of the stereogenic 
centers in the backbone can control the formation of atactic (stereoirregular), 
syndiotactic (RSRSRSRS sequence) or isotactic (RRRRRRRR or SSSSSSSS sequence) 
copolymers (Figure 6). Syndiotactic and isotactic alternating copolymers are 
characterized by vanishing small and high optical activity respectively.11 
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FIGURE 6. Syndiotactic and isotactic copolymers in CO/styrene copolymerization. 
The introduction of substituents of different nature and on different positions of the 
ligand skeleton and the use of chiral bidentate N-N ligands have a remarkable effect on 
the overall catalyst performance, including the catalyst activity, productivity and 
stability and on the features of the synthesized macromolecules like the molecular 
weight, the molecular weight distribution and the stereochemistry. In particular the 
control of the region- and enantioselectivities of styrene insertion, ultimately leading to 
a stereoregular polyketones, can be achieved through a suitable choice of bidentate 
ligands. Indeed the stereochemistry of copolymer could depends on both the efficient 
catalytic system enantioface discrimination strongly dependent on ligands nature and 
on the  influence of the growing chain. 
The first example of enantioselective copolymerizaton of styrene monomer and CO 
has been obtained with cationic palladium catalysts modified with enantiomerically 
pure C2-symmetric bisoxazoline ligands (Figure 7). In a typical reaction the monomers 
react at room temperature yielding copolymers featured by both highly isotactic 
microstructure and high optical activity.9,13 The presence of substituents in the four 
position of oxazoline rings strongly controls the orientation of incoming styrene 
around the metal centre during the propagation process.13 Surprisingly palladium 
catalysts modified with pyridine-oxazoline ligands give polymers that are largely 
syndiotactic, the same result is obtained using C2v-symmetry ligands, such as 1,10-
phenantroline and 2,2’-bipyridine.10,11,12 (Figure 7).  
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FIGURE 7. Few examples of N-N donor ligands used in CO/styrene copolimeryzation. 
 
1.4. P-N LIGANDS 
The most important and widely used of heterodentate ligands in asymmetric catalysis 
are those which bear phosphorous and nitrogen as their donor atoms. This kind of 
ligands have been definite hemilable because of the combination of soft and hard 
donor atoms.14 The π-acceptor character of the phosphorous can stabilize a metal 
centre in a low oxidation state, while the nitrogen σ-donor ability makes the metal 
more susceptible to oxidative addition reaction. This combination can help to stabilize 
intermediate oxidation states or geometries which form during the catalytic cycle. The 
electronic asymmetry can also be used to optimize a ligand for use in particular 
reaction by appropriate choice of the nature of the donor atoms. For instance, bonding 
the phosphorous directly to a more electronegative atom such as oxygen or nitrogen 
will decrease its electron-donating ability while enhancing its π-acceptor capacity. 
Alternatively, the presence of an imino rather than an amino group will result in a 
nitrogen donor atom of greater σ-donating capabilities. Overall this will result in a 
greater electronic disparity between the donor atoms.  
The P-N ligands are not classified by the reaction in which their metal complexes have 
been applied, but by the nature of their donor atoms. Based on this system it is possible 
to recognize: amino N donor-phosphine P donor (Figure 8-(a)), cyclic amino N donor-
phosphine P donor (Figure 8-(b)), amino N donor-heteroatom bound P donor (Figure 
8-(c)), imine N donor-phosphine P donor (Figure 8-(d)), cyclic imino N donor-
phosphine P donor (Figure 8-(e)), imine N donor-heteroatom bound P donor (Figure 8-
(f)),  pyridine type N donor-phosphine P donor (Figure 8-(g)), pyridine type N donor-
heteroatom bound P donor (Figure 8-(h)) and ligands with chiral donor atoms; either 
chiral N donor (Figure 8-(i)) or phosphorous P donor (Figure 8-(l)).2   
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FIGURE 8. Few examples of P-N ligands. 
Moreover, polydentate ligands having both hard and soft donors, are excellent 
candidates for the preparation of homo- or hetero-bimetallyc complexes. Compounds 
comprised of more than one metal center in close proximity might exhibit different 
properties, compared with the monometallic fragment that constitute them: cooperative 
reactivity patterns, stabilization of unusual ligand coordination modes, higher catalytic 
activity or different selectivity than the corresponding mononuclear moieties.14,15  
Very recently attention has been focused on P-N chiral ligands: they have been used 
successfully in asymmetric catalysis reactions such as allylic substitution, 
hydrosilation, hydroboration of olefins and hydrogen transfer of ketones. The reason 
for their good performance is twofold: steric factors, but also the electronic asymmetry 
induced by the presence of very different donor atoms on the metal center.14 
P,N-coordinated nickel or palladium complexes were also described as active 
compounds for the oligomerization16 and polymerization of ethylene.17 
The enantioselective copolymerization of CO and styrene has also been achieved with 
palladium catalysts with hybrid phosphine-nitrogen ligands.18 The isolated material is 
isotactic and its optical activity is comparable to those obtained with the bioxazoline 
derived catalysts. 
1.5. BIOCATALYSIS IN ORGANIC SYNTHESIS 
Biocatalysis encompasses catalysis by bacteria, fungi, yeast, or their true catalytic 
components: enzymes. Enzymes are proteins that are able to accelerate organic 
transformations under mild reaction conditions. The available enzymes are 
traditionally divided into six classes according to the specific type of reaction 
catalyzed: oxidoreductases, transferases, hydrolases, lyases, isomerases and ligases.  
The hallmark of enzymes is their remarkable ability to catalyze very specific chemical 
reactions, some enzymes are so well designed for this purpose that they can accelerate 
the rate of a chemical reaction by as much as 1012-fold over the rate of spontaneous 
reaction. This incredible enhancement results from the juxtaposition of chemical 
reactive groups within the binding pocket of enzyme (the enzyme active site) and other 
groups from the target molecule (substrate), in a way that facilities the reaction steps 
required to convert the substrate into the product.19 
Enzymes display three types of selectivities: 
• Chemoselectivity: Since the purpose of an enzyme is to act on a single type of 
functional group, other sensitive functionalities, which would normally react to 
a certain extent under chemical catalysis, survive. As a result, biocatalytic 
reactions tend to be "cleaner" and laborious purification of product(s) from 
impurities emerging through side-reactions can largely be omitted. 
• Regioselectivity and Diastereoselectivity: Due to their complex three-
dimensional structure, enzymes may distinguish between functional groups 
which are chemically situated in different regions of the substrate molecule. 
• Enantioselectivity: Since almost all enzymes are made from L-amino acids, 
enzymes are chiral catalysts. As a consequence, any type of chirality present in 
the substrate molecule is "recognized" upon the formation of the enzyme-
substrate complex. Thus a prochiral substrate may be transformed into an 
optically active product and both enantiomers of a racemic substrate may react 
at different rates. 
The interest in biocatalysts is mainly due to the need to synthesize enantiopure 
compounds as chiral building blocks for drugs and agrochemicals with a system  
which minimizes problems of undesired side-reactions such as decomposition, 
isomerization, racemization and rearrangement, which often plague traditional 
methodology. Biocatalysts could be use both in full cells and as isolated enzymes, the 
latter could be either native or immobilized on an inert support. 
The enzymes action mechanism consist on a lock-and-key model: the active has the 
right shape and functional groups to bind, activate and draw up the reacting molecules 
forming of enzyme-substrate intermediate. After reaction the products are released and 
the enzyme is ready for a new cycle (Figure 9). 
 
FIGURE 9. Schematic mechanism of enzymes catalysis. 
Some enzymes require the association with additional chemicals to facilitate rapid 
reaction and regeneration. Thus enzymes incorporate non-protein molecules called 
cofactors through non-covalent interactions such as H-bonding and hydrophobic 
interactions. Cofactors can be either inorganic (e.g., metal ions and iron-sulfur 
clusters) or organic compounds (e.g., flavin and heme). Organic cofactors can be either 
prosthetic groups, which are tightly bound to an enzyme, or coenzymes, which are 
released from the enzyme's active site during the reaction. Coenzymes include NADH, 
NADPH and adenosine triphosphate, these molecules transfer chemical groups 
between enzymes. Using enzymes as whole cells is possible to avoid the addition of 
cofactors to regenerate the enzyme during the reaction.  
Enzymatic catalysis in organic solvents significantly broadens conventional aqueous-
based biocatalysis. Water is a poor solvent for nearly all applications in industrial 
chemistry since  most organic compounds of commercial interest are very sparingly 
soluble and are sometimes unstable in aqueous solutions. Furthermore, the removal of 
water is tedious and expensive due to its high boiling point and high heat of 
vaporization. In contrast, biocatalysis in organic solvents offer several advantages. 
Among these advantages are: 
1. the use of low boiling point organic solvents, which facilitates the recovery of 
the product with better overall yield,  
2. non-polar substrates are converted at a faster rate due to their increased 
solubility in the organic solvent,  
3. deactivation and/or substrate or product inhibition is minimized,  
4. immobilization of enzymes is not required,  
5. denaturation of enzymes (loss of the native structure and thus catalytic activity) 
is minimized. 
Stereoselectivity in an enzymatic reaction can be accomplished through kinetic 
control. This means that one enantiomer reacts faster than the other. The 
enantioselective performance of enzymes is expressed as the enantiomeric ratio E, 
which is a measure for the selectivity of a enzyme for one of the enantiomers of a 
substrate. From Michaelis-Menten kinetics equations have been developed for enzyme 
catalyzed reactions. These expressions relate the conversion of the (racemic) substrate, 
the enantiomeric excess, and the enantiomeric ratio (E-value). For instance, 
considering A and B two enantiomer, the faster and slower reacting respectively, that 
compete for the same active site and assuming the reaction virtually irreversible, and 
no product inhibition, the enantiomeric ratio is given in Equation 1. 
 
E= lnln
(A/A0)
(B/ B0)
=
(V A/ KA)
(V B/ KB)
 
EQUATION 1. 
 
VA, KA and VB, KB denote maximal velocities and Michaelis constants of the fast- and 
slow-reacting enantiomers, respectively. Equation 1 shows that the discrimination 
between two competing enantiomers (A and B) by enzymes is equal to the E-value. 
The relationship between the conversion (c) and the enantiomeric excess of the 
recovered substrate fraction (ee(S)) is expressed in the enantiomeric ratio (E). 
Likewise, a relation can be derived that involves the enantiomeric excess of the 
product (ee(P)) in an enzyme catalyzed reaction (Equation 2). 
 
E=
ln [(1-c)(1-ee(S))]
=
ln [(1-c)(1+ee(S))]
ln [1-c(1-ee(P))]
ln [1-c(1+ee(P))]
 
Where:  
c = 1 - A+B
A0+B0
ee(S) = B-A
A+B
 
 
EQUATION 2. 
The use of biocatalysis to obtain enantiopure compounds can be divided in two main 
different methods: 
1. Kinetic resolution of a racemic mixture (KR) 
2. Biocatalyzed asymmetric synthesis 
1.5.1. KINETIC RESOLUTION (KR) AND DYNAMIC KINETIC 
RESOLUTION (DKR) 
In kinetic resolution (KR) of a racemic mixture, the presence of a chiral object (the 
enzyme) converts one of the enantiomers into product at a greater reaction rate than the 
other enantiomer (Scheme 3).  
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SCHEME 3. Schematic kinetic resolution mechanism. 
In an almost ideal situation (E > 200) the difference in the reaction rates of both 
enantiomers is so high that the reactive enantiomer is transformed fast, and the other is 
not converted at all. As a consequence, the reaction ceases at 50% conversion, this 
allowing the isolation of the enantioresolved substrate and product in an optically pure 
form, which can be separated by conventional methods. In practice, however, most 
cases of enzymatic resolution do not show this ideal situation, but the ratio of the 
reaction rates of the enantiomers is not infinite. As a practical rule, Enantiomeric 
Ratios between 15 and 30 are regarded as moderate to good, and are excellent above 
this value.  
The main limitation of kinetic resolutions is that they are intrinsically limited to a 
maximum yield of 50%. For this reason, deracemization strategies were developed to 
overcome this disadvantage.20 Among them, chemoenzymatic Dynamic Kinetic 
Resolution (DKR) is one of the most elegant approach. It combines an enzymatic  
kinetic resolution (KR), with the in situ racemisation of the starting material, usually 
achieved by a chemocatalyst. In this process the R and S enantiomers, reacting at 
different rates (kR >> kS), are kept in rapid equilibrium, so that the racemic starting 
material can be converted into a single optically pure enantiomer of the product with a 
theoretical yield of 100%.  
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SCHEME 4.  Schematic dynamic kinetic resolution mechanism. 
 
In order to design a successful DKR, both the epimerization and resolution steps have 
to be carefully tuned. Here are a few established general guidelines for an efficient 
DKR: 
1. The kinetic resolution should be irreversible in order to ensure high 
enantioselectivity. 
2. The enantiomeric ratio should be at least greater than ~20. 
3. To avoid depletion of the fast reacting enantiomer R, racemization (krac) should be 
at least equal or greater than the reaction rate of the fast enantiomer (kR). 
4. In case the selectivities are only moderate, krac should be greater than kR by a 
factor of ~10. 
5. Obviously, any spontaneous reaction involving the substrate enantiomers as well 
as racemization of the product should be absent. 
6. The enzymatic process and the racemization must be compatible.  
 
A number of common racemization techniques compatible with the biocatalyst used 
for the resolution has been developed. For instance the base-catalyzed racemization of 
α-substituted carboxylic acid derivatives and α-substituted carbonyls,21 has been 
extensively applied in microbial reductions, as well as the nucleophilic halogen 
displacement of secondary α-haloesters,22 combined with the enzymatic hydrolysis or 
ammonolysis of the ester group.  
For the racemization of secondary alcohols transition metal complexes have been 
proved to be very useful,23 in combination with the lipase mediated transesterification 
in organic solvents. Bäckwall and coworkers developed an efficient system for 
racemisation of sec-alcohols via hydrogen transfer based on the use of a redox 
Ruthenium catalyst (Shvo’s catalyst), used in combination with the Candida 
Antarctica B (CALB) mediated transesterification with p-chlorophenyl acetate as acyl 
donor.24 
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SCHEME 5. Shvo’s catalyst 
 
A wide range of substrates including substituted aromatic and aliphatic secondary 
alcohols and secondary diols25 have been converted into the corresponding ester with a 
very high chemical and optical yield.    
Biocatalytic methods, such as chemoenzymatic DKR of sec-alcohols and baker’s yeast 
reduction of prochiral ketones have been employed for the synthesis of the nitrogen 
ligands, synthetic targets of the present work. 
The next paragraphs briefly describes some features of Lipases and Saccharomyces 
Cerevisiae. 
 
1.5.2. LIPASES 
Lipases are ubiquitous enzymes and have been found in most organisms from the 
microbial, plant, and animal kingdom. Lipases not only hydrolyze fat in the digestion 
tract or interesterify triglycerides on a technical scale, but are surprisingly flexible 
biocatalysts for the acylation or deacylation of a wide range of unnatural substrates. 
Lipase-catalyzed transformations of racemic and prostereogenic compounds usually 
proceed with high enantioselectivity. If several functional groups amenable to lipase 
catalysis are present, the reaction is mostly regioselective. Lipases are quite stable and 
can be obtained from animals and plants as well as from natural and recombinant 
microorganisms in good yields. Therefore, they are used industrially as detergent 
enzymes, in paper and food technology, in the preparation of specialty fats, and as 
biocatalysts for the synthesis of organic intermediates. From an enzymological point of 
view, lipases exhibit a unique tertiary structure that exposes the catalytically active site 
only in the presence of a lipid phase or, presumably, in an organic solvent. 
The activity of lipases is low on monomeric substrates but strongly enhanced once an 
aggregated “supersubstrate” (such as an emulsion or a micellar solution for instance) is 
formed above its saturation limit (Figure 10). This property is quite different from that 
of the usual esterases acting on water-soluble carboxylic ester molecules. X-ray 
crystallographic studies revealed a unique mechanism, unlike that of any other 
enzyme: their three-dimensional structures suggested that interfacial activation might 
be due to the presence of an amphiphilic peptidic loop covering the active site of the 
enzyme in solution, just like a lid or flap. From the X-ray structure of co-crystals 
between lipases and substrate analogues, there is strong indirect evidence that, when 
contact occurs with a lipid/water interface, this lid undergoes a conformational 
rearrangement which renders the active site accessible to the substrate (Figure 11). 
However not all lipases subscribe to the phenomenon of interfacial activation. 
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FIGURE 10. Interfacial activation. 
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 FIGURE 11. Structure of Mucor miehei lipase in closed (A, C) and open form (B, D). A and B (side 
view): the catalytic triad (yellow) and secondary structure elements showing the α/β-hydrolase fold 
common to all lipases. C and D (top view): space-filling model, colored by decreasing polarity (dark 
blue ± light blue ± white ± light red ± dark red). Upon opening of the lid, the catalytic triad (yellow) 
becomes accessible (D), and the region binding to the interphase becomes significantly more apolar. 
 
Lipases hydrolyze ester bonds by means of a catalytic triad, composed of a 
nucleophilic serine residue activated by a hydrogen bond in relay with histidine and 
aspartate or glutamate (Scheme 6).26 
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SCHEME 6. A serine protease calalyzed reaction. 
 
The reaction rate and enantioselectivity of enzymatic reactions are affected by the 
reaction temperature. In general, enhanced temperatures cause an increase in catalytic 
activity, but at a certain temperature the enzyme can become completely deactivated. 
Protein denaturation and decrease in enantioselectivity could occur with increase 
temperature. A way to increase the (thermal) stability of lipases is based on 
immobilization. However, the use of immobilized lipases in organic solvents has many 
other advantages compared to their use in the native form:  
1. Lipases are less sensitive to denaturation and therefore the observed reaction 
rate is increased. 
2. Immobilization by adsorbing the enzymes onto solid matrices leads to a higher 
surface area to volume ratio and the enzyme-substrate interaction may be 
improved. 
3. Their recovery is facilitated. 
4. Both activity and selectivity can be increased. 
Candida antarctica lipase B is one of the most frequently employed lipase in organic 
solvents for transesterification reactions. It is commercialized also in an immobilized 
form on polyacrylamide. (Novozyme® 435) (Figure 12). 
 
FIGURE 12. Novozyme® 435 
 
Candida antarctica lipase B (CAL-B) shows a very high and general specificity for the 
(R)-enantiomer in the acylation of chiral secondary alcohols,26,27 which has been fully 
explained at the molecular level.28 
 
 
FIGURE 13. Schematic representation of CALB’s productive binding modes for alcohol enantiomers. 
 
1.5.3. BAKER’S YEAST 
Saccharomyces cerevisiae is a species of budding yeast, it has been widely used in  
microbial transformations, and yeast-mediated transformations in particular, since the 
early days of mankind for the production of bread, dairy products, and alcoholic 
beverages. Baker’s yeast (Saccharomyces cerevisiae) is commercially available as 
fresh or dry form and as immobilized yeast too (Figure 13) 
 
(a)               (b)  
FIGURE 13. (a) dry baker’s yeast. (b) fresh baker’s yeast. 
 
Baker’s yeast is by far the most widely employed microorganism for the asymmetric 
reduction of ketones. It is ideal for non-microbiologists as it is readily available at a 
very low price, does not reqire sterile fermenters  and can be therefore be handled 
using standard laboratory equpments. It is a very complex enzymatic system in which 
a number of different dehydrogenanses are present, possessing opposite stereochemical 
preferences. As a consequence, the stereochemical direction of the reduction may be 
controlled by careful design of the substrate. Bioreduction with B.Y. follows the 
empirical Prelog’s rule (Scheme 7). 
R'
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R
2[H] ∗ R'
OHR
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SCHEME 7. Prelog’s rule. 
 
For the yeast-catalyzed reduction of the prochiral ketone enzyme has to distinguish 
between the Re and the Si enantiotopic faces of the π-system to yield the optically pure 
chiral alcohol. Ketones with different alkyl side chains (CH3, Et, n-Pr, n-Bu, Bz) were 
reduced by B.Y., and the secondary alcohols obtained were mainly of (S) 
configuration. Only few examples of product predominantly R-configured have been 
observed. Sterically hindered ketones were not reduced at all. These results suggest a 
hydrogen transfer to the Re face of the prochiral ketone (Scheme 7) with L 
representing a large substituent and S a small substituent adjacent to the carbonyl 
group to yield alcohol. 
Thanks to its versatility and selectivity differen unnatural substrates were reduced by 
Saccharomyces cerevisiae, such as: cycloalkanones, aliphatic alkanones, sulphur 
containing molecules, nitrocarbonyl compounds, cyclic and acyclic dicarbonyl 
compounds (diketones, α,β-ketoesters), fluorine-containing compounds and 
organometallic compounds. Baker’s yeast has been successful used also in some C-C 
bond formation reaction and cyclization which require high stereoselectivity.29 
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Results and Discussion 
 
Chapter 2: 
Synthesis and application of CNN pincer ligands 
 
 
 
 
 
 
 
 
 
2.1. CHEMOENZYMATIC SYNTHESIS OF CHIRAL PINCER LIGANDS 
Metal complexes of general structure 1 (Figure 1), in which ruthenium(II) and 
osmium(II) are bound to a diphosphine and a bi- or tricyclic, aminomethylpyridine-
based, C,N,N-terdentate ligand (CNN pincer), have recently shown to be extremely 
efficient precatalysts for the catalytic reduction of aromatic ketones.1 Ruthenium(II) 
complexes, in which the CNN pincer ligand 2 is present in combination with different 
diphosphines, are the most active catalysts in the transfer hydrogenation of alkyl aryl 
ketones in 2-propanol, displaying turnover frequencies of up to 106 h-1 at remarkably 
low catalyst loadings (0.005-0.001 mol %).1a Moreover, Ru(II)1b and Os(II)1c 
complexes containing the chiral CNN ligands (R)-3 and (R)-4 gave high 
enantioselectivities (up to 98% e.e. of the alcohol products) in the transfer 
hydrogenation of prochiral ketones. The Os(II) derivatives are also excellent catalysts 
for the asymmetric hydrogenation of ketones.1c More recently,1d comparably high 
enantioselectivities and productivities have been obtained with Ru and Os complexes 
prepared from the racemic tricyclic benzo[h]quinoline ligand 5 and chiral 
diphosphines. On account of their importance as scaffolds for chiral ligands and as 
bioactive compounds,2 the synthesis of chiral aminoalkylpyridines is of special 
interest. Common approaches based on asymmetric synthesis include the addition of 
organometallics to chiral imines,3 the enantioselective catalytic reduction of imines4 
and hydrazones,5 and the catalytic hydroamination of alkenes.6 The synthesis of chiral 
ligands (R)-3 and (R)-4 via the diastereoselective reduction of chiral N-p-
toluenesulfinyl ketimines was also reported.7 An alternative approach to (R)-4 was also 
described,7c via mesylation of the corresponding (S)-alcohol 13, obtained from a chiral 
precursor, and displacement with azide; this method, however, suffered from a 
significant loss of enantiopurity in the substitution step. Biocatalysis with whole cell 
systems and isolated enzymes provides a clean alternative for the synthesis of a variety 
of chiral building blocks with high degree of selectivity under mild reaction 
conditions.8 Enantiomerically pure secondary alcohols, in particular, can be efficiently 
obtained by lipase-catalyzed resolution of the corresponding racemic mixtures9 and by 
the asymmetric reduction of prochiral ketones with baker’s yeast (Saccharomyces 
Cerevisiae).10 The enantiospecific acylation of chiral amines is also described in the 
literature11 but while the dynamic kinetic resolution (DKR)12 of racemic sec-alcohols 
is well established, few protocols have been reported for the DKR of amines.11 When 
we applied these conditions to the resolution of 6-substituted 2-(1-
aminoethyl)pyridines, the resulting enantiospecificity was unsatisfactory, and harsh 
conditions were required for the recovery of amines from the resolved acetamides. 
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FIGURE 1. CNN pincer ligands and metal complexes. 
 
This chapter describes the synthesis of both enantiomers of 1-(6-phenylpyridin-2-
yl)ethanamine 4 and 1-(benzo[h]quinolin-2-yl)ethanamine 5 (Scheme 1),13 starting 
from the prochiral ketones 6,7  by the application of biotransformation procedures.  
leading in enantiocomplementary fashion to both enantiomers of the sec-alcohols S- 
and (R)-8,9, intermediates to the final amine products (R)- and (S)-4,5  
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SCHEME 1. General strategy for the synthesis of chiral not racemic pincer ligands 4 and 5. 
 
2.2. SYNTHESIS OF PROCHIRAL KETONES AND RACEMIC ALCOHOLS 
Prochiral ketones 6 and 7 were used as starting material for the synthesis of amine 
pincer ligands 4 and 5. 
2-Acetyl-6-phenylpyridine (6) was prepared by Suzuki coupling between commercial  
phenylboronic acid (9) and 2-acetyl-6-bromopyridine (8) (Scheme 2).14 
 
N
O
N
O
B(OH)2
Br
698  
SCHEME 2. Reaction conditions: n-propanol, K2CO3 2M, H2O, PPh3, Pd(OAc)2. 
 
The coupling was carried out in n-propanol under mild basic condition, the catalysts  
beeing a Pd(0) system obtained in situ by reduction of  Pd(OAc)2 with PPh3. The 
reaction mixture was refluxed overnight and after purification by column 
chromatography ketone 6 was obtained in 70-90% yield. 
 
Ketone 7 was prepared from benzo[h]quinoline, by a five-steps procedure, (Scheme 3) 
involving the intermediacey of the more active N-oxide intermediate (10), obtained in 
good yield (83%) by oxidation with m-chloroperbenzoic acid. Under the common 
oxidative conditions (H2O2/CH3COOH16) the product was obtained in a much lower 
yield (50%). Chlorination with POCl315 gave a 85:15 mixture of 2-
chlorobenzo[h]quinoline (11a) and 4-chlorobenzo[h]quinoline (11b), from which the 
desired isomer (11a) was separated by flash chromatography. Compound 11a was then 
converted into the more active 2-bromo derivative (12) by reaction with 
bromotrimethylsilane in refluxing propionitrile, or alternatively in a refluxing 33% 
solution of hydrobromic acid in acetic acid.17 Lithiation of 2-bromobenzo[h]quinoline 
(12) (n-BuLi, -78°C, THF) followed by acetylation with N,N-dimethyl-acetamide 
afforded the tricyclic ketone 7 in 5 steps and 40% overall yield from 
benzo[h]quinoline. 
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SCHEME 3. Synthesis of tricyclic ketone 7. Reaction conditions: (a) MCPBA, CHCl3, 4 days. (b) POCl3, 
reflux, 30'. (c) (CH3)3SiBr, CH3CH2CN or HBr 33%, CH3COOH, reflux. (d) THF, Ar, n-BuLi, -78°C, 
N,N-dimethyl-acetamide. 
 
NaBH4 reduction of 6,7 gave quantitatively the racemic alcohols rac-13 and rac-14, 
which were treated for kinetic resolution as described in paragraph 1.3. (Scheme 4). 
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SCHEME 4. Chemical reduction of ketones. Reaction conditions: NaBH4, EtOH. 
 
 
 
 
2.3. BIOREDUCTION WITH BAKER’S YEAST (Saccharomyces Cerevisiae) 
Asymmetric reduction of prochiral ketones with baker’s yeast provides an efficient 
access to the synthesis of optically pure secondary alcohol.  
Prelog’s rule18 anticipated that the baker’s yeast reduction of prochiral ketones 6 and 7 
would proceed with delivery of the hydride to the Re face of the carbonyl, affording 
the (S) alcohols (Figure 2, Scheme 5). 
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FIGURE 2. Hydride attack on the Re face: S= small group; L= large group. 
 
 
Bioreduction of 6,7 was accomplished under fermenting conditions, by preincubating 
baker’s yeast in the reaction medium for 30 minutes at 37°C before substrate addition. 
The reaction were monitored at regular intervals with HRGC, following the conversion 
of the starting ketone 6 and 7 into the corresponding alcohols 13 and 14. 
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SCHEME 5. Baker’s yeast reduction of ketones 6,7. Reaction conditions: baker’s yeast,  phosphate buffer 
Na2HPO4/KH2PO4 0.1 M pH 7.4,  glucose. 
 
Optimization of the reaction conditions needed a screening of solvents, as indicated in 
Table 1, which summarizes the most significant results. 
 
 
 
 
 
 
 
 
 
 TABLE 1. Bioreduction of ketone 6. 
 
Conc.  
(mM) 
 
g B.Y./mmol     
subst. 
B.Y. 
type Solvent 
Glucose 
(g/L) 
Time 
(days) 
Conv. 
 (%) 
e.e.% 
(S)[b] 
 
50 
 
 
10 
 
 
wet 
 
Water 
 
‒ 
 
10 
 
35 
 
> 99.9 
 
26 
 
 
5.6 
 
wet 
 
Water 
 
163 
 
6 
 
44 
 
> 99.9 
 
3.6 
 
 
31 
 
wet 
 
Buffer[a] 
 
112 
 
4-7 
 
86 
 
> 99.9 
 
3.6 
 
 
15.5 
 
dry 
 
Buffer[a] 
 
112 
 
6 
 
98 
 
> 99.9 
[a]Buffer = phosphate buffer Na2HPO4/KH2PO4 0.1 M pH 7.4. [b] The conversion and e.e.% were 
determined by HRGC analysis. 
 
The optically pure alcohol (S)-13 was shown to be formed as a single product in each 
case. As far as the conversion and the reproducibility are concerned, the best results 
were obtained by using dry B.Y. in phosphate buffer.  
All the intermediates and products were fully characterized by spectroscopic (IR, 
NMR, MS) and chirooptical (α, CD) tecniques, while enantiomeric excesses were 
determined by chiral HRGC. 
Surprisingly, under the same conditions, the bioreduction of the tricyclic ketone 7 did 
not proceed beyond 12% conversion, probably as a consequence of both the steric 
hindrance of the rigid tricyclic aromatic structure, preventing the substrate from 
accessing the active site of the alcohol dehydrogenase, and the low solubility of the 
benzo[h]quinoline system in aqueous medium. An attempt to improve the conversion 
was made, by adding DMSO as an organic water miscible co-solvent20 to the reaction 
mixture, in order to increase the solubility of the substrate (Table 2), but with 
unsatisfactory results.  
 
 
 
 
 
 
 
 
TABLE 2. Bioreduction of ketone 7. 
Conc. 
(mM) 
g 
B.Y./mmol     
subst. 
DMSO 
(mL) Solvent 
Glucose 
(g/L) 
Time 
(days) 
Conv. 
(%) 
e.e.% 
(S)[b] 
3.6 15.5 10 Buffer[a] 112 9 4 
‒ 
4.1 22 10 Water 25 9 12 77 
[a] Buffer = phosphate buffer Na2HPO4/KH2PO4 0.1 M pH 7.4. [b] The conversion and was determined 
by HRGC analysis; e.e.% was determined from the 1H NMR analysis of the corresponding Mosher’s 
ester. 
 
The desired alcohol (S)-14 was therefore provided by the classical kinetic resolution 
procedure, as described in paragraph 2.4.. 
 
2.4. KINETIC RESOLUTION 
Candida antarctica lipase B (CAL-B) is known to show a very high and general 
specificity for the (R) enantiomer in the acylation of chiral secondary alcohols.21 
Therefore, we decided to use Novozyme® 435 (CAL-B immobilized on 
polyacrylamide) for the kinetic resolution of racemic alcohols 13 and 14 (Scheme 6). 
The resolution progress was monitored by HRGC, stopping the reaction at 50% 
conversion (1 h). The KR could be quenched just filtering-off the enzyme. 
 
N
OH
N
OH
(S)-13
(S)-14
N
O
O(R)-15
(R)-16
rac-13
rac-14
 
SCHEME 6. Kinetic resolution of racemic alcohol rac-13 and rac-14. Reaction conditions: t-
butylmethylether, Ar, vinyl aceate, CAL-B, 28 °C.  
 
The lipase-catalyzed asymmetric acetylation of rac-13, with Novozyme® 435 and vinyl 
acetate in t-butylmethylether at room temperature gave the corresponding (R)-acetate 
15 with excellent enantioselectivity (enantiomeric ratio E > 500) and with recovery of 
the unreacted alcohol (S)-13 in a 79% e.e.. Similarly, the tricyclic alcohol 14 gave the 
corresponding (R)-acetate 16 in 40% yield (44% conversion) and e.e. > 99% (E > 500), 
while the recovered alcohol (S)-14 had 86% e.e. (Table 3). 
          TABLE 3. Summary of KR data. 
Substrate 
E 
(enantiomeric 
ratio) 
Conversion 
(%) 
   (R)-acetate 
e.e. % (yield %)  
(S)-alcohol 
e.e.% (yield %) 
(±)-13 > 500 46 15[a]  > 99.9(45) 13[a]      79 (50) 
(±)-14 > 500 44 16[b]   > 99  (40) 14[b]      86 (47) 
 Reaction conditions: see Scheme 6. [a] The conversion and e.e.% (after hydrolysis of (R)-15) were 
determined by HRGC analysis. [b] The conversion was determined by HRGC analysis, e.e.% (after 
hydrolysis of (R)-16) was determined from the 1H NMR analysis of the corresponding Mosher’s ester. 
 
After hydrolysis of the acetates 15 and 16 the corresponding (R)-alcohols 13 and 14 
were isolated with the same e.e.. However, the yields in the enantioresolved 
compounds (R)-13 and (R)-14 were low, as intrinsically limited by the 50% maximum 
attainable in a kinetic resolution, and because of the need for a chromatographic 
separation of alcohol and ester.  
Both limitations were overcome by applying to the lipase-catalyzed transesterification 
of rac-13 and rac-14 the conditions developed by Bäckvall et al. for the dinamic 
kinetic resolution of sec-alcohols.22 
 
2.5. DYNAMIC KINETIC RESOLUTION 
Based on the wide literature reported on this topic,11,22 the dynamic kinetic resolution 
of rac-13 and rac-14 was run combining the CAL-B mediated enzymatic acetylation 
with the in situ racemization of the slow reacting enantiomer, catalysed by the Ru 
redox catalyst [Ru2(CO)4(µ-H)(C4Ph4-COHOCC4Ph4)] (Shvo’s catalyst) (Scheme 7). 
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SCHEME 7. Dynamic kinetic resolution of alcohols 13 and 14. Reaction conditions: toluene, Ar, 4-
chlorophenylacetate, CAL-B, [Ru2(CO)4(µ-H)(C4Ph4COHOCC4Ph4)], 70°C. 
Unlike KR, the DKR strategy needs p-chlorophenylacetate as the acyl donor, because 
this reagent is very mild and does not affect the ruthenium complex. The use of vinyl 
acetate or iso-propenylacetate in fact, causes oxidation of the alcohol substrate due to 
the reactivity of acetaldehyde and acetone as hydrogen acceptors, this limiting the 
yield of the acetylation. On the other hand, activated esters bearing protons in the α-
position such as trichloroethyl- or trifluoroethylacetates, which are frequently used in 
the transesterification of alcohols, are not suitable in combination with Ru(II) since the 
alcohol released interfere with the ruthenium catalyst.  
Aryl esters such as p-chlorophenylacetate avoid the problem encountered with 
vinylacetates and with activated trihaloethylacetates and have been used 
successfully.22a 
The DKR reached a complete conversion, enantioconverging to the acetates (R)-15 and 
(R)-16 as unique products. These were isolated in 70% yield (not optimized) after 
column chromatography 
Hydrolysis under mild basic conditions of the optically active esters gave the 
corresponding enantiopure secondary alcohols (R)-13 and (R)-14, in 70% overall yield 
from the racemic alcohols (Table 4). The (R) configuration of the compounds thus 
obtained results from the well-known preferential recognition of (R) enantiomers by 
CAL-B,21 and was confirmed by chirooptical techniques (α, CD).23 
 
 
 
 
                                                      TABLE 4. summary of DKR data. 
Substrate Conversion (%) 
(R)-alcohol[a]  
e.e.% (yield %)    
(±)-13 93 13[b]  >99.9(70) 
(±)-14 92    14[c]    > 99 (70) 
Reaction conditions: see Scheme 7. [a] From ester hydrolysis under basic conditions. [b] The conversion 
and e.e.% were determined by HRGC analysis. [c] The conversion was determined by HRGC analysis, 
e.e.% (after hydrolysis of (R)-16) was determined from the 1H NMR analysis of the corresponding 
Mosher’s ester. 
 
2.6. CONVERSION OF THE ALCOHOLS TO THE AMINES  
To obtain the target amines (S)-4 and (S)-5 in an optically pure form from the 
homochiral alcohols 13 and 14, different attempts were made involving an SN2 
strategy (Scheme 9) with inversion of configuration. Classical Mitsunobu conditions, 
lead to a complex mixture of unidentified products. Therefore the homochiral alcohols 
(R)-13 and (R)-14 were first converted into the corresponding  azides (S)-17 and (S)-
18. This transformation was best carried out with diphenylphosphoroazidate (DPPA) 
in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) (Scheme 9, entry 4).26 
These conditions lead to a clean SN2 inversion, avoiding racemization and olefin 
formation, which are commonly observed in the classical Mitsunobu reaction. The 
reaction mechanism takes place in two discrete steps (Scheme 8), the first being the 
formation of a phosphate intermediate (19) followed by releasing of the N3- from the 
hindered DBU salt (20). 
Ar
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SCHEME 8. Nucleophilic displacement. Reaction conditions: toluene, DPPA, DBU, 0-50°C.  
 
By this procedure, alcohols (R)-13 and (R)-14, having >99.9% e.e. and >99% e.e. 
respectively, were converted into the corresponding azides (S)-17 and (S)-18, with 
only a slight erosion of the enantiomeric purity, which dropped to 97% and 95% 
respectively. 
On the other hand, conversion of  the alcohols to the azides through the corresponding 
methansulphonate (entry 2) or with PPh3, DIEA, DPPA (entry 3)25 dramatically 
decreased the enantiomeric purity to an approximately 50% e.e. value (Scheme 9).  
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SCHEME 9. Attempted Mitsunobu reactions. Reactions conditions: Entry 124: (a) phtalimide, PPh3, THF, 
DIEA; (b) NH2NH2*H2O, EtOH, reflux. Entry 2: (c) CH3SO2Cl, Et3N; (d) NaN3, 18_crown 6; (e) PPh3, 
THF/H2O. Entry 3: (f). PPh3, DIEA, DPPA; (e) PPh3, THF/H2O. Entry 4: (g) DPPA, DBU, 0°C-50°C, 
(e) PPh3, THF/H2O.  
 
Finally, conversion of the azides (S)-17 and (S)-18 into the corresponding amines (S)-4 
(97% e.e.) and (S)-5 (95% e.e.) was carried out by treatment with Ph3P in refluxing 
THF/H2O.27  
The best results observed in the conversion of the optically pure sec-alcohols (R) and 
(S)-13,14 into both enantiomers of the corresponding amines (R) and (S)-4,5 are 
summarized in the following table (Table 5).  
 
 
 
 
 
 
                                 TABLE 5. Enantiomeric excesses of azides 17 and 18 and amines 4 and 5. 
Alcohol e.e.% Azide                   
e.e.%  (yield %) 
Amine               
e.e.%  (yield %) 
(R)-13    > 99.9 (S)-17[a]     97(75) (S)-4         97 (95) 
(S)-13    > 99.9 (R)-17[a]   > 99.9 (75) (R)-4       > 99.9 (95) 
(R)-14    > 99 (S)-18        95 (75) (S)-5[b]       95 (95) 
(S)-14      86 (R)-18        80 (75) (R)-5[b]       80 (95) 
Reaction conditions: see Scheme 9, entry 4. [a] e.e.% was determined by chiral HRGC analysis. [b] 
e.e.% was determined from the 1H NMR analysis of the corresponding mandelic amide. 
 
The e.e. % values reported for (R)- and (S)-4 were determined directly by HRGC (β-
cyclodextrin) analysis of the azides intermediates (R)-17 and (S)-17, while in the case 
of (R)-5 and (S)-5, derivatization into the corresponding mandelic acid amide 
derivative, followed by 1H-NMR analysis of the diastereoisomeric mixture obtained 
was necessary.  
The CD spectra of chiral ligands (S)-4 and (S)-5 thus obtained support the 
configurational assignments (Figure 3). In particular, the Cotton effect for at 280 nm is 
the same for both ligands, suggesting that they have the same configuration. The same, 
of course, must be true for all of their precursors. As the (R) configuration had already 
been attributed to the acetate 15 derived from the CAL-B catalyzed transesterification 
of racemic alcohol 13, the same configuration can also be assigned to the acetate 16 
derived from the kinetic resolution of 14.  
-8000
-6000
-4000
-2000
0
2000
4000
6000
8000
200 220 240 260 280 300 320 340
E
ll
ip
. M
o
l.
wavelength (nm)
 
(R)-4 ee%>99.9%
N
NH2
(S)-4 ee%=97%
N
NH2
N
NH2
N
NH2
(S)-5 ee%=95%(R)-5 ee%=80%
 
FIGURE 3. CD spectra of the four optically pure CNN pincer ligands (2.5 × 10-4 M in CH3OH). 
  
 
2.7. SYNTHESIS OF NEW CNN PINCER LIGANDS 
As an extension of this work,  we have synthesized new chiral CNN pincer ligands, 
analogous to 1-[6-phenylpyridin-2-yl]methanamine (sp2 and sp3 N donor atoms), 
having different steric and electronic properties, in order to investigate their effect on 
the formation of the [MCl(CNN)(PP)] complexes (M = Ru/Os) and on the catalytic 
activity of the relative complexes. These new pincer CNN ligands differed in the 
nature of the aryl group at position 6, which ranged from 1- and 2-naphtyl (derivatives 
4a,b) to differently substituted phenyl groups (derivatives 4d-h)  
The aim of this part of the work was to generate a library of new Ru(II) and Os(II) 
catalysts using commercially available chiral diphosphines, in search of the correct 
combination of the electronic and steric effects of the disphosphines and of the pincer 
ligand to achieve the best  catalytic system in transfer hydrogenation reactions.  
 
M
o
l.
 E
ll
ip
. 
N
NH2
N
NH2
N
NH2
H3CO
N
NH2
N
NH2
F3C
CF3
N
NH2
F3C
N
NH2
N
NH2
4a 4b
4c 4d
4e 4f
4g 4h
 
 
FIGURE 4.  
 
The strategy for the synthesis of ligands 4a-h, starting from the commercially available 
ketone 2-acetyl-6-bromo pyridine (Scheme 10) involved the application of the 
stereocomplementary biocatalytic approaches described above, to the obtainment of 
the alcohol (R)- and (S)-14, which were key intermediates to the final amines 4a-h. 
These have been obtained with a very high optically purity in both the enantiomeric 
forms, by Suzuki coupling between the appropriate commercial boronic acid and (S)-
21 and (R)-21, enantiomers of 1-(6-bromopyridin-2-yl)ethanamine, derived from the 
alcohol intermediates (R)-22 and (S)-22 respectively.  
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SCHEME 10. General strategy for the synthesis of chiral not racemic pincer ligands 4a-h. 
B.Y. asymmetric bioreduction of 2-acetyl-6-bromopyridine under the conditions 
discussed above, occurred in accordance with the Prelog’s rule to give (S)-(+)-1-(6-
bromopyridin-2-yl)ethanol ((S)-22). The reaction reached a complete conversion (99 
%) in a very short time (24 h), this allowing the alcohol (S)-22 to be isolated in a 96% 
enantiomeric excess (Scheme 11) and 80% yield after purification.  
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SCHEME 11. Reaction conditions: dry baker’s yeast, saccharose, phosphate buffer Na2HPO4/KH2PO4 pH 
7.4,  substrate concentration 3.6 mM.  
  
On the other hand, CAL-B mediated DKR of the racemic alcohol rac-22, in the 
presence of Shvo’s catalyst, lead to optically pure (R)-(‒)-1-(6-bromopyridin-2-
yl)ethanol ((R)-22) obtained in 98% enantiomeric excess after hydrolysis of the acetate 
intermediate (R)-23. 
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SCHEME 12. Reaction conditions: (a) DKR: toluene, Ar, p-chlorophenylacetate, CAL-B, [Ru2(CO)4(µ-
H)(C4Ph4COHOCC4Ph4)], 70 °C.22 (b) Basic hydrolysis: K2CO3, H2O/CH3OH.  
The next step in the ligands synthesis was the nucleophilic displacement of the 
hydroxy for the amine group through the azide intermediate (24). Unfortunately 
epimerization occurred under the conditions described previously for amines 4 and 5. 
In fact, starting from the alcohol (R)-22 having 98% e.e., the corresponding (S)-24, 
isolated after the reaction, was shown to have a 85 % e.e. (Table 6, entry 1). An 
accurate screening of all the reaction conditions, including temperature, base, reaction 
time and reactants addition order, (Tables 6,7) allowed to establish the best conditions 
for the nucleophilic substitution, leading to the azide (S)-24 with the maximum e.e.%. 
 
   TABLE 6. Variation on reactant addition order. 
Entry  I addition II addition T (°C) e.e.%
 [a] 
  
Alcohol-22 
e.e.% [a] Azide-24 
(yield %) 
1 DPPA (1.2eq) DBU (1.2 eq) 
0°C  2h  
then 50°C o.n. 
94 90   (74) 
2 DBU (1.2 eq) DPPA (1.2eq) 94 93   (74) 
[a] e.e.% was determined by chiral HRGC analysis. 
 
 
 
 
 
 
 
 
 
       TABLE 7. Conditions variations. 
Entry  Base Conditions e.e.%
 [a] 
  
Alcohol-22 
e.e.% [a]                   
Azide-24 (yield %) 
1 DBU (1.2 eq)  0°C x 2h ₊ 50°C 
o.n. 
98       85      (79) 
2 DBU (1.2 eq) 0°C x 2h ₊ t.a.o.n. 98       97      (70) 
3    DBU (2 eq) 0°C x 2h ₊ t.a.o.n. 98       78      (76) 
4 NaH (1.5 eq) 0°C x 2h ₊ t.a.o.n. 98 NO N3  
5 DBU (1.2 eq)  0°C x 2h ₊ 4°C o.n. 98       98      (12) 
[a] e.e.% was determined by chiral HRGC analysis. 
 
These involved the addition of DBU first, followed by DPPA, at 0 °C. After two hours 
the reaction mixture was allowed to reach room temperature, until complete 
conversion into the azide (S)-24, which was obtained in a slightly lower e.e. with 
respect to the parent alcohol (R)-22 (Table 7, entry 2). Application of this protocol to 
the enantiomeric alcohol (S)-22 (e.e. 96%), allowed the amine (R)-21 to be obtained in 
a 70% yield and 95% e.e..  
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SCHEME 13. Reaction  conditions: (a) DPPA, DBU, 0 °C, r. t.; (b) PPh3, THF/H2O. 
 
After reduction of the azide with PPh3/H2O, the optically active amines (S)-and (R)-21 
so obtained were coupled to different aryl groups via Suzuki coupling with arylboronic 
acids (Scheme 14).  
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SCHEME 14.  Reaction conditions: : n-propanol, K2CO3 2 M, H2O, PPh3, Pd(OAc)2. 
 
 
2.8. ACTIVITY OF RUTHENIUM AND OSMIUM COMPLEXES WITH 
CHIRAL CNN PINCER LIGANDS IN ASYMMETRIC REDUCTION OF 
PROCHIRAL KETONES 
The use of the Ru(II) and Os(II) complexes of the optically pure CNN ligands 
described, in combination with chiral phosphanes, in transfer hydrogenation reaction 
(ATH) and asymmetric hydrogenation (AH) of aromatic and aliphatic prochiral 
ketones was explored by the group of Prof. Rigo and Prof. Baratta (University of 
Udine).  
The results obtained with these new complexes were compared with those previously 
reported using the complexes of the ligands shown in Figure 1. In fact, ruthenium and 
osmium complexes derived from the ortho-metalation of achiral 1-(6-arylpyridin-2-
yl)methanamines,1 had already been found to be highly active catalysts in both AH and 
ATH4a,28 of carbonyl compounds. For instance ruthenium complexes with ligand 2 and 
Josiphos as the chiral diphosphanes, converted quickly (TOF = 1 × 105 h-1) and 
enantioselectively acetophenone into 1-phenylethanol in both ATH and AH processes 
with e.e. up to 90% and 70% respectively.1f 
A method to obtain a Ru(II) complex as a predominantly diasteroisomer (> 92% major 
isomer) from rac-4 has been performed1f, by carrying out the reaction with an excess 
of racemic ligands (4 equiv) in the presence of NEt3 and 0.5 equiv of acetic acid.  
The weak acid proved to facilitate the formation of the thermodynamically most stable 
diastereoisomer, possibly through protonation and decoordination of the ortho 
metalated CNN ligand of the kinetic product.1f 
Control experiments showed that the complexation reaction performed with (R)-4 
(60% e.e.) lead to the same diasteroisomer as the predominant product (Scheme 15). 
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SCHEME 15. Synthesis of complexes 25a and 25b with different phosphanes. Reaction conditions: 
toluene, precursor [RuCl2(PPh3)3], Josiphos, 105°C then CH3COOH, Et3N, 4, refluxed 2-propanol. 
In agreement with reported studies on Ru and Os complexes1, the phosphane of (S,R)- 
configuration (either (S,R)-Josiphos or (S,R)-Josiphos*) was correctly matched with 
the ligand of R configuration in affording derivatives 25a and 25b. Indeed, in order to 
investigate the matched/mismatched ligand effect, the in situ prepared catalytic system 
[RuCl2(PPh3)3]/(R,S)-Josiphos*/(R)-4 afforded a slow reduction of acetophenone to 
(R)-1-phenylethanol (TOF = 3.6 × 104 h-1, 74% e.e.), whereas the use of (S,R)-
Josiphos* led to the S alcohol with a higher rate and enantioselectivity (TOF = 1.6 × 
105 h-1, 94% e.e.). These results and the NMR control experiments indicate that (S,R)-
Josiphos*/(R)-4 is the most correctly matched combination for the catalysis. 
Complexes 25a-b were found to be highly efficient catalysts for the ATH and AH of 
different alkyl-aryl ketones  in alcohol medium (Figure 5). 
 
ROH
R'
O O
OCH3
O
O
A C
G
I
O
ClB
O
OCH3
D
OCH3
O
N
O
CF3
o-E F
O
H
R
OH
R'R
O
R'
O
M
O
L
O
N
H3CO
RR'C=O :
ATH AH
 
FIGURE 5. Asymmetric AH and ATH catalyzed by chiral pincer complexes 25a and 25b and ketones 
used as substrates. Reaction conditions: ATH: [Ru] complexes 25a-b, 2-propanol/NaOi-Pr, 60°C. AH: 
[Ru] complex 25a-b, H2, EtOH or EtOH/CH3OH, 40°C.  
Comparing these results with those observed with complexes containing achiral CNN 
pincer1f ligand, the use of chiral CNN complexes in hydrogen transfer reaction  leads to 
a slight accelleration of the reaction (TOF up to 106 h-1) and a significant increase in 
e.e.% value of the alcohol products (Table 8). 
 
 
 
 
 
 
 
 
 
              TABLE 8. Catalytic ATH of alkyl aryl ketones with 25a-b. 
Entry Complex Ketone Time (min) 
Conv. 
(%)[a] 
TOF    
(h-1)[b] 
e.e. 
(%)[a] 
1 25a A 30 98 1.6 × 105 81 S 
2 25b A 10 98 1.8 × 105 95 S 
3 25b[c] A 30 94 2.1 × 105 95 S 
4 25b B 10 97 1.5 × 105 96 S 
5 25b C 30 97 1.4 × 105 97 S 
6 25b D 10 97 1.8 × 105 98 S 
7 25b[d] D 2 98 1.3 × 106 95 S 
8 25b o-E 30 99 1.2 × 105 93 S 
9 25b F 30 98 1.6 × 105 95 S 
10 25b[c] F 30 96 2.1 × 105 95 S 
11 25b[e] G 5 97 2.0 × 105 97 S 
12 25b[e] H 60 98 5.5 × 104 98 S 
13 25b I 60 98 1.1 × 104 99 S 
Reaction conditions: 0.1 M alkyl aryl ketones, 0.005 mol% 25a-b, 2 mol% NaOi-Pr in 2-propanol as 
solvent, 60°C. [a] The conversion and e.e.% were determined by HRGC analysis. [b] Turnover 
frequency (moles of ketone converted into alcohol per mole of catalyst per hour) at 50% conversion. [c] 
[Ru] = 0.002 mol%. [d] T = 82°C. [e] [Ru] = 0.01 mol%. 
 
Transfer hydrogenation of acetophenone (A), taken as a model substrate under the 
condition indicated the Table 8, afforded optically pure 1-phenyletanol with high TOF, 
(up to 2.1 105 h-1) and good enantioselectivities (up to 95 %.) It is noteworthy that a 
lower loading of the bulky complex 25b (0.002 mol %, 30 min) did not affect the 
reaction rate and the enantioselectivity (entry 3). 25b also catalyzed the 
enantioselective reduction of different alky aryl ketones always in good rate (up to 1.3 
× 106 h-1, entry 7) and excellent enatiomeric excess (up to 99%, entry 13). The 
configuration of the alcohol products was S in all cases. 
Interestingly, the chiral pincer complex 25b dispalyed high catalytic activity also in the 
asymmetric hydrogenation of ketones in ethanol or methanol/ethanol mixtures, under 5 
atm of H2 (Table 9).   
 
TABLE 9. Catalytic AH of alkyl aryl ketones with 25a-b. 
Entry Complex Ketone Solvent Time (min) 
Conv. 
(%)[a] 
TOF      
(h-1)[b] 
e.e. 
(%)[a] 
1 25a[d] A EtOH 60 > 99 1.7 × 104 77 S 
2 25b[d] A MeOH/EtOH 3:7 30 > 99 2.8 × 104 87 S 
3 25b[d] A MeOH/EtOH 1:1 30 > 99 3.3 × 104 90 S 
4 25b L MeOH/EtOH 1:1 20 99 3.8 × 104 93 S 
5 25b M MeOH/EtOH 1:1 30 99 3.0 × 104 90 S 
6 25b N MeOH/EtOH 1:1 30 > 99 2.9 × 104 91 S 
7 25b G MeOH/EtOH 1:1 30 > 99 3.6 × 104 93 S 
8 25b I MeOH/EtOH 1:1 30 > 99 2.5 × 104 99 S 
Reaction conditions: 0.5 M alkyl aryl ketones, 0.02 mol% 25b, 6 mol% KOt-Bu, and 5 atm of H2, 40 °C. 
[a] Ratio by volume. [b] The conversion and e.e.% were determined by HRGC analysis. [c] Turnover 
frequency (moles of ketone converted to alcohol per mole of catalyst per hour) at 50% conversion. [d] 
[Ru] = 0.01 mol%. 
 
The results achieved clearly suggest that the alcoholic solvent plays an important role 
in AH of ketones mediated by pincer complex 25b, improving both the catalytic 
activity and selectivity displayed in the model reaction with acetophenone. In the 1:1 
CH3OH/EtOH mixture, also ketones (A, L, M, N, G, I) have been converted 
completely to the corresponding S alcohol in 20-30 min and with e.e.% reaching 99% 
in the case of I.  
Also Osmium complexes derived from orthometalation of 1-(6-arylpyridin-2-
yl)methanamine ligands have been prepared. These systems were found to be highly 
active catalysts in hydrogenation (AH) as well as in asymmetric transfer hydrogenation 
(ATH) of prochiral carbonyl compounds, with reaction rates comparable to those of 
the analogous ruthenium complexes [RuCl(CNN)(diphosphane)].1 It is worth noting 
that on account of the stronger bonding ability, osmium is thought to give more stable 
and less active catalysts29 compared to ruthenium for hydrogenation and transfer 
hydrogenation of ketones.30  
Based on the excellent catalytic performances of the Ru and Os diphosphane 
derivatives containing an achiral CNN benzo[h]quinoline type ligand,1d a particular 
attention has been given to the 2-aminoethylbenzo[h]quinoline framework, 
characterized by a higher conformational rigidity, compared to CNN ligands 
containing the 2-arylpyridine moiety. 
In order to isolate a catalysts displaying the highest enantioselectivity, the optically 
pure ligand 5 was employed in combination with a Josiphos ligand. Also in this case 
the best matching ligand effect was obtained by (S,R)-phosphane and the ligands with 
R configuration. The derivative 26 was prepared by reaction of [OsCl2(PPh3)3] with the 
bulkier diphosphane (S,R)-Josiphos* (Scheme 16). 
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SCHEME 16. Synthesis of Os(II) complexes 26. Reaction conditions: mesitylene, precursor 
[OsCl2(PPh3)3], Josiphos*, 110°C, then 5, Et3N and 140°C.  
 
The complex 26 was isolated as a single stereoisomer in 64 % yield. The coordination 
chemistry and the catalytic potential of the new chiral pincer complexes have been 
tested. The selective hydrogenation (AH) of aryl-alkyl ketones (A, C, G, I in Figure 6) 
to secondary alcohols in methanol or methanol/ethanol mixtures was catalyzed by 26. 
The results are reported in Table 10, compared with those obtained for the previous 
Os(II) and Ru(II) complexes (Os1 and Ru1 in Figure 6). 
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FIGURE 6. Ru and Os complexes of achiral benzo[h]quinoline type CNN pincer ligands. 
 
TABLE 10. Catalytic AH of alkyl aryl ketones with 26. 
 
Entry Complex Ketone T (°C) Time (min) 
Conv. 
(%)[a] 
TOF      
(h-1)[b] e.e.(%)
[a]
 
1 Ru1 A 40 30 > 99 4.3 × 104 92 S 
2 Ru1 C 40 60 > 99 1.6 × 104 94 S 
3 Ru1 G 40 30 95 5.6 × 104 93 S 
4 Ru1 I 40 60 97 2.0 × 104 > 99 S 
5 Os1 A 70 30 > 99 2.0 × 104 86 S 
6 26 A 70 60 97 1.4 × 104 92 S 
7 26 in situ[c] A 70 30 > 99 2.4 × 104 90 S 
8 26 in situ[c] C 70 30 > 99 2.2 × 104 91 S 
9 26 in situ[c] G 70 30 > 99 1.6 × 104 94 S 
10 26 in situ[c] I 70 60 > 99 1.3 × 104 > 99 S 
Reaction conditions: Ketone/complex/KOtBu = 10000/1/200, H2 5 atm, solvent = CH3OH/EtOH mixture 
(7:3 by volume). [a] The conversion and e.e. were determined by HRGC analysis. [b] Turnover 
frequency (moles of ketone converted to alcohol per mole of catalyst per hour) at 50 % conversion. [c] 
[OsCl2(PPh3)3]/(S,R)-Josiphos*/benzo[h]quinoline = 1/1.5/2. 
 
For the best performances, methanol/ethanol mixtures were used in analogy with the 
case of the chiral CNN Ru complexes catalysed reactions1e,f  
The system 26 was an efficient catalyst for the reduction of acetophenone A, which 
was rapidly and selectively converted to (S)-1-phenylethanol in 92% e.e. (TOF = 1.4 × 
104 h-1) as in the case of the reaction catalyzed by Ru1. A good catalytic performance 
was also observed with a Os/Josiphos*/(R)-benzo[h]quinoline system prepared in situ, 
in CH3OH/EtOH mixture and using KOt-Bu/Os = 200. As a matter of fact, treatment 
of [OsCl2(PPh3)3] with the bulky (S,R)-Josiphos* in refluxing CH3OH/EtOH for 3 h, 
followed by the addition of 5 (1 h), lead to a chiral Os system which catalyzed the 
asymmetric hydrogenation of A affording in 30 min the corresponding (S)-alcohol 
with 90 % e.e. and TOF = 2.4 × 104 h-1 (Table 10, entry 7). These results improve the 
ones obtained with the isolated complex Os1 containing the less bulky (S,R)-Josiphos 
and the achiral pincer ligand 2-aminomethylbenzo[h]quinoline (see Figure 6). By 
employment of the in situ generated osmium catalyst 26 the ketones C, G and I have 
been fast reduced to the corresponding (S)-alcohols with 91-99 % e.e.  
The Os benzo[h]quinoline based complexes 26 showed the same enantioselectivity for 
both AH in methanol/ethanol and ATH in 2-propanol. Thus, the Ru1 complex 
catalyzed the reduction of A to S-alcohol with 92 vs. 96 31 % e.e. in AH and ATH 
respectively, whereas the Os derivative Os1 and the corresponding 26-“in situ” 
system31 led to 86 and 80 % e.e., respectively  
Compared with Ru1 and Os1, complex 26 shows a better enantioselectivity in the AH 
of A with (in particular with respect to Os1). Furthermore, the stronger bonding of 
osmium allowed to operate at higher temperature (70 °C), compared to ruthenium (40 
°C). 
The optically pure ligands (S)-4a-b and (S)-4e-h have been employed in the transfer 
hydrogenation reaction of acetophenone in both Ru(II) and Os(II) systems formed in 
situ. In these cases the best combination was with (R,S)-Josiphos*. The reactions were 
performed at 60°C in 2-propanol with 2% mol NaOi-Pr. The pre-catalysts systems 
consist on [MCl2(PPh3)3]/(R,S)-Josiphos*/CNN (where M = Ru or Os). The results are 
listed in Table 11. 
 
 
 
 
 
 
 
 
 
TABLE 11. Catalytic ATH of acetophenone (0.1M) with the systems [MCl2(PPh3)3]/(R,S)-
Josiphos*/ligand. 
  Precursor RuCl2(PPh3)3 Precursor OsCl2(PPh3)3 
Entry  Ligand Conv. (%)[a] 
Time 
(min) 
TOF      
(h-1) [b] 
e.e. 
(%)[a] 
Conv. 
(%)[a] 
Time 
(min) 
TOF       
(h-1) [b] 
e.e. 
(%)[a] 
1 4a 98 30 1.5 × 105 90 R 97 60 1.5 × 105 87 R 
2 4b 95 60 6.5 × 104 85 R 70 120 6.6 × 104 81 R 
3 4e 97 30 1.3 × 105 86 R 96 60 1.2 × 105 85 R 
4 4f 95 30 6.5 × 104 85 R 76 120 6.0 × 104 83 R 
5 4g 27 120 ‒ 84 R 39 120 ‒ 75 R 
6 4h 4 60 ‒ ‒ 8 60 ‒ ‒ 
Reaction conditions: Os: 0.005 mol %, Ru: 0.005 mol % and NaOi-Pr (2 mol %) in 2-propanol at 
60°C.[a] The conversion and ee were determined by GC analysis. [b] turnover frequency (moles of 
ketone converted into alcohol per mole of catalyst per hour) at 50% conversion.  
 
The reduction product was in each case (R)-1-phenylethanol with e.e. % up to 87 %. 
The data collected in the table clearly suggest that the Ru complexes of ligands 4g and 
4h (entries 5 and 6) are not efficient catalysts for the reduction of acetophenone. The 
double 3,5-disubstitution of the phenyl group results infact in a dramatic decrease of 
the productivity, which is undependent on the different electronic properties of the -
CH3 and -CF3 groups, but is a consequence of the steric effect of the substituents at the 
meta position of the aromatic ring. On the contrary, different substituents at the para 
position of the phenyl group, played a relevant role on the catalysis. In fact, both 
Ru(II) and Os(II) complexes with ligand 4e (entry 3), bearing the strong electron-
releasing methoxy group, reduced acetophenone with a double rate (TOF = 1.3 × 105  
h-1) with respect to the case of the analogue complexes of ligand 4f (entry 4, TOF = 6.5 
× 104  h-1) in which the strong electron-withdrawing effect of the CF3 group affects the 
stability of the M-C σ-bond. 
Of the ligands 4a and 4b (entries 1 and 2), having similar electronic properties but a 
different geometry of the naphtylic residue, 4a gave the most productive and selective 
Ru and Os complexes, which displayed the highest TOF (1.5 × 105  h-1 in each cases) 
and gave the products with the highest enantiomeric excesses (up to 90%). Moreover 
the variation of the geometric requirements in going from 4a to 4b had a stronger 
effect on the Os complexes. 
On the basis of the good results obtained using ruthenium and osmium-4a “in situ” 
catalytic systems, the Ru(II) and Os(II) complexes with pincer ligands 4a and chiral 
phosphane were isolated and tested in the transfer hydrogenation reaction of different 
prochiral ketones (Figure 7). 
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FIGURE 7. 
 
The best results have been obtained in the catalytic ATH on aryl-alkyl ketones, while 
complexes 27 and 28a-b showed a low activity in the reduction of diaryl and dialkyl 
ketones. The substrates chosen are shown in Figure 8, in addition to those already 
reported in Figure 5. 
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FIGURE 8. 
Complexes 27 and 28a-b showed good activity and selectivity giving the optically 
pure (R)-products with high enantiomeric excess (up to 99 %, Table 12).  
 
 
 
 
 
 
             TABLE 12. Catalytic ATH of alkyl aryl ketones with 27, 28a-b. 
 
 
 
Entry Complex Ketone Conv. (%)[a] 
Time 
(min) TOF(h
-1) [b] e.e. (%)[a] 
1 
27 
A 
95 30 1.15 × 105 92 R 
28a 96 30 2.5 × 105 89 R 
28b 97 30 3.2 × 105 91 R 
2 
27 
C 
96 60 9.0 × 104 94 R 
28b 97 30 2.0 × 105 99 R 
3 
27[f] 
D 
97[i] 1 1.8 × 106 91 R 
27 97 30 2.5 × 105 95 R 
28b[g] 97[i] 10 9.0 × 105 97 R 
4 
27 
o-E 
93 60 3.9 × 104 86 R 
28b 99 30 1.2 × 105 91 R 
5 
27[h] 
m-E 
99 30 6.6 × 104 92 R 
28b[h] 99 30 7.6 × 104 90 R 
6 
27[c][h] 
p-E 
99 10 1.2 × 105 97 R 
28b[c][h] 99 10 8.3 × 104 97 R 
7 
27 
F 
99 30 2.6 × 105 96 R 
28b 99 10 1.8 × 105 94 R 
8 
27[c] 
G 
96 30 1.6 × 105 93 R 
28b[c] 96 10 3.4 × 105 99 R 
9 
27 
H 
98 30 4.7 × 104 96 R 
28b 98 30 5.9 × 104 96 R 
             TABLE 12. Continuation. 
Entry Complex Ketone Conv. (%)[a] 
Time 
(min) TOF(h
-1) [b] e.e. (%)[a] 
10 
27 
I 
90 120 7.7 × 104 99 R 
28b 93 30 1.4 × 105 99 R 
11 
27[c] 
O 
80 60 2.5 × 104 96 R 
28b[c] 93 60 5.9 × 104 94 R 
12 
27 
P 
99 30 1.25 × 105 99 R 
27[f] 99[i] 2 8.4 × 105 99 R 
28b[g] 99[i] 180 
‒ ‒ 
28b[f] 99[i] 3 4.8 × 105 99 R 
13 
27[c][h] 
Q 
99 60 1.9 × 104 98 R 
28b[c][h] 99 30 5.1 × 104 98 R 
[a] The conversion and e.e. % were determined by HRGC analysis. Reaction condition: NaOi-Pr (2 mol 
%) in 2-propanol at 60 °C. [b] Turnover frequency (moles of ketone converted to alcohol per mole of 
catalyst per hour) at 50% conversion. [c] substrate/M/base = 10000/1/200. [d] substrate/M/base = 
5000/1/100. [e] substrate/M/base = 2000/1/40. [f] Reaction at reflux. [g] Reaction at reflux 
substrate/M/base = 50000/1/1000. [h] In situ reaction. [i] T = 100 °C. 
 
Both ruthenium and osmium complexes were efficient systems for ATH process, in 
particular complex 28b with a bulkier diphosphane showed a better activity and 
selectivity with respect to the corresponding complex 28a, in analogy with the data 
previously reported for complexes 25a-b. Catalyst 28b reduced acetophenone (entry 1) 
with high TOF value (TOF = 3.2 × 105 h-1) and selectivity (e.e. 91 %), comparable to 
the Ru(II) derivatives 27.  
Reactions reached conversion up to 99% in all cases but one (entry 11), and displayed 
very high enantioselectivity (e.e.% up to 99%). It is worth noting that pincer catalysts 
with ligand 4a displayed TOF (105-106 h-1) and enantiomeric excesses comparable with 
those of 25a-b Ru complexes. Interestingly, Os complex 28b gave the alcohols product 
with the best enantiomeric excess (see Table 12 entries 2, 8, and Table 8 entries 5, 11).    
2.9. CONCLUSIONS 
A new series of chiral CNN-pincer ligands have been synthesized in good yield and 
optical purity (e.e. from 80% to > 99%) through the sec-alcohol intermediates obtained 
in turn by two enantiocomplementary biotransformation procedures, such as the 
baker’s yeast bioreduction of the parent prochiral ketones and the lipase catalyzed 
dynamic kinetic resolution of rac-alcohol mixtures.  
The best conditions for a SN2 conversion of the homochiral sec-alcohol to the 
corresponding amine ligands, with a clean inversion of configuration were found. 
Chiral complexes 25a-b, 26, 27 and 28a-b, of general formula [MCl(CNN)(PP)] 
(where M = Ru or Os), were formed by coordination of the synthesized pincer ligands 
and chiral Josiphos-type diphosphane. They were isolated and tested in the 
enantioselective reduction of different alky-aryl prochiral ketones. High e.e. % values 
(up to 99%) have been achieved in ATH with a remarkably high rate (TOF = 105-106 
h-1) and low catalyst loading (0.005–0.002 mol%) using complexes 25a-b. By 
changing the reaction conditions (0.02–0.01 mol% of Ru) pincer complex 25a-b were 
also used in the AH of ketones with H2 (5 atm), where they displayed a very high 
degree of stereoselctivity. Under the same conditions the Os(II) complex 26, of the 
rigid tricyclic ligand 5, was active (TOF = 104 h-1).in AH reactions producing the 
alcohol products with excellent e.e. % (> 99%). The group of optically pure aryl-
pyridine-type pincers were tested in the reduction of acetophenone with ATH 
mechanism, forming in situ Ru and Os catalysts. The results obtained suggest a strict 
dependence of the complexes activity on the steric and electronic characteristics of the 
different aryl rings. In particular Ru and Os complexes with ligand 4a displayed  the 
best activity, thus complex 27 and 28a-b were isolated and used in ATH reactions. The 
data observed showed that the activity of complexes 27 and 28a-b is comparable to the 
one of complexes 25a-b in transfer hydrogenation process.   
On account of the remarkably high activity and productivity of these complexes, that 
could be applied both in ATH and AH reduction processes, this class of ruthenium and 
osmium derivatives have good potential for application in homogeneous asymmetric 
catalyst. 
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Results and Discussion 
 
Chapter 3: 
Synthesis and application of pyridine ligands 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1. SYNTHESIS OF PYRIDINE LIGANDS FOR CO-OLIGOMERIZATION 
REACTION 
During the last two decades, the co- and terpolymerization reaction of carbon 
monoxide with terminal aliphatic and aromatic alkenes has attracted much interest  
from both academic and industrial point of view.1 The products of this reaction are 
perfectly alternating polyketones (Scheme 1).  
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SCHEME 1. The  CO/alkene copolymerization. 
 
It is well known that when carbon monoxide is copolymerized with an aromatic 
alkene, like styrene or its substituted derivatives, the best performing catalytic systems 
are based on palladium complexes with bidentate nitrogen donors ligands.1c For the 
synthesis of syndiotactic CO/styrene copolymers, the best performing catalysts are 
based on Pd-complexes either with pyridine-imidazoline ligands2,3 or with 1,10-
phenanthrolines.4,5 In the latter case, the introduction of fluorine atoms in positions 5 
and 6, obtaining the 5,5,6,6-tetrafluoro-5,6-dihydro-1,10-phenanthroline, led to a long-
lived catalysts with a lifetime longer than 96 h, yielding a polyketone with a high 
degree of stereoregularity (96% content of uu triad) and molecular weight up to 
1000000.6 When the substituents are on ortho positions with respect to the nitrogen 
donor atoms, like in the 2,9-dimethyl-1,10-phenanthroline or in the 6-R-2,2'-bipyridine 
(R = CH3, Et, i-Pr), the related palladium complexes did not show any catalytic 
activity in the CO/vinyl arene copolymerization.7 
Whereas there is an extensive literature on the synthesis of polyketones from carbon 
monoxide and aromatic alkenes, to the best of our knowledge, few data have been 
reported on the synthesis of the corresponding oligomers. The synthesis of low 
molecular weight compounds starting from CO and styrene, obtained as esters like the 
dimethyl-2-phenylbutanedioate, dimethyl-2,5-diphenyl-4-oxo-pimelate and 2-
oxoglutarates, was achieved by using Pd-phenanthroline or Pd-diphosphine complexes 
in the presence of a large excess of 1,4-benzoquinone (BQ)8,9 or under high pressure of 
carbon monoxide (350 bar).10 On the other hand, the corresponding co- and ter- 
oligomers with terminal aliphatic alkenes, like ethylene and propylene, have been 
exploited at industrial level under the trademark of Carilite®.11 They show a range of 
potential applications, and among them the most promising, after proper curing, being 
an adhesive for wood.12   
With the aim to investigate in more detail the effect of the substituents on ortho 
position with respect to the N-donors, the new chiral 6-(1-methoxyethyl)-2,2'-
bipyridine (29) ligand, both as a racemate and in the enantiopure R and S forms, has 
been synthesized. The coordination chemistry of 29 to Pd(II) has been studied and 
compared with that of the known 6-iso-propyl-2,2'-bipyridine (31), rac-6-sec-butyl-
2,2'-bipyridine (rac-32), and the new achiral 2-(methoxymethyl)-6-(1H-1,2,3-triazol-1-
yl)pyridine (30) (Figure 1).  
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FIGURE 1. The studied bipyridine and pyridine-triazole ligands. 
 
The catalytic behavior of the corresponding monocationic organometallic Pd(II) 
complexes [Pd(CH3)(CH3CN)(N-N')][PF6] and [Pd(CH3)(N-N')2][PF6] (N-N' = 29-32) 
in styrene carbonylation was analyzed in detail, together with some mechanistic 
investigations on their reactivity with carbon monoxide. 
 
3.2. SYNTHESIS OF THE PYRIDINE TYPE LIGANDS 
Racemic ligand rac-29 was synthesized from ketone 33 obtained following a literature 
procedure (Scheme 2).13 Ketone 33 was the parental compound also for optically pure 
(R) and (S)-29 that have been afforded by chemoenzymatic methods. 
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SCHEME 2. Synthesis of the ketonic precursor 33. Reaction conditions: Step 1: (a) i. 1 M NaOH, EtI, 
room temperature; ii. magnesium monoperoxyphthalate, CH3OH, 0 °C. Step 2: (b) ethane-1,2-diol, 4-
toluensulfonic acid, benzene, reflux; (c) n-butyl-lithium, THF, -70 °C. Step 3: (d) i. THF, 25 °C; ii. 2M 
HCl, 60 °C. 
 
Steps 1 and 2 involved two commercially available compounds: 2-mercaptopyridine 
(34) and 2-acetyl-6-bromopyridine (8). The first step was the oxidation of 2-
mercaptopyridine into 2-(ethylsulfinyl)pyridine (35) by reaction with 1-iodoethane in 
basic medium and then with magnesium monoperoxyphthalate in methanol. Step 2 
consisted on the protection of the carbonyl group as acetal with 1,2-ethandiol and p-
toluensulfonic acid obtaining Br-36 that has been lithiated at -70°C achieving the 
active species Li-36. Products Li-36 and 35 were coupled at room temperature and, 
after deprotection of acetal under acid conditions, ketone 33 was isolated.  
The desired methyl ether rac-29 was synthesized in high yield by reduction of the 
carbonyl group of 33, under standard conditions (NaBH4 in EtOH at r. t.), followed by 
methylation of the corresponding alcohol 37 with CH3I and NaH (Scheme 3). 
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SCHEME 3. Synthesis of the racemic bipyridine ligand rac-29. Reaction conditions: (a) NaBH4, EtOH; 
(b) NaH, CH3I, THF. 
The homochiral (R)-29 and (S)-29 were synthesized starting from 33 by 
chemoenzymatic methods, leading first to the alcohol intermediates (R)-37 and (S)-37. 
As shown in the case of pincer ligands, enantiomerically pure secondary alcohols are 
efficiently prepared from prochiral ketones by asymmetric microbial reduction with 
baker’s yeast (Saccharomyces cerevisiae),14 or, in a widely used alternative, by the 
lipase-catalyzed resolution of racemic sec-alcohols, by enantioselective acylation of 
the hydroxylic function.15  
Based on the results obtained by us in the synthesis of chiral 1-heteroarylethanols in 
both enantiomeric forms by application of these biotransformation procedures,16(see 
Chapter 2) and on the high selectivity already observed in the lipase-catalyzed 
transesterification of 37,17 we carried out the dynamic version of the reported classical 
kinetic resolution of rac-37 by using Novozyme® 435 (Candida antarctica lipase B 
(CAL-B), immobilized on polyacrylamide) and the bioreduction with full cells of 
Saccharomyces cerevisiae (Scheme 4). 
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SCHEME 4. Synthesis of optically pure bipyridine ligands with chemoenzymatic methods. Reaction 
conditions: (a) baker’s yeast, saccharose, phosphate buffer pH 7.4, 37 °C; (b) NaH, CH3I, THF; (c) 
NaBH4, EtOH; (d) p-chlorophenylacetate, toluene, 70 °C, [Ru2(CO)4(µ-H)(C4Ph4COHOCC4Ph4)], 
Novozyme® 435; (e) H2O/EtOH K2CO3. 
 
DKR with p-chlorophenylacetate as the acyl donor, in the presence of the Ru-based 
redox catalyst [Ru2(CO)4(µ-H)(C4Ph4-COHOCC4Ph4] (Shvo’s catalyst) reached the 
complete conversion in 48 h, giving the corresponding (R)-acetate 38 with excellent 
optical purity (e.e. > 99.9%) and in 70% yield (not optimized) after column 
chromatography. Its hydrolysis under mild basic conditions (aq. K2CO3) gave the 
corresponding enantiopure secondary alcohol (R)-37 in 70% overall yield from the 
racemic alcohol 37. The (R) configuration of this compound was verified by 
comparison with the reported optical rotation data.17 This result confirms the well 
known enantiopreference of CAL-B for the (R) enantiomers of benzylic sec-alcohols.18  
As already observed by us,16 baker’s yeast (Saccharomyces cerevisiae) reduction of 
the prochiral ketone 33 proceeded in an enantiocomplementary fashion, allowing the 
obtainment of the opposite enantiomer (S)-37 with comparable high stereoselectivity 
and yield. The reduction was run under fermenting conditions, (37 °C, saccharose, 
phosphate buffer, pH 7.4), reaching 93% conversion in 48 h. As predicted from the 
Prelog’s rule, it afforded the alcohol in the S configuration,19 isolated in 99% e.e., and 
75% yield after purification. The methylation of the homochiral (R)-37 and (S)-37, as 
described above, gave the target ligands (R)-29 and (S)-29 in both cases in 68% and 
74% overall yield, respectively, from ketone 33.  
An alternative procedure for the synthesis of both racemic and optically pure 29 have 
been developed. Following the procedure already reported in Chapter 2 (Chapter 2: 
Figures 11 and 12), rac-, (S)- and (R)-22 were synthesized. After alcohol methylation, 
the derivative 39 was lithiated and coupled with 35 affording product rac-, (S)- and 
(R)-29 (Scheme 5) in the same yield obtained using the strategy previously reported 
(see Schemes 2 and 3).  
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SCHEME 5. Alterantive synthesis of ligand 29. Reaction conditions: (a) NaH, CH3I, THF. (b) n-butyl-
lithium, THF, -70°C. (c)  THF, 25°C. 
 
The synthesis of the achiral ligand 30 started from the known alcohol 40,20 which was 
the product of NaBH4 reduction of the commercial 6-bromopicolinaldehyde (Scheme 
6). The alcohol 40 was transformed into the acetylene 41, following a procedure 
described in the literature for an analogous transformation,21 which concerned a 
[Pd(PPh3)4]/CuI promoted coupling with trimethylsilylacetylene, followed by 
desilylation to 42 with Bu4NF in THF. The conversion into the 1-methyl-1H-1,2,3-
triazolederivative 43 was run through a microwave-assisted copper(I)-catalyzed three-
component reaction, involving the acetylene 42, sodium azide and CH3I, which 
afforded with complete regioselectivity the triazolylpyridine 43.22 The OH methylation 
was reached under the conditions described previously for 37 (Scheme 3), accessing 
the target ligand 30 in a 50% overall yield from the aldehyde. 
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SCHEME 6. Synthesis of the achiral pyridine ligand 30. Reaction conditions: (a) NaBH4, EtOH; (b) 
trimethylsilylacetilene, [Pd(PPh3)4] (cat), CuI/NEt3; (c) Bu4NF; (d) CH3I, NaN3, t-BuOH, H2O, MW; (e) 
CH3I, NaH, THF, 0°C. 
Ligands 31 and rac-32 were synthesized in the Prof. Gladiali’s group (University of 
Sassari).23 
 
3.3. SYNTHESIS OF THE Pd(II) COMPLEXES WITH LIGANDS 29-32 
The synthesis of the monocationic Pd(II) complexes [Pd(CH3)(CH3CN)(N-N')][PF6] 
29b-32b was performed in the Dr. Milani’s group (University of Trieste) starting from 
[Pd(CH3COO)2] and following the five-steps procedure reported in the literature,6 
which involves a dehalogenation reaction of the neutral derivatives [Pd(CH3)(Cl)(N-
N')] 29a-32a (N-N' = 29-32) as last step (Scheme 7).  
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SCHEME 7. Synthesis of the Pd(II) complexes. Reaction conditions: (a) CH2Cl2, r. t.; (b) CH3CN, 
AgPF6, CH2Cl2.   
 
Single crystals of the neutral derivative [Pd(CH3)(rac-29)(Cl)] (rac-29a) were 
obtained at 4 °C, upon the addition of diethyl ether to a methylene chloride solution of 
the complex (Figure 2).  
 
FIGURE 2. ORTEP drawing (ellipsoid 35% probability level) of the complex rac-29a. Coordination 
bond lengths [Å] and angles [°]: Pd-N(1) 2.229(4), Pd-N(2) 2.053(4), Pd-C(11) 2.033(5), Pd-Cl(1) 
2.312(1), N(1)-Pd-N(2) 78.50(16)°, N(1)-Pd-Cl(1) 103.06(11)°, N(2)-Pd-Cl(1) 171.88(11)°, C(11)-Pd-
N(2) 92.9(2)°, C(11)-Pd-N(1) 171.3(2)°, C(11)-Pd-Cl(1) 85.32(18)°. 
 
The X-ray analysis revealed that the palladium atom attains the usual square planar 
geometry being bound to the chloride, to the methyl group and chelated by the 
nitrogen-atoms of 29. The coordination bond lengths appear in the range usually found 
for Pd(II) complexes.6  
The Pd–N(1) distance trans to the methyl bond is longer by about 0.17 Å with respect 
to the Pd-N(2) distance, due to the trans influence of the methyl group. The pyridine 
rings are twisted with a dihedral angle between the planes of 20°. In the unit cell only 
the isomer with Pd-CH3 bond trans to the Pd-N bond of the substituted pyridine ring 
was found. Both complexes with the two enantiomeric forms of the racemic ligand 
were present. 
Both neutral and monocationic complexes were characterized by elemental analysis, 
and NMR spectroscopy, recording the spectra in CD2Cl2 solution, at room temperature, 
for all complexes, but 30a-b whose spectra were recorded in DMSO-d6 solution at 60 
°C. Coordination to palladium resulted in significant variation of protons chemical 
shifts in comparison with those of the free ligands (Figure 3). 
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FIGURE 3. Protons numbering scheme for complexes 29-32a-b. 
 
The 1H assignments were based on the number of signals, on their integration, on NOE 
and on 2D homonuclear COSY experiments. In particular, the number of signals and 
their integration indicate the presence of one species in solution. NOE experiments, 
performed upon irradiation of the H6’ signal, indicated the cis relationship between the 
Pd-CH3 moiety and H6’, thus confirming the trans geometry between the Pd-CH3 group 
and Pd-N bond where N belongs to the substituted pyridine ring. The trans isomer 
present in solution is in agreement with X-ray analysis of rac-29. This result differs 
from the literature data, which reported a preferential tendency of the methyl group to 
coordinate trans to less basic bipyridine N atom,3,6,24 obviously in case of Pd 
complexes characterized by ligands with non-equivalent N-donor atoms. The different 
geometry shown by the complexes studied here might be due to the steric hindrance of 
the alkyl chain bound to bipyridine. 
The discussion of NMR characterization starts from complexes 29a-b, 31a-b and 32a-
b. The most diagnostic bipyridine signals are H3, H4, H3’ and H4’, the -CH proton of 
the substituent in position 6 and the characteristic singlet of Pd-CH3 moiety. Selected 
1H NMR data for 29a-b, 31a-b and 32a-b and the corresponding free ligands are 
reported in Table 1.  
 
 
 
 
 
 
 
 
 
TABLE 1.  Selected 1H NMR data for 29a-b, 31a-b and 32a-b[a]. 
N-N′/complex H3 H3’ H4 H4’ Pd-CH3 -CH CIS [b](δl-δc) 
29 8.26(d) 8.45(d) 7.83(d) 7.81(pst) ‒  4.51(m) ‒  
29a 7.97(m) 8.04(m) 7.97(m) 8.04(m) 1.34(s) 6.23(m) -1.72 
29b 8.17(m) 8.24(m) 8.17(m) 8.24(m) 1.35(s) 4.68(m) -0.17 
31 8.20(d) 8.50(d) 7.72(t) 7.80(pst) ‒   3.13(m) ‒   
31a 7.88(m) 8.00(m) 7.88(m) 8.00(m) 1.32(s) 4.74(m) -1.61 
31b 8.01(m) 8.17(m) 8.01(m) 8.17(m) 1.30(s) 3.42(m) -0.29 
32 7.81(t) 8.50(d) 7.73(t) 8.22(d) ‒   2.87(m) ‒   
32a 7.92(m) 8.00(m) 7.92(m) 8.00(m) 1.18(s) 4.57(m) -1.7 
32b 8.05(m) 8.00(m) 8.05(m) 8.00(m) 1.32(s) 3.22(m) -0.36 
[a] Spectra recorded in CD2Cl2 at room temperature, δ in ppm, s=singlet, t = triplet, pst = pseudo-triplet, 
m= multiplet. [b] CIS = Coordination Induced Shift for -CH in the complexes (δc) and in the free ligand 
(δl). 
 
The singlet of the methyl bound to palladium appears in the range of frequency 
between 1.10 and 1.40 ppm in both neutral and cationic species.  
The secondary carbon -CH proton was the most affected by the coordination to 
palladium. It was downfield shifted in comparison with the same signal in the free 
ligand spectra, in particular, for the neutral derivatives, the coordination induced shift 
(CIS) is about 1.70 ppm, and it is more pronounced than for the cationic complexes. 
This large chemical shift variation was due to the presence of Cl- ion in cis position to 
it.25 The aromatic protons H3, H4, H3’ and H4’ were also influenced by Pd coordination: 
in the free ligand their four well-separated signals were easily recognized, while in 
neutral and cationic derivatives the signals overlapped resulting in multiplets.  
1H NMR analysis of Pd-complexes bearing ligand 30 (30a-b) also showed that the 
most significant signals variations include the Pd-CH3 moiety and H4 and H5 of the 
pyridine ring. Selected 1H NMR data for free 30 and complexes 30a and 30b are 
reported in Table 2. 
                           TABLE 2.  Selected 1H NMR data for 30 and 30a-b[a]. 
N-N’/complex Pd-CH3 H4 H5 
30 ‒ 7.75(t) 8.00(d) 
30a 1.01(s) 7.91(bs) 7.91(bs) 
30b 0.98(s) 7.94(bs) 7.94(bs) 
[a] Spectra recorded in DMSO-d6 at 60 °C, δ in ppm,  s = singlet, d = doublet, t = triplet, bs = broad 
singlet. 
 
Complexes 30a-b containing the triazolo-derived ligand were soluble in DMSO. The 
1H NMR spectra recorded in DMSO-d6, at room temperature, showed broad signals 
that became sharp at 60 °C. Even for these complexes the NMR characterization 
indicated the presence in solution of one species only, that was not possible to 
recognize as the cis or the trans isomer via NOE experiments. In the spectrum of 30b 
the signal of free acetonitrile (in 1:1 ratio with respect to the Pd-CH3 moiety) was 
detected, due to the exchange process between the coordinated acetonitrile and 
dimethyl sulfoxide. The broadening of the signals observed at room temperature is 
indicative of a dynamic process in solution, that is reasonably attributed to an 
exchange process between dimethylsulfoxide and at least one of the Pd-N bond of the 
chelating ligand. 
 
3.4. CATALYTIC ACTIVITY OF COMPLEXES 29b-32b 
The monocationic complexes 29b-32b were tested as pre-catalysts in the styrene 
carbonylation reaction under standard conditions: T = 30 °C, CO pressure = 1 atm, 1,4-
benzoquinone (BQ) as oxidant with [BQ]/[Pd] = 40, solvent = 2,2,2-trifluoroethanol 
(TFE) and [styrene]/[Pd] = 6800.  
At the end of the catalytic runs no solid was isolated, either upon addition of methanol. 
The reaction mixture was dried under vacuum, yielding a yellow/orange oil that was 
characterized by ESI-MS spectroscopy and 1H and 13C NMR experiments (in CDCl3, at 
room temperature). The mass analysis revealed that the product was a mixture of low 
molecular weight molecules (Mw ≈ 368–896 Da). The repetitive unit corresponded to 
132 Da and the molecular weight distribution was symmetrically centred at 655.3 Da, 
that represented the oligomer with three repetitive units (Figure 4). On the basis of this 
analysis the product was characterized as CO/styrene oligoketones with a number of 
repetitive units ranging from 1 to 5.  
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FIGURE 4. ESI-MS spectroscopy of CO/styrene oligoketones synthesized with 29b. 
 
The oligomeric nature of the reaction products was also confirmed by the comparison 
of the 1H-NMR with that of a typical polyketone (Figure 5): in the spectrum of the 
copolymer three broad signals are observed for the methynic and the two diasterotopic 
methylenic protons, whereas in the spectrum of the oligomeric material several sharp 
signals are present, also allowing the recognition of the end groups. 
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FIGURE 5. 1H-NMR spectrum in CDCl3, at r.t. of: (a) CO/styrene copolymer; (b) CO/styrene oligomer. 
Aliphatic region. 
 
In agreement with literature data,26 the set of doublets observed in the range 1.35-1.55 
ppm was indicative of a diphenylpentyl-5-one end group (Figures 6 and 7). In 
particular, the two internal doublets (1.48 ppm and 1.50 ppm) were assigned to the l 
(like) and u (unlike) stereoisomeric forms of 2,5-diphenylpentyl-3-one group (A), 
which was the main termination present. The doublet at higher field (1.40 ppm) was 
analogously attributed to the regioisomeric termination 2,4-diphenylpentyl-3-one, of 
which only the signal of the l diastereoisomer (B) was observed (Figures 6 and 7). 
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FIGURE 6. Possible CO/styrene oligomers chain ends. 
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FIGURE 7. 1H NMR spectra in CDCl3: region of the methyl group signals of oligoketones obtained with 
rac-29b. 
 
The CO/styrene oligomerizations were carried out with all the synthesized complexes 
(29b-32b) and all of them generated active species for this reaction. The ligand nature 
remarkably influenced the catalyst productivity. The cationic complex with the triazole 
ligand (30b) gave the least productive catalyst, while rac-29b afforded the most active 
one, among those tested, reaching a productivity of almost 200 g PK/g Pd (grams of 
oligoketones per gram of palladium) (Figure 8 and Table 3). In each case no 
decomposition to Pd metal was observed. The nature of the ligand did not affect the 
product distribution. 
Thus, the introduction of a substituent on the ortho position, with respect to the N-
donor, of one of the two pyridine rings of the bpy-derived ligand, remarkably affected 
the selectivity of the carbonylation reaction that was directed towards the synthesis of 
oligomers. When no substituents was present on this position, polymers of different 
molecular weight were the products.27 
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FIGURE 8. CO/styrene oligomerization: effect of nitrogen-donor ligand. Pre-cat.: [Pd(CH3)(N-
N')(CH3CN)][PF6]. Reaction conditions: nPd = 1.27 x 10-5, styrene V = 10 mL, TFE V = 20 mL, pCO = 1 
atm, [BQ]/[Pd] = 40, T = 30 °C, time = 24 h, [styrene]/[Pd] = 6800.  
 
      TABLE 3. CO/styrene oligomerization: effect of the ligand nature. 
Entry Pre-cat. Yield (mg) 
Productivity          
(g PK/g Pd) A/B (%) 
A (%) 
l u 
1 rac-29b 254 185 63/37 40 60 
2 31b 187 136 75/25 > 99 ‒ 
3 rac-32b 155 113 75/25 > 99 ‒ 
4 30b 103 79 88/12 80 20 
       Reaction conditions: see Figure 8. 
 
The nature of the N-N' ligand affected the regioisomeric and the diasteroisomeric 
distribution of the end-groups. With all the tested pre-catalysts, the oligomer with the 
2,5-diphenyl-pentan-3-one end group was the prevailing regioisomer: the A to B ratio 
depended on the substituent on the pyridine ring, being the least for rac-29 and the 
highest for 30. Even the ratio between the two diasteroisomers, Al and Au, appeared to 
be related to the nature of the substituent on the pyridine ring and it should be noted 
that the pre-catalyst containing ligands 31 and rac-32 gave the Al diasteroisomer, 
exclusively.  
 
 
 
 
 
 
 
g 
PK
/g
 
Pd
 
It is reasonable to assume that the high enantioface discrimination obtained with pre-
catalysts 31b and rac-32b might be due to the steric hindrance of the alkyl substituents 
of ligands 31 and rac-32, larger than that of the methoxy group of  rac-29 and 30. Due 
to this steric hindrance, the growing chain is preferentially coordinated trans to the 
substituted pyridine ring, thus the incoming styrene has to coordinate cis to it by 
experiencing the presence of the bulky substituent that finally determines the styrene 
enantioface to be coordinated (Figure 9). 
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FIGURE 9. The two possible styrene coordinations on the Pd-aryl intermediate.  
 
A similar mechanistic hypothesis, implying the site selective coordination of the 
alkene, was introduced by Consiglio for the CO/styrene copolymerization catalyzed by 
a Pd-complexes with P-N ligands,28 later on was involced by Nozaki for the 
CO/propene copolymerization29 and by us to explain the synthesis of the isotactic 
CO/styrene polyketone with Pd-amine-imine complexes.30   
To optimize the reaction conditions, a series of experiments was carried out with pre-
catalyst rac-29b varying some reaction parameters. 
The variation of [BQ]/[Pd] ratio (Table 4) evidenced that the productivity increased on 
increasing the [BQ]/[Pd] ratio. Noteworthy, when the oxidant was not added to the 
reaction mixture the formation of inactive palladium black was observed after 2 h and 
no product was isolated after 24 h. The addition of a remarkable excess of 1,4-
benzoquinone, with respect to palladium, resulted in a stabilization of the active 
species and in no formation of Pd(0) over the investigated range of time. The amount 
of benzoquinone did not show any effect on oligomers distribution. 
 
 
 
 
 
                          TABLE 4.  CO/styrene oligomerization: effect of [BQ]/[Pd] ratio. 
[BQ]/[Pd] Yield (mg) 
Productivity          
(g PK/g Pd) 
0 0 0 
5 75 55 
20 186 135 
40 251 185 
Pre-cat.: [Pd(rac-29)(CH3)(NCCH3)][PF6], reaction conditions: see Figure 8. 
 
Prolonging the reaction time (Figure 10) from 8 to 48 h resulted in a remarkable 
increase in the productivity; the trend showed that the catalyst was still active after 48 
h, without any evident decomposition to palladium metal. The reaction time did not 
affect the number of repetitive units inserted into the oligomer chain.  
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FIGURE 10. CO/styrene oligomerization: effect of reaction time. Pre-cat.: [Pd(CH3)(rac-
29)(CH3CN)][PF6], reaction conditions: see Figure 8. 
 
With the aim to evaluate if chiral ligand effects were present, some CO/styrene 
oligomerizations were carried out using the complexes with ligand 29 in its 
enantiomerically pure forms: [Pd((S)-29)(CH3)(NCCH3)][PF6] ((S)-29b) and [Pd((R)-
29)(CH3)(NCCH3)][PF6] ((R)-29b) (Table 5, entries 2, 3; Figure 11). The highest 
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productivity was achieved with (S)-29b as pre-catalyst, followed by rac-29b and (R)-
29b. In all cases the A regioisomer was preferentially formed, even though the A/B 
ratio depended on the chirality of the ligand, being the highest with the (S) enantiomer 
and the lowest when the racemic ligand was used. 
 
   TABLE 5. CO/styrene oligomerization: effect of ligand chirality and of [Pd]/[ligand] ratio. 
Entry Pre-cat. Yield (mg) 
Productivity             
(g PK/g Pd) A/B (%) 
A (%) 
l u 
1 rac-29b 254 185 63/37 40 60 
2 (S)-29b 267 194 90/10 25 75 
3 (R)-29b 211 153 75/25 75 25 
4[a] rac-29b + rac-29 203 158 75/25 > 99 ‒ 
5[a] (S)-29b + (S)-29 145 105 79/21 > 99 ‒ 
6[a] (R)-29b + (R)-29 129 94 69/31 > 99 ‒ 
Pre-cat.: [Pd(CH3)(N-N')(CH3CN)][PF6], reaction conditions: see Figure 8. [a] [Pd]/[free ligand] =    
1/0.5. 
 
As far as the diastereoisomeric relationship was concerned, the Al/Au ratio was low by 
using rac-29b (Table 5, entry 1), whereas with complexes (S)-29b and (R)-29b an 
increase in the ratio was obtained, but in the opposite diasteroisomer. 
A series of oligomerization reaction was carried out with the addition of a free ligand 
excess ([Pd]/[free ligand] = 1/0.5) to the corresponding catalytic system (Table 5, 
entries 4, 5, 6). A decrease in the productivity was observed with respect to the 
catalytic system containing the pre-catalyst only, more pronounced for complex (S)-
29b, thus suggesting that the excess of free ligand has an inhibiting effect: it should 
compete with the two monomers for the fourth coordination side on palladium.  
Oligomers composition was not affected either by the ligand configuration or by the 
[Pd]/[ligand] ratio. 
Free ligand addition slightly affected the regioisomer ratio: for the optically pure 
ligands, the A/B ratio decreased, while it increased when the racemic ligand was used. 
More interesting it was the effect of free ligand addition on oligomers stereochemistry: 
regardless to the ligand configuration, complete stereoselectivity for the l 
diastereoisomers synthesis was observed (Table 5, Figure 11). 
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FIGURE 11. 1H NMR spectra in CDCl3: methyl group signals of oligoketones obyained with: 1) rac-
29b; 2) rac-29b + rac-29; 3) (S)-29b; 4) (S)-29b + (S)-29; 5) (R)-29b; 6) (R)-29b + (R)-29. Reaction 
conditions: see Table 8. 
 
The oligoketones obtained with the chiral complexes (S)-29b and (R)-29b and upon 
addition of the free enantiomerically pure ligand, (S)-29 and (R)-29 respectively, were 
analyzed by Circular Dichroism (Figure 12). 
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FIGURE 12. Circular dichroism spectra of oligoketones obtained by (R)-29b + (R)-29 (blue curve) and 
(S)-29b + (S)-29 (red curve). 
 
The oligomers were optically active, but the CD curves were not symmetric. The low 
molar ellipticity values observed indicated a low stereoregular structure. As expected, 
the oligomers obtained with rac-29b + rac-29 did not show any optical activity.  
The CD curve analysis combined with the 1H-NMR data (Table 5) indicated that a 
high enantioface discrimination took place for the insertion of the first two styrene 
units but, afterwards, a loss of enantioface discrimination occurred, thus suggesting 
that the chirality of (S)-29b or (R)-29b catalyst site was not sufficient to overcome the 
effect of the chirality of the growing chain. Furthermore, the opposite sign of the 
ellipticity of the CD band for the oligoketones indicated that, for the first two repetitive 
units, the opposite enantioface of styrene was inserted into the oligoketone chain when 
ligand (S)-29 or (R)-29 was used.  
These results suggested that when an excess of ligand was present, a different catalytic 
species might be formed, with respect to that generated by the complex only. It is 
reasonable to assume that two molecules of N-N' ligand were bound to the same Pd-
centre. Actually when the oligomerization reactions were carried out by adding 
different amounts of the free ligand with respect to palladium, no effect on the 
productivity and on the product features was observed (Table 6): in all the catalytic 
runs a value of 150 g PK/g Pd was obtained. Thus suggesting that only a small 
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percentage of the pre-catalyst was transformed into the active species, that should have 
two molecules of N-N' bound to palladium. 
 
            TABLE 6. CO/styrene oligomerization: effect of [Pd]/[ligand] ratio. 
[free lig]/[Pd] Yield (mg) Productivity          (g PK/g Pd) A/B (%) 
A (%) 
l u 
0.1/1 207 151 63/37 > 99 ‒ 
0.5/1 203 150 64/36 > 99 ‒ 
0.25/1 202 149 62/38 > 99 ‒ 
             Pre-cat.: [Pd(CH3)(rac-29)(CH3CN)][PF6], reaction conditions: see Figure 8. 
 
 
 
Complex rac-29b was also proved to be catalyst for the oligomerization of CO with 4-
methylstyrene. The reaction was carried out under the same conditions used for styrene 
(Table 7). 
 
            TABLE 7. CO/alkene oligomerization: effect of the alkene nature. 
Olefin Yield (mg) Productivity             (g PK/g Pd) A/B (%) 
A(%) 
l u 
styrene 254 185 63/37 40 60 
4-CH3-styrene 405 295 67/33 42 58 
             Pre-cat: [Pd(rac-29)(CH3)(NCCH3)][PF6], reaction conditions: see Figure 8. 
 
As for styrene, also for 4-methylstyrene the product isolated at the end of catalytic run 
was the corresponding oligoketone as characterized by ESI-MS and NMR 
spectroscopy. In addition, the concomitant formation of poly-(4-methylstyrene) was 
observed. 
The productivity in CO/4-methylstyrene oligomers was higher than that obtained with 
styrene, in analogy with the results reported in the literature for the CO/vinyl arene 
copolymerization.5,24 
No effect of the nature of the vinyl arene on the regioisomeric and diasteroisomeric 
ratio of the oligomers end groups was found. 
  
3.5. MECHANISTIC INVESTIGATIONS 
With the aim to understand the role played by the second molecule of the N-N' ligand, 
the complexes [Pd(N-N')2(CH3)][PF6] (N-N'= rac-29, (R)-29, 31, rac-32) containing 
two molecules of the N-N' ligand were synthesized from the corresponding 
monocationic derivatives, through an exchange reaction of the coordinated acetonitrile 
with a second molecule of the nitrogen-donor ligand (Scheme 8).31,32 
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SCHEME 8. Synthesis of the [Pd(N-N')2(CH3)][PF6] complexes 29c, 31c, 32c. Reaction conditions: 
CH2Cl2, r. t. 
 
Single crystals, suitable for X-ray analysis, of rac-29c derivative were obtained upon 
addition of diethyl ether to a CD2Cl2 solution of the complex, kept overnight at 4 °C 
(Figure 13). The palladium ion has the typical square planar coordination geometry. 
One molecule of the N-N' ligand acts as a bidentate ligand, while the second molecule 
shows a monodentate coordination being bound to the metal centre with the nitrogen 
atom of the unsubstituted pyridine ring. This bond is trans to the Pd-N bond of the 
unsubstituted pyridine ring of the chelating N-N' molecule, while the Pd-N bond of the 
substituted pyridine ring is trans to the Pd-CH3 fragment. The second nitrogen atom of 
the monocoordinated N-N' ligand occupies a pseudo-apical position at 2.656(4) Å from 
Pd, indicating a weak interaction between these two atoms. In the literature there are 
few other examples of palladium-organometallic complexes of general formula [Pd(N-
N)2(L)][X] (in which N-N = Ar-BIAN, phen and its derivatives; L = CH3, CH2NO2; X 
= triflate, PF6-) with two molecules of bidentate nitrogen ligands, one of which acting 
Pd N
N
MeO
H3C
N
N
OMe
as a monodentate ligand. They involve bis(aryl)acenaphthenequinonediimine ligands 
(Ar-BIAN)31, or 1,10-phenanthroline and their derivatives.32  
In the reported crystal structures the Pd---N interaction, where the nitrogen atom 
belongs to the uncoordinated ring of the N-N molecule, has a distance varying between 
2.562(6) Å and 2.73(8) Å. The Pd---N4 distance found in the crystal structure of rac-
29c falls in this range. 
 
 
FIGURE 13. ORTEP drawing of the cation [Pd(rac-29)2(CH3)]+ (29c). Only a stereoisomer is reported 
for clarity. Coordination bond lengths [Å] and angles [°]: Pd-CH3 2.026(4), Pd-N(1) 2.055(3) Pd-N(3) 
2.087(4), Pd-N(2) 2.247(3), Pd---N(4) 2.656(4), N(1)-Pd-N(2) 78.10(15)°, N(1)-Pd-N(3) 172.31(16)°, 
C(21)-Pd-N(1) 92.91(18)°, N(3)-Pd-N(2) 106.58(14)°, C(21)-Pd-N(2) 170.39(18)°, C(21)-Pd-N(3) 
82.74(18)°. 
 
A shared feature of the [Pd(N-N)2(L)][X] complexes reported in literature was the 
equivalence in solution of the two N-N molecules, as shown by NMR studies, that 
appeared to be in contrast with the structure in the solid state. Low temperature NMR 
experiments evidenced the presence of a fluxional process, which rendered both of the 
two molecules of N-N  ligand as well as both halves of each of them equivalent.31,32b,c 
Complexes rac-29c, (R)-29c, 31c, 32c were also characterized in solution by recording 
1H NMR spectra in CD2Cl2, at room temperature. 
In the 1H NMR spectrum of (R)-29c two signals for the Pd-CH3 fragment were present, 
together with two sets of resonances for all the protons of the N-N' ligand (Figure 14a). 
The number of signals and their integration indicated the presence in solution of two 
species. In each species the two molecules of N-N' ligand are equivalent and NOE 
experiments, performed both upon irradiation of the H6' signal or the Pd-CH3 singlet, 
evidence the relative cis position of these two groups. A ROESY experiment indicate 
that these two species are in exchange with a rate that, at room temperature, is slow on 
the NMR time scale. 
The 1H NMR spectrum of (rac)-29c showed the same signals observed in the spectrum 
of (R)-29c plus an additional set of resonances with chemical shift values similar to 
those found for (R)-29c, indicating that other two species were present in solution 
(Figure 14b). 
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FIGURE 14. 1H NMR spectra in CD2Cl2, at room temperature, of: (a) (R)-29c; (b) (rac)-29c. 
 
With the aim to explain these static proton NMR spectra, a frozen trigonal bipyramid 
coordination geometry of palladium was assumed (Figure 15). The coordination 
positions in the equatorial plane are occupied by the methyl group and the nitrogen 
atoms of the two substituted pyridine rings, while the two nitrogen donors of the 
unsubstituted rings are in the axial positions. In this geometry the palladium is a 
stereogenic centre and the species present in the solution of (R)-29c are the two 
diastereoisomers differing for the palladium absolute configuration, R,R,∆Pd and 
R,R,ΛPd. For the complex (rac)-29c the signals of the two diasteroisomers R,S,∆Pd and 
R,S,ΛPd were also evident. 
 
∆ ∆
 
FIGURE 15. Computer modelling of the two diastereoisomeric palladium complexes. 
 
This hypothesis was also confirmed by the 1H NMR spectra of complexes 31c and 32c. 
In particular, in the region of the aliphatic protons signals of 32c, having the racemic 
rac-6-sec-butyl-2,2'-bipyridine coordinated to palladium, the resonances of four 
species were evident, that were assigned to the racemic and the meso forms of the Pd-
complex (Figure 16). 
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FIGURE 16. 1H NMR spectrum in CD2Cl2, at room temperature, of 32c. Region of aliphatic protons. 
 
Finally, in the spectrum of complex 31c, having the 6-iso-propyl-2,2'-bipyridine, two 
doublets were observed for the methyl groups of the iso-propyl substituent indicating 
that they are diastereotopic (Figure 17). Since the ligand is achiral, the unique source 
of chirality is the stereogenic palladium. 
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FIGURE 17. 1H NMR spectrum in CD2Cl2, at room temperature, of 31c. 
 
Palladium(II) has a strong preference, in the absence of a particularly bulky 
environment, for the square planar coordination geometry and this is confirmed by the 
crystal structure of (rac)-29c. Thus, even for complexes rac-29c, (R)-29c, 31c, 32c, as 
reported in the literature for the [Pd(N-N')2(L)][X] derivatives, a fluxional process that 
renders equivalent the two molecules of N-N' should be present in solution and the two 
modelled pentacoordinated molecules represent two limiting structures. At room 
temperature, the rate of this process is slow on the NMR time scale. 
To gain some insights into the mechanism of the co-oligomerization reaction, the 
reactivity of complexes rac-29b, rac-29c and (R)-29c with labelled carbon monoxide 
was studied by in situ NMR spectroscopy. 
When 13CO was bubbled for 5 min into a 10 mM solution of complex rac-29b, in 
CD2Cl2, at 25 °C, in the 1H NMR spectrum of the resulting solution the signal of the 
Pd-CH3 disappeared, replaced by a doublet at 2.92 ppm. The signal of free acetonitrile 
was present, while no signal due to free rac-29, was observed. In the carbonyl region 
of the 13C NMR spectrum the two signals at 214.0 and 173.6 ppm were assigned to the 
carbonyl group of the Pd-acetyl fragment and to the CO bonded to Pd, respectively 
(Figure 18a). On the basis of these data and on the literature, 30,32c,33 it was reasonable 
to assume that the species resulting from the carbonylation reaction was the Pd-acetyl-
carbonyl derivative [Pd(COCH3)(CO)(rac-29)][PF6]. No information was obtained 
about the geometry of this species (Scheme 9a). 
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FIGURE 18. 13C NMR spectra in CD2Cl2, at r. t. of: (a) rac-29b + 13CO; (b) (R)-29c + 13CO; (c) rac-29c 
+ 13CO. Carbonyl region. 
 
The same experiment, under the same conditions, was carried out on complexes rac-
29c and (R)-29c. In the 1H NMR spectrum of the solution obtained from the reaction of 
(R)-29c with 13CO, no signal due to the Pd-CH3 complex was present anymore, and 
two new doublets at 1.94 and 1.99 ppm appeared. No signal due to the free ligand was 
evident and all the signals of the ligand were shifted with respect to the same 
resonances in the precursor (Figure 19). Analogous variations were observed in the 
spectrum of the solution resulting from the reaction of rac-29c with labelled carbon 
monoxide. The carbonyl region of the corresponding 13C NMR spectra showed, in 
addition to the signals at 214.7 and 172.9 ppm, two or three new resonances at 225.9 
(RR or SS), 226.3 (RS or SR), and 226.8 (RR or SS) ppm, depending if the complex 
with the R enantiomer or the racemic form of the ligand was studied (Figure 18 band 
c). These NMR data indicated that even the complexes rac-29c and (R)-29c easily 
reacted with CO at room temperature leading to the palladium-acetyl species 
containing both N-N' ligands coordinated to the metal ion, [Pd(N-N')2(COCH3][PF6]. 
This species was in equilibrium with the corresponding Pd-acetyl-carbonyl derivative 
[Pd(COCH3)(CO)(N-N')][PF6] (Scheme 9b). 
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FIGURE 19. 1H NMR spectra in CD2Cl2 of (R)-29c + 13CO; region of aliphatic protons. 
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SCHEME 9. Reactivity with 13CO of complexes 29b (a), rac-29c and (R)-29c (b). 
 
An analogous reactivity with carbon monoxide was reported in the literature for 
complexes [Pd(N-N)2(CH3)][PF6] (N-N = phen and its substituted derivatives).32c 
On the basis of these NMR studies and of the co-oligomers end-groups it has been 
possible to depict an hypothesis for the mechanism of the oligomerization reaction 
(Scheme 10).  
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SCHEME 10. The proposed mechanism: (a) activation step; (b) insertion of the first two repetitive units; 
(c) termination step (GOC = growing oligomer chain). 
 
The catalitycally active species is the Pd-H intermediate that might be formed from the 
pre-catalyst via insertion of carbon monoxide into the Pd-CH3 bond, followed by the 
nucleophilic attack of water (present in traces in TFE) on the Pd-acetyl intermediate, 
leading to acetic acid and the Pd-H (Scheme 10a). On the latter the 
coordination/insertion of styrene occurs with a secondary regiochemistry, followed by 
the insertion of CO into the Pd-alkyl bond. Afterwards, the second molecule of styrene 
inserts into the Pd-acetyl bond, but the insertion reaction is not regiospecific anymore, 
since the insertion with a primary regiochemistry also takes place (Scheme 10b). The 
growing of the oligomeric chain proceeds up to a maximum of five repetitive units, 
then a β-hydrogen elimination occurs with the formation of the co-oligomer having a 
vinylic termination and of the Pd-hydride that can start a new catalytic cycle. 
An analogous mechanism might be proposed for the oligomerization reaction carried 
out in the presence of an excess of the N-N' ligand with the only difference that it was 
reasonable to assume that both molecules of nitrogen-donor ligand were bonded to 
palladium during the oligomerization process, maybe both of them in a unidentate 
fashion (Scheme 11). Their presence in the palladium coordination sphere is of 
importance to determine the enantioface selection for at least the first two inserted 
molecules of styrene. 
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SCHEME 11. The proposed mechanism for complexes [Pd(N-N')2(CH3)][PF6]. 
 
3.6. CONCLUSIONS 
The effect of the substituent in ortho position with respect to a N-donor atom of 
bipyridine and pyridine-triazole ligands was investigated. In particular, chiral 6-(1-
methoxyethyl)-2,2’-bipyridine ligand both as racemate and in the enantiopure forms 
were synthestized from the respective alcohols. The optically pure alcohols 
intermediates (R)-37 and (S)-37 were obtained by chemoenzimatic synthesis, such as 
baker’s yeast bioreduction and lipase catalyzed dynamic kinetic resolution, that had 
demonstrated to be superior methods for the synthesis of nonracemic bypiridine 
ethanol systems in good yield and optical purity (e.e. 99%).  
The monocationic Pd(II) complexes of general formula [Pd(CH3)(CH3CN)(N-
N')][PF6] 29b-30b containing the new N-N' ligands were prepared from the neutral 
derivatives [Pd(CH3)(Cl)(N-N')] 29a-30a (N-N' = 29-30) and their activity was 
compared to that of complexes with the already known ligands 31 and rac-32. 
All of the Pd-complexes 29-32a-b have shown to be pre-catalysts for the styrene 
carbonylation reaction leading to oligoketones with up to 5 insered repetitive units. 
The nature of the N-N' ligand remarkably influenced the productivity of the catalytic 
system, in particular the steric hindrance of the alkyl substituents played a relevant 
role: the higher productivity was achieved with the complex (S)-29b (194 g PK/g Pd), 
while the triazole ligand (30) gave the least productive catalyst. 
In order to evaluate if the ligand chirality effects were present, the activity of 
complexes rac-29b and (R)- and (S)-29b in the oligomerization reactions was 
investigated. The ligand chirality affected the region- and diasterochemistry of the 
oligomer end-groups. indeed in each case the oligomers were obtained in the two 
regioisomeric forms A and B, being A the major species formed. The formation of the 
species B, indicated that a styrene insertion with primary regiochemistry also accurred, 
that was observed for the first time in a catalytic system based on N-N' ligands.34 As 
for the diasteroisomeric ratio (Al/Au), it was low using rac-29b, whereas it increased, 
in a opposite way, using (R)- and (S)-29b. Moreover the addition of 0.5 eq of free 
ligand with respect to palladium, in the catalytic mixture, resulted in a decrease in the 
productivity, and in a complete stereoselectivity in the Al diastereoisomer formation. 
In order to understand the role of the second molecule of the ligand the corresponding 
bisbipyridine complexes of general formula [Pd(N-N')2(CH3)][PF6] (N-N' = rac-, (R)-, 
and (S)-29) were synthesized. The NMR studies confirmed that the second molecule of 
ligand plays a crucial role in determining the styrene enantioface discrimination at 
least for the insertion of the first two styrene molecules. 
Finally the study of the reactivity of [Pd(N-N')2(CH3)][PF6] complewes with labelled 
carbon monoxide evidenced the preferential formation of the Pd-acetylspecies with 
two N-N' molecules bonded to the same Pd-centre over that of the Pd-acetyl-carbonyl 
derivative with only one molecules of N-N' in the Pd-coordination sphere. By 
considering the high affinity of palladium for carbon monoxide, this result is of 
remarkable importance. 
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Results and Discussion 
 
Chapter 4: 
Synthesis and application of P-N ligands 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1. HYBRID PHOSPHOROUS-NITROGEN DONOR LIGANDS 
The concept of hemilability has been coined for ligands possessing a combination of 
soft and hard donor atoms. A distinguished family of hemilable ligands is that 
combining phosphorous and nitrogen atoms. One important property of these 
potentially multidentate ligands is that they can stabilize metal ions in a variety of 
oxidation states and geometries. These ligands can display quite different coordination 
modes, in fact the π-acceptor character of phosphorous atom can stabilize a metal 
center in a low oxidation state, while the nitrogen σ-donor ability makes the metal 
more susceptible to oxidative addition reactions. These properties can help to stabilize 
intermediate oxidative states or geometries during a catalytic cycle.1 The possibility of 
varying the electronic and steric properties of this kind of ligands allows to obtain 
potentially multidentate ligands that are able to bind or bridge one or more metallic 
ions affording homo- or hetero-, bi- or polymetallic complexes. 1,2 
Unsymmetrical P-N ligands play an important role in catalysis thanks to their bonding 
versatility. Despite their wide applications in asymmetric synthesis,3 only few papers 
reported the use of P-N ligands in transition metal catalyzed oligomerization, 
polymerization and copolymerization reactions of aromatic olefins. In the field of 
ethylene homo- and co-, oligo- and polymerization, in fact, a lot of coordination and 
reaction studies were reviewed, in particular Ni(II) complexes with very different 
kinds of P-N ligands were used (Figure 1).4 
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FIGURE 1. Examples of P-N ligands applied in ethylene oligo- and polymerization reactions. 
 
The reported structures are only few examples of the very large family of P-N ligands 
used to perform oligo-4b,c and polyethylene4d,e synthesis or CO/ethylene 
copolymerizations.4a They give an idea about the versatility of the possible ligands 
available, with different steric and electronic properties. Differently, papers that 
describe P-N ligands application in CO/alkene copolymerization are rare. Pd(II) 
complexes with ligands A-D were investigated as pre-catalysts in CO/styrene 
copolymerization by Consiglio,4a but the results were unsuccessful. The most 
promising P-N ligands studied in the CO/styrene copolymerization were oxazoline-
phosphine type ligands (Figure 2).5 
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FIGURE 2. 
 
Their cationic diaquo Pd(II) complexes showed good activity and selectivity in 
producing isotactic copolymers, but only at very high CO pressure (320 bar),6 in fact 
the productivity increased, on increasing PCO. 
With the aim of looking for a new Pd(P-N) system which might catalyze CO/styrene 
copolymerization under mild conditions, new chiral P-N ligands have been developed 
from an original idea of Prof. Sergio Castillón (University Rovira i Virgili, Tarragona, 
Spain). The new ligands, unlike the previous discussed structures, consist on a proline-
pyridine skeleton bound to a phosphine group through two N-P bonds (Figure 3). 
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FIGURE 3. The new optically pure P-N ligands. 
 
Ligands 44 (PNCO) and 45 (PN) were synthesized starting from the enantiomerically 
pure L-proline following a procedure reported for the synthesis of similar ligands in 
Figure 4.3 
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FIGURE 4. 
 
Ligands M-O were used in different systems and for different synthesis. For instance 
ligand M was applied in asymmetric copper-catalyzed cyclopropanation;3b iridium 
complexes containing N were good pre-catalysts for enantio- and regioselective allylic 
etherification,3f and O was used in the enantioselective allylic amination studies.1 No 
evidences about the application of these chiral ligands in CO/styrene copolymerization 
were reported. 
 
 
 
4.2. SYNTHESIS OF PNCO AND PN LIGANDS 
The optically pure PNCO and PN ligands were synthesized from amide (S)-46 and 
amine (S)-47, respectively. These parental compounds were prepared following a 
literature procedure (Scheme 1).8-12  
 
N
H HN
N
O
N
H HN
N
N
H
OH
O
N
OH
OBoc
N
OH
OBoc
N
H HN
N
H2N
N O
STEP 1:
STEP 2:
STEP 3:
(a)
(b)
(c)
(S)-46
(S)-46 (S)-47
48
 
SCHEME 1. Synthesis of chiral precursors of 46 and 47. Reaction conditions: (a) NEt3, DCM, Boc2O. (b) 
i. EDC, DCM ii. TFA, DCM. (c) LiAlH4, THF. 
 
The first step consists on the proline’s amine group protection (48) with a standard 
procedure using di-tert-butyl-dicarbonate,7 followed by the coupling that was carried 
out with a revisited procedure involving only EDC as a condensation reagent instead 
of DCC8 or DCC/HOBt.9  
The reaction between the Boc-proline and the commercially available 2-aminopyridine 
afforded a protected amide which was treated in acid medium10 to obtain the amide 
(S)-46. By reduction of the carbonyl group with LiAlH4 (STEP 3) the pure amine (S)-
47 was achieved after column chromatography.11  
The last step was the most sensitive of the whole synthesis, in fact phosphine 
derivatives could be quickly converted into the relative phosphine-oxide by the air 
oxygen or by oxygen traces present in solvents. To avoid oxidation only distilled and 
degassed solvents were used, and all reactions involved phosphines were performed 
with Schlenk technique under inert atmosphere. Thus, amide (S)-46 and amine (S)-47 
were reacted with bis(diethylamino)-phenylphosphine in toluene at 90 °C over night 
(Scheme 2).12   
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SCHEME 2. The last step of chiral ligands 44 and 45 synthesis. Reaction conditions: toluene, 90 °C. 
 
This reaction was completely stereoselective affording only one of the two possible 
diasteroisomers α- and β- (Figure 5).3f-13 
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FIGURE 5. α- and β-diasteroisomers of compound 44. 
 
In agreement with the literature data,3f for ligand 44 only the signal of the β-
diasteroisomer, in which the stereogenic phosphorous has the R configuration, has 
been recognized by 31P-NMR analysis. The same considerations could be applied to 
compound 45. 
Ligands 44 and 45 differ for the presence of the carbonyl group on the bridge 
connecting the nitrogen atom bound to the pyridine ring and the stereogenic carbon of 
the pyrrolidine ring. Both new optically active phosphine-nitrogen ligands have been 
fully characterized by NMR and chirooptical analysis. 
 
 
 
 
4.3. SYNTHESIS OF Pd(II) COMPLEXES CONTAINING PNCO AND PN 
LIGANDS 
4.3.1. Neutral Complexes 
The Pd(II) system chosen to study the coordination capability of the new ligands was 
[Pd(COD)(CH3)(Cl)] (COD = 1,5-cyclooctadiene). This complex is the usual parental 
compound for the synthesis of neutral complexes stabilized by N-N ligands and then 
used in CO/styrene copolymerization in their cationic forms (see Chapter 3 and 
references therein). [Pd(COD)(CH3)(Cl)] was synthesized following the two step 
procedure reported in the literature (Scheme 3).14 
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SCHEME 3. Synthesis of the [Pd(COD)(CH3)(Cl)]. Reaction conditions: (a) i. H2O/HCl (37%) 1:1, r.t., 
30 min; ii. EtOH, 1,5-cyclooctadiene. (b) DCM, (CH3)4Sn, r.t.  
 
Starting from PdCl2 and using an excess of 1,5-cyclooctadiene, the derivative 
[Pd(COD)Cl2] was obtained in 92% yield. The dichloride derivative was reacted with 
tetra-methyl-tin to provide the transmethylation reaction and the product 
[Pd(COD)(CH3)(Cl)] in high yield.    
 
Initially the coordination behavior of PNCO and PN to palladium was studied by in 
situ NMR spectroscopy of the CD2Cl2 solution containing [Pd(COD)(CH3)(Cl)] and 1 
equivalent of the proper ligand. For both ligands the reaction progress, monitored by 
1H- and 31P-NMR spectroscopy, showed that the ligand coordinated almost 
instantaneously to the metal centre: no signals of the free ligand were present after 5 
min from the mixing of the two species (Scheme 4).  
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SCHEME 4. Schematic representation of the neutral complexes formation: a) with PNCO, b) with PN. 
 
The neutral complexes were fully characterized in CD2Cl2 solution by multinuclear 
NMR spectroscopy (Figure 6, Table 1).  
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FIGURE 6. Protons numbering scheme. 
 
TABLE 1. Selected chemical shift values for the free ligands and the neutral complexes.[a] 
P-N/complex 31P             CIS
[b]             
(δl-δc) CH3 
JP-CH3 
(Hz) 
44 106.3       
44a 
67.0 (M) 39.3 (M) 2.12 (M) 13 (M) 
75.6 (m) 30.7 (m) 2.45 (m) 11.5 (m) 
45 99.7       
45a 
119.9 (M) - 20.2 (M), 0.69 (M) 2 (M) 
133.8 (m) - 34.0 (m) 1.65 (m) 8.5 (m) 
 [a] Spectra recorded in CD2Cl2 at r. t., values in ppm. M = major species, m = minor species. [b] CIS = 
Coordination Induced Shift for -CH in the complexes (δc) and in the free ligand (δl). 
 
In the 1H NMR spectra of both neutral species the –CH3 group, that was bound to Pd in 
the metal precursor, generated two doublets at very different chemical shift: 0.69 and 
1.64 ppm for 45a and 2.12 e 2.45 ppm for 44a. These signals indicated for both 
complexes the presence, in solution, of two different species, that were in ratio of 9:1 
and 2:1 for 44a and 45a, respectively. The 31P NMR spectra confirmed these results 
showing two singlets for each complex. Interestingly, the 31P NMR signals of the two 
complexes showed opposite variation of the chemical shift with respect to the free 
ligands, depending on the nature of the P-N ligand: an upfield shift in the case of 44a 
(CIS -34.0 and -20.2 ppm), and a downfield shift for 45a (CIS 39.3 and 30.7 ppm) 
(Table 1). 
The NMR analysis showed also the characteristic signals of the ligand protons shifted 
with respect to those of the free ligands, that was diagnostic of the coordination to the 
palladium centre. 
The comparison of 1H and 31P NMR spectra of 44a and 45a suggests that from the 
reactivity of 44 and 45 with [Pd(COD)(CH3)(Cl)] two different complexes were 
obtained depending on the nature of the ligand. In particular, for ligand 45 the data 
indicated that the isolated species was the expected mononuclear complexes 
[Pd(45)(CH3)(Cl)] (45a) (Figure 7).4a-15 It is reasonable to assume that the two species 
observed in solution for 45a were the cis and trans isomers differing for the relative 
position of the Pd-CH3 fragment with respect to the two halves of the ligand. 
Conventionally we called trans the isomer having the Pd-CH3 in trans to the Pd-P 
bond (Figure 7). 
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FIGURE 7. cis and trans isomers of complex 45a. 
 
The downfield shifted 31P signals for complex 45a, and the JPd-CH3 values suggested 
that the major isomer was the cis isomer. This is in agreement with the complex 
electronic pattern: chloride is trans to the better donor atom (phosphorous), while 
methyl is in trans to the poor donor (nitrogen) (Figure 7)4a and with the fact that the 
ligands having the highest trans influence are cis to each other. 
The nature of the neutral complex 44a with ligand 44 was elucidated after the 
characterization of the corresponding cationic derivative. 
4.3.2. Cationic Complexes 
The reaction between the neutral complexes 44a-45a and CH3CN, at room 
temperature, with AgPF6 was unsuccessful. When the same reaction was carried out 
with pyridine or its derivatives, 4-methyl-pyridine and 4-trifluoromethyl-pyridine, 
instead of CH3CN, the corresponding cationic complexes were isolated (Scheme 5).    
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SCHEME 5. Synthesis of the cationic complexes a) with PNCO, b) with PN. Reaction conditions: 
CH2Cl2, AgPF6, pyridine-type ligands. 
 
Complexes 49a-c and 50a-b were fully characterized by 1H and 31P NMR 
spectroscopy  (Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 2. Selected chemical shift values for the neutral and the cationic complexes.[a] 
Complex 31P CIS[b ](δl-δc) CH3 JP-CH3 (Hz) 
44a 
67.0 (M) 39.3 (M) 2.12 (M) 13 (M) 
75.6 (m) 30.7 (m) 2.45 (m)  11.5 (m) 
49a 50.7 55.6 2.38 11.5 
49b 50.7 55.6 2.36 11.5 
49c 50.7 55.6 2.38 11.5 
45a 
119.9 (M) - 20.2 (M)  0.69 (M) 2 (M), 
133.8 (m) - 34.0 (m) 1.65 (m) 8.5 (m) 
50a 122.9[c]  - 23.2   1.71  8.5  
50b 
122.9 (M) - 23.2 (M) 0.50 (M) 1.5 (M) 
134.2 (m) - 34.5 (m) 1.72 (m) 8.5 (m) 
[a] Spectra recorded in CD2Cl2 at r. t., values in ppm. M = major species, m = minor species. [b] CIS = 
Coordination Induced Shift for -CH in the complexes (δc) and in the free ligand (δl). [c]The NMR 
spectrum indicate the presence of unreacted 45a and of a new species in low amount, that should 
reasonably be major isomer of the target product 50a. 
 
For complex 49b single crystals suitable for X-ray analysis were obtained. Even 
though the quality of the crystals was not excellent, it was possible to characterize the 
palladium coordination sphere and the ligand molecule (Figure 8). 
 
 
 
 FIGURE 8. Crystal structure of the cation of complex 49b. selected bond lengths [Å] and angles [°]: Pd1-
N1 2.037(17), Pd1-N7 2.10(3), Pd1-N2 2.145(15), Pd1-P2 2.204(11), Pd2-N3 2.06(3), Pd2-N5 
2.104(19), Pd2-N6 2.095(14), Pd2-P1 2.207(14), N1-Pd1-N7 173.7(10), N1-Pd1-N2 86.7(8), N7-Pd1-
N2 89.3(9), N1-Pd1-P2 97.4(7), N7-Pd1-P2 86.3(8), N2-Pd1-P2 174.2(6), N3-Pd2-N5 177.1(10), N3-
Pd2-N6 88.5(9), N5-Pd2-N6 89.9(8), N3-Pd2-P1 88.8(9), N5-Pd2-P1 92.4(8), N6-Pd2-P1 170.2(7). 
 
The X-ray structure evidenced the dinuclear nature of the complex, in which two 
ligand molecules bridged two Pd ions. A peculiarity of this system was the 
transmethylation reaction occurred between the metal centers and the phosphorous 
atoms; to the best of our knowledge no evidence of this phenomena has been 
previously reported in the literature. 
It is worth noting that 44 acted as a tridentate ligand being coordinated to one Pd ion 
with the phosphorous atom and the amidic nitrogen, that is prone to the coordination 
due to the cleavage of the P-Namidic bond, and to the other Pd ion with the pyridine 
nitrogen. In the same way a second ligand molecule bound the two palladium ions 
leading to an head-to-tail dinuclear complex. The palladium complex geometry was, as 
usual, square planar with no particular distortion. The coordination sphere of each 
palladium was completed by the monodentate 4-methyl-pyridine, that showed a π-
stacking interaction with the phenyl ring bonded to phosphorous. 
As regard complexes 49a-c with PNCO ligand, both the 31P and the 1H signals were 
shifted compared to the same signals in the neutral compound 44a. The signals of the 
protons of the pyridine-type ligand coordinated to palladium were also present. It is 
worth noting that the 31P and the CH3 group signals were not affected by the fourth 
ligand nature, as well as the value of the P- CH3 coupling constant, the latter being 
very similar to the value found for the complex 44a (Table 2). On the basis of these 
NMR data it is reasonable to assume that all the synthesized complexes containing 
ligand 44 are dinuclear species with a geometry analogous to that observed in the solid 
state for 49b. 
The 1H NMR spectrum of 49b at room temperature showed a single signal at low field 
for protons in ortho position of the 4-picoline. In the homonuclear COSY spectrum 
this signal was not associated with any cross peak; moreover this signal was broad, 
thus indicating the presence of a dynamic phenomenon in solution. In order to 
understand the nature of this phenomenon we studied spectral variations upon 
decreasing temperature in the range + 25 °C ÷ - 35 °C. 
Upon decreasing temperature the signal at low fields attributed to the o-protons of 4-
picoline became broader, until when at T = - 20 °C, it disappeared indicating that the 
coalescence temperature has been reached. A further decrease of temperature (up to -
35 °C) resulted in its splitting into two signals at 8.44 and 8.63 ppm, which were 
correlated with the signals at 6.87 and 7.33 ppm in the homonuclear COSY spectrum 
recorded at - 35 °C (Figure 9). These signals were assigned to the ortho and meta 
protons of the 4-picoline ligand bound to palladium. In addition to these signals, even 
the peaks of the phenyl ring bound to phosphorus varied with temperature. These 
NMR data indicated the presence of a dynamic process in solution, which mainly 
involved the 4-picoline, that, due to coordination to palladium, had lost the C2 
symmetry axis passing through the nitrogen atom and the p-CH3 group. Thus, the two 
halves of 4-picoline were no longer equivalent. This suggested that the fluxional 
process was an hindered rotation around the Pd-N bond, due to the π-stacking 
interaction between the 4-picoline and the phenyl ring bound to the phosphorus atom. 
Indeed, both for ortho and meta picoline’s protons, the signal at higher fields could be 
attributed to the half of the 4-picoline falling into the shielding cone of the phenyl ring. 
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FIGURE 9. Homonuclear COSY spectrum of 49b,  in CD2Cl2 at -35 °C: the ortho and meta protons of 4-
picoline are evidenced. 
 
As expected complexes 49a-c were optically active and the chirooptical analysis (CD 
and α, Figure 10) showed the same Cotton effect for all of them, that confirmed the 
same configuration for each system. 
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FIGURE 10. CD spectra of complexes 49a-c (1 x 10-4 M in CH3OH). 
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Complexes 50a-b were also characterized in CD2Cl2 solution by multinuclear NMR 
spectroscopy. As in the case of the corresponding neutral derivative 45a, even for 50b 
two species were present in solution (Table 2), showing chemical shift values very 
similar to those of the parent compound for the Pd-CH3 fragment (1H NMR spectrum) 
and for the phosphorus atom (31P NMR spectrum). Both the presence of the signals of 
4-picoline in the 1H NMR spectrum and the strong IR bands typical of the 
hexafluorophosphate anion indicate the formation of the desired product 
[Pd(CH3)(45)(4-CH3Py)][PF6]. 
As far as the solid isolated from the reactivity of 45a with pyridine is concerned, the 
NMR characterization indicate the presence of unreacted palladium precursor and of a 
new species, that should reasonably be the target product [Pd(CH3)(45)(Py)][PF6]. 
Further investigations are required. 
 
4.4. CATALYTIC ACTIVITY OF THE CATIONIC COMPLEXES 
Initially the cationic complexes 49a-c were tested as pre-catalysts for the CO/styrene 
copolymerization under standard conditions: T = 30 °C, 1 atm of CO, [styrene]/[Pd] = 
6800, an excess of benzoquinone with respect to palladium ([BQ]/[Pd] = 40), 24 hours, 
in 2,2,2-trifluoroethanol (TFE). No polymer was isolated at the end of the catalytic 
runs. After drying the reaction mixture an oil was obtained that was characterized as 
trans-1,3-diphenyl-1-butene. Despite the optical activity of the complexes, the product 
was always obtained as racemic mixture. 
Reference experiments were carried out converting in situ the neutral complex 44a in 
the cationic form by AgPF6 addition, and varying some reaction parameters.  
 
           TABLE 3. Styrene dimerization: in situ experiments. 
Entry Cat Pd (mol) 
AgPF6 
(mol) 
PCO 
(atm) Product 
Conversion[a] 
(%) 
1 1.27 × 10-5 1.27 × 10-5 1 1,3-diPh-1-butene low 
2 / 1.27 × 10-5 1 No reaction / 
3 1.27 × 10-5 / 1 Mixture of products / 
4 1.27 × 10-5 1.27 × 10-5 / 1,3-diPh-1-butene 11 
Pre-cat: [Pd(CH3PNCO)(Cl)]2 (44a); reaction conditions: [BQ]/[Pd] = 40, T = 30 °C, [styrene]/[Pd] = 
6800, styrene V = 10 mL, TFE V = 20 mL. [a] Conversion determined by weight after 24h.  
The results, summarized in Table 3, indicated that the Pd-complex acted as catalyst for 
the styrene dimerization reaction (Scheme 7) and showed the inhibiting effect of CO in 
this reaction (entry 1 vs 4). 
∗
t rans-1,3-diphenyl-1-butene
Cat.
 
SCHEME 7. Styrene dimerization reaction. 
 
In the literature some examples of co-dimerization of styrene with α-olefins catalyzed 
by Pd16 , Co17 and Ni18 complexes have been reported. Only few articles discussed the 
styrene dimerization, in particular the most recent work19 reported the non selective 
styrene dimerization catalyzed by [Pd(acac)2]/[BF3] system that yielded also to styrene 
trimers and polymers. In the present case only the trans-1,3-diphenyl-1-butene was 
obtained, the characteristic value of the JHHtrans = 15 Hz and the IR band at 965 cm-
1attributable to the δC-H  vibration of trans structure confirm the product geometry.19      
The styrene dimerization was followed by HRGC analysis By using the cationic 
complex 49b, the effect of temperature was investigated evidencing a remarkable 
influence of this parameter on the catalytic activity. In particular, at T = 30 °C or 50 °C 
an induction time was observed, that it is not evident at 70 °C any more (Figure 11).  
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FIGURE 11. Styrene dimerization: effect of the temperature. Pre-cat [Pd(CH3PNCO)(4-CH3Py)]2[PF6]2 
(49b); reaction conditions: nPd = 1.27 × 10-5mol, [BQ]/[Pd] = 40, styrene/Pd = 6800, styrene V = 10 mL, 
TFE V = 20 mL. 
 
Working at 70 °C the catalyst activity was remarkably improved with respect to that 
obtained at 30 °C (entries 1 and 3, Table 4).  
 
TABLE 4. Styrene dimerization: effect of  temperature. 
Entry T (°C) TON[a] Conversion
[b]
 
(%)  
1 30 301 4.41 
2 50 571 8.35 
3 70 850 12.41 
Pre-cat: [Pd(CH3PNCO)(4-CH3Py)]2[PF6]2; reaction conditions: see Figure 11. [a] Turnover number 
(moles of substrate converted per mole of catalyst after 24 hours). [b] Conversion determined by HRGC 
analysis after 24 h.  
 
A 50% decrease of [styrene]/[Pd] ratio, realized by increasing the amount of the 
palladium pre-catalyst, led to an additional improvement of the conversion up to 16 %. 
(Figure 12). 
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FIGURE 12. Styrene dimerization: effect of the [styrene]/[Pd] ratio. Pre-cat [Pd(CH3PNCO)(4-
CH3Py)]2[PF6]2; reaction conditions: nPd = 2.54 × 10-5mol, [BQ]/[Pd] = 40, T = 70°C, styrene V = 10 
mL, TFE V = 20 mL. 
 
Thus, the temperature of 70 °C and a styrene to Pd ratio of 3400 were considered now 
standard conditions, and working with these values, the effect of the different pyridine-
type ligand in fourth position was investigated (Figure 13). 
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FIGURE 13. Styrene dimerization: effect of the fourth ligand nature. Reaction conditions: nPd = 2.54 × 
10-5mol, [BQ]/[Pd] = 40, T = 70°C, [styrene]/[Pd] = 3400, styrene V = 10 mL, TFE V = 20 mL. 
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Each complex tested generated an active species for the styrene dimerization, but 
showing modest catalytic activity and leading to a maximum conversion of 25%, after 
24 h, reached with complex 49a (Table 5, entry 1).  
This catalytic trend evidences that the nature of the fourth ligand affects both the 
activity and the stability of the catalyst, which appear to be related to the Lewis 
basicity of this ligand. Indeed, within the first two hours of reaction, the catatytic 
activity increases on decreasing the Lewis basicity of the pyridine-type ligand, being 
the complex 49c with the 4-CF3Py the most active and complex 49b with 4-CH3Py the 
least active among those tested (Figure 13 and Table 5). 
 
                TABLE 5. Styrene dimerization: effect of the fourth ligand nature. 
Entry Complex Conversion
[b] 
(%) (2h) 
TON[a] 
(2h) 
Conversion[b] 
(%) (24 h) 
TON[a] 
(24h) 
1 49a 12.19 374 24.43 750 
2 49b 7.08 217 16.26 499 
3 49c 13.6 417 16.56 567 
Reaction conditions: see Figure 13. [a] Turnover number (moles of substrate converted per mole of 
catalyst). [b] Conversion determined by HRGC analysis after 24 h.  
 
On the other hand for longer reaction times both catalysts generated by 49b and 49c 
deactivated, while the catalyst obtained from complex 49a was active for at least 8 h. 
To gain some information on the catalyst stability, the effect of [1,4-
benzoquinone]/[palladium] ratio was studied by varying the amount of BQ present in 
the reaction mixture and using complex 49a as pre-catalyst (Figure 14).  
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FIGURE 14. Styrene dimerization: effect of the [BQ]/[Pd] ratio. Pre-cat: [Pd(CH3PNCO)(Py)]2[PF6]2 
(49a), reaction conditions: see Figure 13.  
 
The variation of [BQ]/[Pd] ratio (Figure 14) evidences that the productivity increases 
on increasing the [BQ]/[Pd]. Noteworthy, when the oxidant was not added to the 
reaction mixture the formation of product was very low, and after 24 h only 6% of the 
dimer was isolated. The addition of a remarkable excess of 1,4-benzoquinone with 
respect to the palladium ([BQ]/[Pd] = 80) resulted in prolonging the catalyst lifetime 
and increasing its activity, reaching a conversion into the product of 40% after 24 h. 
The addition of benzoquinone did not show any particular effect on the product nature. 
The catalytic activity of complexes 50a-b is currently under study. 
 
4.5. MECHANISTIC INSIGHTS 
From these catalytic data no information on the nature of the catalytic species can be 
derived, i. g. if a mononuclear or a dinuclear species is the active catalyst. 
Nevertheless, the trend reported in Figure 13 and Table 5 suggests that the activation 
step requires the dissociation of the monodentate pyridine-type ligand. 
From the nature of the product obtained from this catalytic reaction some mechanistic 
speculations can be drawn. The following discussion is based on considering the 
catalyst as a mononuclear species with the ligand chelating the palladium centre with 
the phosphorous and the amidic nitrogen. 
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The active species is a Pd-hydride intermediate, that might be formed from the reaction 
of the pre-catalyst with the TFE and traces of water present in the solvent. An 
analogous activation step has been proposed for the Pd-complexes with N-Nˈ ligands 
(see Chapter 3). 
On the Pd-H, styrene coordination occurs, followed by styrene insertion with a 
secondary regiochemistry leading to the Pd-alkyl intermediate 51a (Scheme 8a). On 
this species the second molecule of styrene coordinates and inserts, always with a 
secondary regiochemistry leading to the Pd-alkyl intermediate 51b (Scheme 8b), on 
which a β-hydrogen elimination takes place yielding the 1,3-diphenyl-1-butene as the 
product and the Pd-H which can start a new catalytic cycle (Scheme 8c).  
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SCHEME 8. The proposed main steps of the catalytic cycle. 
 
Thus, on the studied complexes the styrene insertion is a regiospecific reaction. 
 
4.6. CONCLUSIONS 
Optically pure hybrid P-N ligands 44 and 45 were synthesized starting from L-proline 
and their coordination chemistry to palladium was studied. Both neutral and cationic 
complexes were prepared and fully characterized, finding that the two ligands 
coordinated differently the palladium centre depending on their nature. In particular, 
the derivative 44 led to a dinuclear complex, while 45 to a mononuclear species. The 
cationic complexes 49a-c, with different pyridine-type ligands in fourth position, have 
been deeply investigated and all of them generated catalytic species for the styrene 
dimerization reaction yielding in all cases the trans-1,3-diphenyl-1-butene selectively 
as product. The reaction conditions were optimized investigating the effects of 
temperature, [styrene]/[Pd] ratio and [BQ]/[Pd] ratio, and the role played by the fourth 
pyridine-type ligand. 
Actually, the complex 49a, that was the most active among those tested, is under 
investigation in the styrene/ethylene co-dimerization reaction, that is of considerable 
importance from an industrial point of view. In fact, the selective co-dimerization 
between styrene and ethylene to give 3-phenyl-1-butene is investigated as a model 
reaction for the synthesis of drugs as Ibuprofene and Naproxen.20 
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General  
1H NMR and 13C NMR spectra were run at 400 and 500 MHz for proton and 100.1 
MHz for carbon using deuterochloroform and methylene chloride as solvents and 
tetramethylsilane as internal standard, the spectra were recorded at 25°C where not 
differently indicated. Optical rotations and CD spectra were determined at 25 °C. 
HRGC analyses were run on a OV 1701 capillary column (25 m x 0.32 mm), carrier 
gas He, 40 KPa, split 1:50 and in a SE 30 capillary column (30m x 0.32 mm) carrier 
gas He 50 KPa, split 1:60. Chiral High Resolution GC analyses were run on a 
Shimadzu GC-14B instrument, the capillary columns being ChiraldexTM type G-TA, γ-
cyclodextrin (40m X 0.25mm) (carrier gas Helium, 180 KPa, split 1:100), or DiMePe 
β-cyclodextrin (25m X 0.25mm) (carrier gas He, 110 KPa, split 1:50); TLC were 
performed on silica gel, using light petroleum-ethyl acetate or methylenechloride-
methanol mixtures as the eluent. Flash chromatography was run on silica gel, 230 – 
400 mesh using mixtures of light petroleum 40-70°C or chloroform and ethyl acetate 
as the eluent. CAL-B (Novozyme® 435) was purchased from Novo Nordisk A/S, 7000 
u/g. Dry Yeast from Saccaromyces Cerevisiae Type II was purchased from Sigma-
Aldrich. All complexes synthesis were carried out under argon atmosphere with 
Schlenk technique and at room temperature. The synthesis of chiral PN ligands were 
carried out with Schlenk technique and using freshly distilled and degassed solvents. 
 
SYNTHESIS OF LIGANDS 
N
O
 
2-Acetyl-6-phenylpyridine (6). Ketone 6 was prepared by means of a Suzuki–
Miyaura cross-coupling reaction. Palladium (II) acetate (5 mg, Mw 224, 0.025 mmol,), 
triphenylphosphine (0.02 g, Mw 262.28, 0.076 mmol), 2.0 M aqueous K2CO3 (5.0 mL, 
10 mmol,) and distilled water (10 ml) were added to a degassed solution of 2-acetyl-6-
bromopyridine (1.3 g, Mw 200, 6.50 mmol) and phenylboronic acid (1.0 g, Mw 
121.93, 8.2 mmol) in 1-propanol (16.0 mL), and the mixture was refluxed overnight. 
After cooling at room temperature, distilled water (5.0 mL) was added and the mixture 
was extracted with ethyl acetate, (2 x 25 mL). The organic layer was dried over 
anhydrous Na2SO4
 
and the solvent was evaporated to give the crude ketone, which was 
purified on a SiO2
 
column (petroleum ether 100%, then gradient to 2% ethyl acetate). 
Yield 92%. 1H NMR (400 MHz, CDCl3) δ 2.83 (s, 3H, COCH3), 7.46-7.54 (m, 3H), 
7.89-7.91 (m, 3H), 8.11 (m, 2H). 13C NMR 100.1 MHz, CDCl3) δ 25.4, 119.4, 123.0, 
126.5, 128.5, 129.1, 137.3, 138.0, 153.0, 155.9, 200.0. ESI-MS 198 (M+H+), 220 
(M+Na+). 
N
O
 
Benzo[h]quinoline-1-oxide (10). To a solution of benzo[h]quinoline (5 g, Mw 179.22, 
28 mmol) in 112 mL CHCl3 cooled to 0°C, was added a solution of MCPBA (12 g, 
Mw 172.17, 42 mmol, 60% purity) in 280 mL of CHCl3. The resulting mixture was 
stirred at room temperature for 5 days, then washed with 5% solution of K2CO3 (4 x 
125 mL), dried on sodium sulfate and concentrated under reduced pressure. 
Purification with column chromatography (CHCl3, then CHCl3/CH3OH 8:2 as eluent) 
gave pure  10 in 83% yield as a crystalline solid (m.p. 122 °C). 1H NMR (400 MHz, 
CDCl3) δ 7.43 (dd, J = 1.6, 6.4 Hz, 1H), 7.68 (d, J = 8.8 Hz, 1H), 7.77-7.82 (m, 3H), 
7.88 (d, J = 8.8 Hz, 1H), 7.95 (m, 1H), 8.69 (dd, J = 1.2, 6.4 Hz, 1H), 10.86 (m, 1H). 
13C NMR (100.1 MHz, CDCl3) δ 121.2, 125.0, 125.8, 127.8, 128.0, 128.3, 129.1, 
130.6, 131.3, 134.1, 139.3. ESI-MS 196 (M+H+), 218 (M+Na+).  
N Cl
 
2-Chlorobenzo[h]quinoline (11a-b). A mixture of 10 (4.533 g, Mw 195.22, 23 mmol) 
in 28 mL (Mw 153.33, δ 1,675 g/mL, 312 mmol) of POCl3 was refluxed for 30 min. 
The cooled reaction mixture was poured into crusher ice, neutralized with NH3 32% 
solution and extracted with CH2Cl2 (3 x 100 mL). the combined extracts were washed 
with water, dried on Na2SO4 and evaporated under reduce pressure. The residue was 
flash-chromatographed with CH2Cl2 as the eluent to give (11a) as the less-polar 
fraction (white solid m.p. 111 °C) . 1H NMR (400 MHz CDCl3) δ 7.52 (d, J = 8.4 Hz, 
1H), 7.67-7.76 (m, 3H), 7.85 (d, J = 9.2, 1H), 7.92 (m, 1H), 8.14 (d, J = 8.4, 1H), 9.23 
(m, 1H). 13C NMR (100.1 MHz, CDCl3) δ 122.6, 124.5, 124.7, 124.9, 127.3, 127.7, 
128.1, 128.7, 130.5, 133.8, 138.5, 146.6, 149.8. ESI-MS 214 (M+H+), 236 (M+Na+). 
4-Chlorobenzo[h]quinoline (11b) was isolated from the above flash-chromatography 
as the more polar fraction (10% yield). 1H NMR (400 MHz CDCl3) δ 7.661 (d, J = 4.8 
Hz, 1H), 7.72-7.79 (m, 2H), 7.93 (m, 2H), 8.14 (d, J = 9.2 Hz, 1H), 8.87 (d, J = 4.8 Hz, 
1H), 9.29 (m, 1H).  
N Br
 
2-Bromobenzo[h]quinoline (12). A solution of 2-chlorobenzo[h]quinoline (11a) 
(4.225 g, Mw 213.66, 20 mmol), and bromotrimethylsilane (5.28 mL, Mw 153.10, δ 
1.160 g/mL, 40 mmol) in propionitrile (20 mL) was heated under reflux 4 days. The 
mixture was poured into a 2M NaOH solution/ice mixture, and the aqueous solution 
extracted with diethyl ether (3 x 50mL). The combined organic phase was dried and 
evaporated to dryness obtaining 12 without further purifications. Yellow solid (96 % 
yield) m.p. 113-114 °C. IR (nüjol) 1621, 1577, 1561, 1463, 1020, 838, 798, 750, 741, 
714 cm-1. 1H NMR (400 MHz CDCl3) δ 7.66 (dd, J = 8, 2 Hz, 2H), 7.73 (m, 2H), 7.85 
(d, J = 8.8 Hz, 1H), 7.91 (m, 1H), 8.02 (d, J = 8.0, 1H), 9.22 (m, 1H). 13C NMR (100.1 
MHz, CDCl3) δ 124.6, 124.8, 125.2, 126.2, 127.4, 127.8, 128.3, 129.0, 130.5, 133.9, 
138.2, 141.0, 144.0, 147.3. ESI-MS 258, 260 (M+H+). 
N
O
 
2-Acetylbenzo[h]quinoline (7). To a stirred solution of 12 (1.520 g, Mw 258.11, 5.98 
mmol) in dry THF (36 mL), n-BuLi (4 mL, 6.18 mmol, 1.6 M in hexane solution) was 
added dropwise at -78 °C during 5-10 min under inert atmosphere (Ar). The resulting 
dark red solution was stirred for 1h, then anhydrous DMA (0.6 mL, Mw 87.12, δ 0.942 
g/mL, 6.45 mmol) was added at the same temperature. The reaction mixture was 
stirred for further 60 min and then the temperature was left to rise spontaneously 
ovenight. The solution was then quenched with HCl 1M (7.5 mL) and the two phases 
was separated. The organic layer was concentrated under reduce pressure, the residue 
was washed with water and extracted with Et2O. The organic phase was dried over 
MgSO4, evaporation of the solvent gave the crude ketone 7 which was 
chromatographed on SiO2 column (eluent: EP/EtOAc). 61% yield. 1H NMR (400 
MHz, CDCl3) δ 3.00 (s, 3H, COCH3), 7.68 – 7.83 (m, 3H); 7.91 (d, J = 9.1 Hz, 1H), 
7.95 (d, J = 8.4 Hz, 1H); 8.27 (AB quartet, J = 8.4 Hz, 2H), 9.37 (dm, 1H). 13C NMR 
(100.1 MHz, CDCl3) δ 25.8, 118.9, 124.5, 124.9, 127.5, 128.1, 128.3, 128.6, 130.0, 
131.6, 133.7, 136.5, 145.4, 151.6, 200.7. ESI-MS 222.1 (M+H+), 244.1 (M+Na+).  
NBr O
O
 
6-Bromo-2-(2’-methyl-1’,3’-dioxolan-2’-yl)pyridine (Br-36). A solution of 1.0 g 
(Mw 200, 5 mmol) of 2-Acetyl-6-bromo pyridine, 0.34 mL (Mw 62.07, δ 1.113 g/mL, 
6 mmol) of 1,2-ethandiol and 0.1 g (Mw 200, 0.5 mmol) of 4-toluensulfonic acid in 15 
mL of benzene was heated for 24 h under reflux in a Dean-Stark apparatus. The 
mixture was cooled to room temperature, and washed  twice with satured Na2CO3 (15 
mL). The aqueous phase was washed with benzene and the combined organic extracts 
dried on dry Na2SO4. After solvent removal at low pressure the crude was purified via 
column chromatography (PE/EtOAc as eluant). 93% yield. 1H NMR (400 MHz, 
CDCl3) δ 1.72  (s, 1H), 3.84-3.95 (m, 2H), 4.04-4.15 (m, 2H), 7.41 (dd, J = 2.0, 6.8 
Hz, 1H), 7.49-7.58 (m, 2H). 13C NMR (75 MHz, CDCl3) δ 25.1, 65.1, 108.0, 118.2, 
127.5, 138.7, 142.0, 162.5.  
N S(O)Et
 
Ethyl 2-pyridyl sulfoxide (35). To a solution of 2-mercaptopyridine (8.040 g, Mw 
111.17, 72 mmol) in 72 mL of aqueous 1 N NaOH were added 5.8 mL (Mw 155.97, δ 
1.95 g/mL, 73 mmol). The mixture was stirred vigorously over night and then 
extracted with Et2O (3 x 30 mL). The combined ethereal extract were washed with 2 N 
NaOH (2 x 20 mL), once with brine and dried on Na2SO4. Evaporation of the solvent 
in vacuo gave 2-(2-mercaptoethyl)pyridine as a pale orange oil in 95% yield. This 
product was used in the next step without further purification. The 2-(2-
mercaptoethyl)pyridine (9.526 g, Mw 139.22, 68 mmol) was dissolved in 144 mL of 
CH3OH and 21 g (Mw 494.65, 34 mmol, 80% purity) of magnesium 
monoperoxyphthalate was added in several portions while the temperature was 
maintained at 0°C. The mixture was stirred overnight and carefully concentrated by 
rotary evaporation keeping the bath temperature bellow 50°C. To the viscous slurry 
obtained  H2O was added and the resulting mixture was extracted with CHCl3. The 
organic extracts were washed with brine (2 x 20 mL) and dried (Na2SO4). Solvent 
removal under reduce pressure gave a crude which was cromatographed on SiO2 
(Et2O/EtOAc as eluant), 80% yield. 1H NMR (400 MHz, CDCl3) δ 1.20 (t, J =  7.4 
Hz, 3H), 2.90-2.97 (m, 1H), 3.15-3.22 (m, 1H), 7.37 (ddd, J = 1.5, 4.7, 7.3 Hz, 1H), 
7.93 (dt, J = 1.7, 7.6 Hz, 1H), 8.00 (dt, J = 1.1, 7.5 Hz, 1H), 8.62 (dd, J = 1.6, 4.7 Hz, 
1H).  
N
N
O
 
6-Acetyl-2,2’-bipiridine (33). A slurry of 4.412 g (Mw 244.08, 18 mmol) of  Br-36 in 
100 mL of freshly distilled THF, was cooled in a acetone/liquid nitrogen bath (- 80 °C) 
under argon atmosphere and 13.5 mL (1.6 M in n-hexane, 22 mmol) of n-Butyllithium 
was added dropwise. After being stirred for 45’, a solution of  35 (5 g, Mw 152.17, 32 
mmol) in THF (50 mL) was dropped in the mixture at -70°C. the intensely red mixture 
was stirred overnight at room temperature and then quenched wit satured NH4Cl 
solution (40 mL). the organic phase was separated, the aqueous phase was washed 
twice with ethyl acetate (40 mL) and the combined organic extracts were dried 
(Na2SO4) and evapored at low pressure. The remaining red oil was stirred for 3 h at 
60°C in 2 M HCl (85 mL) and cooled to room temperature, EtOAc (30 mL) was added 
and the mixture was carefully neutralized by addition of solid NaHCO3. The resulting 
mixture was extracted with EtOAc (4 x 30 mL) and the combined organic phases were 
washed repeatedly with water and once with brine, then dried on Na2SO4 and 
evapored. The residual solid was purified by column chromatography (CH2Cl2/EtOAc 
as eluant) obtaining the ketone 33 in 60% yield. 1H NMR (400 MHz, CDCl3) δ 2.81 
(s, 3H, CH3CO), 7.31 (ddd, J = 1.2, 4.7, 7.5 Hz, 1H), 7.82 (dt, J = 1.7, 7.7 Hz, 1H), 
7.90 (t, J = 7.8 Hz, 1H), 8.02 (dd, J = 1.2, 7.7 Hz, 1H), 8.49 (d, J =  8.0 Hz, 1H), 8.59 
(dd, J = 1.2, 7.8 Hz, 1H), 8.67 (dm, J = 4.8 Hz, 1H). 13C NMR (100.1 MHz, CDCl3) δ 
25.8,121.0, 121.4, 124.1, 124.2, 136.9, 137.7, 149.2, 152.9, 155.3, 155.3, 200.0. ESI-
MS 199 (M+H+), 221 (M+Na+). 
NBr
OH  
(6-bromopyridin-2-yl)methanol (40). Was prepared in quantitative yield by NaBH4 
reduction of 6-bromo-2-pyridinecarboxaldehyde (see the general procedure for the 
synthesis of racemic alcohol reported below). 1H NMR (400 MHz, CDCl3) δ 3.20  (s, 
1H, OH), 4.63 (s, 2H, CH2), 7.15-7.46 (m, 3H). 13C NMR (100.1 MHz, CDCl3) δ 
64.1, 119.3, 126.5, 139.1, 141.2, 161.4. 
N
OHMe3Si  
 (6-((Trimethylsilyl)ethynyl)pyridin-2-yl)methanol (41). Trimethylsilylacetylene 
(1.11 mL, Mw 98.22, δ 0.695 g/mL, 8.0 mmol) was added to a stirred solution of 40 
(376 mg, Mw 188.02, 2.0 mmol), Pd(PPh3)4 (48 mg, Mw 1155.58, 0.04 mmol) and 
CuI (11 mg, Mw 190.45, 0.08 mmol) in 8 mL of triethylamine. The mixture, from 
which a white precipitate formed, was heated at 50°C then cooled at room temperature. 
The conversion of into the product was complete in a few minutes (TLC with ethyl 
acetate). After addition of ether, the solution was washed with aq. NH4Cl (sat.), dried 
over Na2SO4, and evaporated to give a crude product  which was used in the further 
step without purification. For analytical pourposes, a pure sample of 41 was obtained 
by flash chromatrography (eleuent petroleum ether/ethyl acetate 3:2) 1H NMR (400 
MHz, CDCl3) δ 0.36 (s, 9H, Me3Si), 4.57 (s, 2H, CH2OH), 7.21 (d, J = 7.7 Hz, 1H, 
H5), 7.35 (d, J = 7.7 Hz, 1H, H3), 7.62 (t, J = 7.7 Hz, 1H ,H4). 13C NMR (100.1 MHz, 
CDCl3) δ –0.4 (SiMe3), 64.3 (CH2OH), 95.1, 103.4, 120.0, 126.0, 136.7, 141.8, 159.9. 
ESI-MS 206.1 (M+H+). 
N
OH  
(6-Ethynylpyridin-2-yl)methanol (42). The crude 41 (410 mg, Mw 205.33, 2 mmol 
assuming a 100% yield in the previous step) was dissolved in THF, then Bu4NF (1M 
solution in THF, 3 mL, 3 mmol) was added at room temperature. After 10 min stirring, 
ether was added and the solution washed with water first, then with sat. NH4Cl, finally 
dried over Na2SO4 and evaporated to give an oily residue which was purified on 
column chromatography (petroleum ether/ethyl acetate 8:2); yield 78%. Crystalline 
product, mp 108 °C. 1H NMR (400 MHz, CDCl3) δ 3.15 (s, 1H, CCH), 3.90 (bs, OH), 
4.73 (s, 2H. CH2OH), 7.29 (d, J = 7.9 Hz, 1H), 7.36 (d, J = 7.7 Hz, 1H), 7.64 (dd, J =  
7.7, 7.9 Hz, 1H). 13C NMR (100.1 MHz, CDCl3) δ 64.2 (t, CH2OH), 77.4, 82.4, 120.4, 
126.0, 136.9, 141.0, 160.2. ESI-MS 156.1 (M+Na+). 
N
OHN N N  
(6-(1-methyl-1H-1,2,3-triazol-4-yl)pyridin-2-yl)methanol  (43). Acetylene 42 (0.146 
g, Mw 133.15, 1.1 mmol), CH3I (0.142 g, Mw 141.94, 1.0 mmol), and sodium azide 
(0.071 g, Mw 65.01, 1.1 mmol) were suspended in a 1:1 mixture of water and tert-
BuOH (1 mL each) in a 10 mL glass vial equipped with a small magnetic stirring bar. 
CuI (0.1 g, Mw 190.45, 0.52 mmol) was added and the mixture was irradiated under 
MW for 10 min at 100 °C, using an irradiation power of 100 W. A yellow precipitate 
was filtered off, and the solution concentrated to dryness in vacuo, giving a residue 
from which compound 43 was obtained  in a 74% yield after flash chromatography. 
White solid, mp > 200°C; IR (Nujol) 3445, 3310, 3063, 1599, 1580 cm-1. 1H NMR 
(400 MHz, CDCl3) δ 4.14 (s, 3H, CH3N), 4.76 (s, 2H, CH2OH), 4.82 (s, 1H, OH), 
7.16 (d, J = 7.9 Hz, 1H, H3), 7.74 (t, J = 7.9 Hz, 1H, H4), 8.01 (d, J = 7.9 Hz , 1H, H5), 
8.12 (s, 1H, triazole13C NMR (from CH COSY, 100.1 MHz, CDCl3) δ 36.8 (CH3N), 
63.9 (CH2OH), 118.7 (C5 Py), 119.6 (C3 Py), 123.1 (C5 triazole), 137.6 (d, C-4 py), 
148.1, 148.9, 158.7. ESI-MS 191.1 (M+H+), 214.1 (M + Na+).  
 
Racemic alcohol synthesis: general procedure 
NaBH4 (190 mg, Mw 37.82, 5 mmol) was added portionwise, at room temperature, to 
an ethanol solution of prochiral ketone (5 mmol). The mixture was stirred for 2 h 
(TLC); the solvent was evaporated under reduced pressure and the residue was washed 
with saturated solution of NH4Cl and extracted with CH2Cl2. The organic phase was 
dried on anhydrous Na2SO4
 
and evaporated to give the racemic alcohol in 99% yield, 
which was used without further purification. 
N
OH
 
(±)-2-(1-Hydroxyethyl)-6-phenylpyridine (rac-13). 1H NMR (400 MHz, CDCl3) δ 
1.55 (d, J = 6.4 Hz, 3H, CHCH3), 4.75 (d, J = 4.4 Hz, 1H, OH), 4.95 (m, J = 2.0, 4.4, 
6.4 Hz, 1H, CHCH3), 7.20 (ddd, J = 0.7, 1.5, 7.6 Hz, 1H), 7.41-7.51 (m, 3H), 7.65 (d, J 
= 7.2 Hz, 1H), 7.76 (dd, J = 7.6, 8.0 Hz, 1H), 8.03 (m, 2H). 13C NMR (100.1 MHz, 
CDCl3) δ 24.2, 68.5, 118.2, 118.8, 126.8, 128.7, 129.1, 137.6, 138.7, 155.6, 162.5. 
ESI-MS 200 (M+H+), 222 (M+Na+).  
N
OH
 
(±)-2-(1-Hydroxyethyl)benzo[h]quinoline (rac-14). IR (neat) 3403, 3050, 1623, 
1596, 1566, 1504 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.64 (d, J = 6.6, 3H, CH3CH), 
5.12 (dq, J = 4.4, 6.6 Hz, 1H, CHOH), 5.26 (d, J = 4.4 Hz, 1H, OH), 7.47 (d, J = 8.0 
Hz, 1H), 7.70 (d, J = 9.0 Hz, 1H), 7.73 (m, 3H), 7.93 (dd, J = 1.8, 8.8 Hz, 1H), 9.29 
(dm, 1H). 13C NMR (100.1 MHz, CDCl3) δ 24.7, 68.8, 118.4, 124.2, 124.9, 125.4 , 
127.0, 127.4, 127.8, 128.3 , 131.4, 133.7, 136.8, 145.9, 158.9. ESI-MS 224.1 (M+H+), 
246.1 (M+Na+). 
N
OH
Br
 
(±)-1-(6-bromopyridin-2-yl)ethanol (rac-22). From 2-acetyl-6-bromopyridine: 1H 
NMR (400 MHz, CDCl3) δ 1.48 (d, J = 6.4 Hz, 3H, CHCH3), 3.40 (d, J = 4.9 Hz, 1H, 
OH), 4.86 (m, 1H, CHCH3), 7.28 (d, J = 7.7 Hz, 1H), 7.38 (d,  J = 8.0 Hz, 1H), 7.55 
(dd, J = 7.6, 8.0 Hz, 1H). 13C NMR (100.1 MHz, CDCl3) δ 24.5, 69.6, 118.9, 127.0, 
139.6, 141.6, 165.6. ESI-MS 202, 204 (M+H+). 
N
N
OH
 
(±)-1-(2,2’-bipyridin-6-yl)ethanol (rac-37). 1H NMR (400 MHz, CDCl3) δ 1.56 (d, J 
= 6.4 Hz, 3H, CH3), 4.59 (d, J = 4.8 Hz, 1H, OH), 4.97 (m, 1H, CHCH3), 7.29 (d, J = 
7.6 Hz, 1H), 7.33 (ddd, J = 1.2, 4.8, 7.6 Hz, 1H), 7.84 (m, 2H), 8.33 (d,  J = 7.6 Hz, 
1H), 8.43 (dm , J = 8.0 Hz, 1H), 8.68 (dm,  J = 4.8 Hz, 1H). 13C NMR (100.1 MHz, 
CDCl3) δ 24.1, 68.7, 119.3, 119.7, 120.9, 123.6, 136.7, 137.6, 148.9, 154.2, 155.4, 
162.4. ESI-MS 202 (M+H+), 223 (M+Na+). 
 
Enantiopure sec-alcohols synthesis  
1. Baker’yeast reduction  
To a stirred suspension of dry baker’s yeast (15.5 g/mmol substrate) in phosphate 
buffer (Na2HPO4/KH2PO4 0.1 M, pH 7.4, 1000 mL) was added glucose (112 g) or 
sucrose (56 g). The mixture was pre-incubated for 30 min at 37 °C and the prochiral 
ketone (3.6 mmol) was added at room temperature. The reaction was monitored by 
HRGC. At the end of the reaction, (reaction time depending on the substrate) the broth 
was extracted with ether. The organic phase was dried and evaporated to give a residue 
which was chromatographed on SiO2 (PE/EtOAc as eluent). 
 
N
OH
 
(S)-(+)-2-(1-Hydroxyethyl)-6-phenylpyridine ((S)-13). 6 days, 76% yield at 
98%conv., e.e.>99.9% (by HRGC), [α]D
 
+22.0 (c 0.55, CHCl3) [lit.:
 
[α]D
 
+28.0 (c 1.00, 
CHCl3)]. 
N
OH
Br
 
(S)-(‒)-1-(6-bromopyridin-2-yl)ethanol ((S)-22). 24 h, 87% yield at 97% conv., e.e. 
= 96% (by HRGC), [α]D  ‒ 7.2 (c 0.25, CHCl3) [lit.:
 
[α]D ‒ 11
 
 (c 2.15, CHCl3)]. 
N
N
OH
 
(S)-(+)-1-(2,2’-bipyridin-6-yl)ethanol ((S)-37). 48 h, 75% yield at 93% conv., e.e. = 
99% (by HRGC), [α]D + 21.7 (c 0.35, CHCl3) [lit.: [α]D + 26 (c 1.62, CHCl3)].  
 
2. Enzymatic acetylation of racemic secondary alcohols  
A mixture of the racemic secondary alcohol (0.5 mmol), CAL-B (Novozyme®
 
435, 50 
mg), anhydrous tert-butyl methyl ether (8.4 mL) and vinyl acetate (140 µL, Mw 86.09, 
δ 0.934 g/mL, 1.55 mmol) was vigorously stirred at 28 °C under an argon 
athmosphere. At approximately 50% conversion (determined by HRGC) the mixture 
was filtered through celite, the pad was washed with dichloromethane and the 
combined organic phases were evaporated under reduced pressure. The crude reaction 
mixture was purified by flash column chromatography (petroleum ether/ethyl acetate 
as eluent) to obtain the (R)- acetates and the unreacted (S)-alcohols. 
(R)-(+)-2-(1-Acetoxyethyl)-6-phenylpyridine 45% yield, e.e. > 99.9% 
(S)-(+)-2-(1-Hydroxyethyl)-6-phenylpyridine 50% yield, e.e. = 79% 
(R)-(+)-2-(1-Acetoxyethyl)benzo[h]quinoline 40% yield, e.e. > 99% 
N
OH
 
(S)-(+)-2-(1-Hydroxyethyl)benzo[h]quinoline ((S)-14) obtained by this route (47% at 
44% conversion) had e.e. = 86% (from the 1H-NMR analysis of the corresponding 
Mosher’s ester), [α]D +58.0 (c 0.4, CHCl3).  
3. Dynamic kinetic resolution of racemic secondary alcohols 
Catalyst [Ru2(CO)4(µ-H)(C4Ph4-COHOCC4Ph4)] (21 mg, Mw 1085.15, 0.04 mmol) 
and Novozyme® 435 (60 mg) were suspended in toluene, under argon. A degassed 
solution of the racemic alcohol (2 mmol) and 4-chlorophenyl acetate (1.02 g, Mw 
170.59, 6 mmol) in toluene (5 mL) was transferred to this suspension, and the mixture 
was stirred under argon, at 70 °C, until complete conversion (HRGC). The enzyme 
was filtered off, and the reaction mixture was separated on silica (petroleum 
ether/ethyl acetate as eluent) to yield optically pure (R)-acetate.  
 
N
O
O  
(R)-(+)-2-(1-Acetoxyethyl)-6-phenylpyridine ((R)-15) was obtained in 71% yield, 
after chromatography, from the DKR of alcohol 13 (93% conversion), e.e. > 99.9% (by 
chiral HRGC), [α]D + 87.0 (c 0.25, CHCl3); [lit.: [α]D
 
+86.0 (c 1.00, CHCl3) e.e. = 
98%]. 1H NMR (400 MHz, CDCl3) δ 1.66 (d, J = 6.4 Hz, 3H, CH3CH), 2.15 (s, 3H, 
CH3CO), 6.01 (q,  J = 6.4 Hz, 1H, CHOAc), 7.27 (d, J = 8 Hz, 2H), 7.45 (m, 3H), 7.64 
(dd, J = 0.8, 7.6 Hz, 1H), 7.74 (dd,  J = 7.6, 8.0 Hz, 1H), 8.03 (m, 2H). 13C NMR 
(100.1 MHz, CDCl3) δ 20.6, 21.3, 73.3, 118.4, 119.2, 126.9, 128.7, 128.9, 137.3, 
139.2, 156.6, 160.2, 170.3. ESI MS 242 (M+H+), 264 (M+Na+). 
N
O
O
 
 (R)-(+)-1-(benzo[h]quinolin-2-yl)ethyl acetate ((R)-16). e.e. > 99.9 % at 90 % conv., 
yield 75%, [α]D + 119.0 (c 0.5, CHCl3). IR (neat) 3050, 1738, 1623, 1596, 1566, 1504 
cm-1. 1H NMR (400 MHz, CDCl3) δ 1.64 (d, J = 6.6, 3H, CH3CH), 2.19 (s, 3H, 
CH3CO), 6.22 (q, J = 6.6 Hz, 1H, CH3CH), 7.58 (d, J = 8.0 Hz, 1H), 7.65 (d, J = 9.2 
Hz, 1H), 7.70 (m, 2H), 7.89 (dd, J
 
= 1.5, 8.8 Hz, 3H), 8.17 (d, J
 
= 8.0 Hz, 1H), 9.34 (d, 
J = 7.3 Hz, 1H). 13C NMR (100.1 MHz, CDCl3) δ 20.7, 21.4, 73.7, 118.7, 124.6, 
125.0, 125.4, 126.9, 127.6, 127.65, 128.1, 131.4, 133.7, 136.5, 145.6, 158.9, 170.5. 
ESI MS 266.1 (M+H+), 288.2 (M+Na+). 
N
O
Br
O
 
(R)-(+)-1-(6-bromopiridyn-2-yl)ethyl acetate ((R)-23). e.e. = 98.6% (by chiral 
HRGC) at  88 % conv., yield 78%. [α]D + 70 (c 0.5, CHCl3) [lit.: [α]D + 72 (c 2.09, 
CHCl3)]. 1H NMR (400 MHz, CDCl3) δ 1.51 (d, J = 6.7 Hz, 3H, CH3CH), 2.13 (s, 
1H, CH3CO), 5.86 (q, J = 6.7 Hz, 1H, CH3CH), 7.29 (d, J = 7.7 Hz, 1H), 7.43 (d, J = 
7.7 Hz, 1H), 7.55 (dd, J = 7.7, 8.0 Hz, 1H).  13C NMR (100.1 MHz, CDCl3) δ 20.6, 
21.1, 72.3, 118.9, 127.0, 139.0, 141.5, 161.8, 170.0. ESI MS 245, 247 (M+H+). 
N
N
O
O
 
(R)-(+)-1-(2,2’-bipyridin-6-yl)ethyl acetate ((R)-38). e.e. > 99.9 % (by chiral HRGC) 
at 78 % conv., yield 60%. [α]D + 89 (c 0.5, CHCl3) [lit.: [α]D + 85 (c 1.87, CHCl3)]. IR 
(neat) 1735 cm-1. 1H NMR (400 MHz, CDCl3) δ 1.66 (d, J = 6.8 Hz, 3H, CH3CH), 
2.15 (s, 3H, CH3CO), 6.02 (q, J = 6.8 Hz, 1H, CH3CH), 7.30 (m, 1H), 7.35 (d, J = 7.6 
Hz, 1H), 7.81 (t, J = 8.0 Hz, 2H), 8.31 (d, J = 8.0 Hz, 1H), 8.46 (dm, J = 8.0 Hz, 1H), 
8.66 (dm, J = 4.8 Hz, 1H). 13C NMR (100.1 MHz, CDCl3) δ 20.5, 21.2, 73.1, 119.7, 
120.1, 121.3, 123.7, 136.8, 137.5, 148.9, 155.3, 156.0, 159.6, 170.2. ESI-MS 243 
(M+H+). 
 
Acetate hydrolysis: general procedure. 
The acetate (1.4 mmol) was hydrolyzed by K2CO3 (193 mg, Mw 138.21, 1.4 mmol) in 
methanol/water (1:1) mixture at room temperature following the reaction with TLC. 
Methanol was evaporated under reduced pressure, and the aqueous phase was 
extracted with CH2Cl2 (3 × 20 mL). The combined organic phases were washed with 
brine, dried over Na2SO4, and concentrated in vacuum. Flash chromatography on silica 
(eluent depending on the substrate: CH2Cl2/Ethyl Acetate for 37, EP/EtOAc other 
alcohols) gave the pure alcohol quantitatively. 
 
 
N
OH
 
(R)-(‒)-2-(1-Hydroxyethyl)-6-phenylpyridine ((R)-13). e.e. > 99.9% (by chiral 
HRGC) [α]D –24.0 (c 0.30, CHCl3). 
N
OH
 
(R)-(‒)-2-(1-Hydroxyethyl)benzo[h]quinoline ((R)-14). e.e. > 99.9% (from the 1H 
NMR analysis of the corresponding Mosher’s ester), [α]D – 85.3 (c 0.3, CHCl3).  
NBr
OH  
(R)-(+)-1-(6-bromopyridin-2-yl)ethanol ((R)-22).  e.e. = 98.6% (by chiral HRGC), 
[α]D + 12 (c 0.5, CHCl3).  
N
N
OH
 
(R)-(‒)-1-(2,2’-bipyridin-6-yl)ethanol ((R)-37). e.e.>99.9% (by chiral HRGC), [α]D – 
21.3 (c 0.6, CHCl3). 
 
Mosher’s ester synthesis: general procedure 
To a solution of 0.01 mmol of alcohol Et3N (4µL, Mw 101.19, δ 0.726 g/mL, 0.03 
mmol) and DMAP (a small crystal, ca. 1 mg) were added at room temperature, then a 
solution of (R)-(‒)-Mosher’s chloride (0.012 mmol) in DCM was added dropwise and 
the total mixture refluxed, the reaction was followed with TLC. The crude mixture was 
the evaporated and the residue recovered with a 5% solution of citric acid and 
extracted with DCM. The organic phases were dried on Na2SO4 and evapored. The 1H-
NMR analysis to get e.e.% value of alcohols were done on the crude diasteromeric 
Mosher’s esters.  
 
 
 
N
NHO
OCH3
CF3
H
N
NHO
OCH3
CF3
H
(R,R) (R,S)
 
N-(1-(benzo[h]quinolin-2-yl)ethyl)-3,3,3-trifluoro-2-methoxy-2-
phenylpropanamide.1H NMR (400 MHz, CDCl3) δ 1.83 (d, 3H, CH3CH RR diast.), 
1.89  (d, 3H, CH3CH RS diast.), 8.11 (d, 1H, aromatic proton RS diast.), 8.18 (d, 1H, 
aromatic proton RR diast.),9.27 (d, 1H, H10 RS diast.), 9.35 (d, 1H, H10 RR diast.). 
 
Transformation of the alcohols  into amines with inversion of configuration (SN2): 
general procedure  
 
Diphenylphoshoroazidate (2.2 mL, Mw 275.20, δ = 1.717 g/mL, 10 mmol) was added 
dropwise, at 0 °C, under argon atmosphere, to a solution of alcohol  (7.0 mmol) and 
DBU (1.5 mL, Mw 152.24, δ = 1.019 g/mL, 10 mmol) in dry toluene and the reaction 
mixture was stirred for 2 h at 0 °C, then at 50 °C overnight (room temperature 
overnight to obtain (S)-(–)-24 and (R)-(+)-24). The resulting two-phase mixture was 
extracted with brine, and 5% HCl. The organic phase was dried over Na2SO4
 
and the 
solvent was evaporated in vacuo. The crude reaction mixture was purified by flash 
chromatography (eluent: petroleum ether/ethyl acetate 8:2) giving the pure azide 
(75%). 
N
N3
 
(R)-(+)-2-(1-Azidoethyl)-6-phenylpyridine ((R)-17) e.e. > 99.9% (by chiral HRGC), 
[α]D +9.4 (c 0.85, CHCl3), [lit.:
 
+ 7.4 (c 2.4 CHCl3). IR (neat) 3063, 2099, 1590, 1574, 
1516 cm-1. 1H NMR (400 MHz, CDCl3) δ 1.67 (d, J = 6.9 Hz, 3H, CH3CH); 4.66 (q, J 
= 6.9 Hz, 1H, CH3CH),
 
7.26 (dd, J = 0.7, 5.8 Hz, 1H), 7.42 (m, 1H), 7.47 (m, 2H), 
7.68 (dd, J
 
= 1.1, 8.0 Hz, 1H), 7.77 (dd, J
 
= 7.7, 8.0 Hz, 1H), 8.05 (dm, 2H). 13C NMR 
(100.1 MHz, CDCl3) δ 20.0, 61.4, 118.8, 119.4, 127.0, 128.7, 129.1, 137.7, 139.0, 
156.9, 160.0. ESI-MS 225.1 (M+H+), 247.0 (M+Na+). 
 
N
N3
 
(S)-(–)-2-(1-Azidoethyl)-6-phenylpyridine ((S)-17). e.e. = 97% (by chiral HRGC), 
75% yield (from (R)-13 having > 99.9% e.e.), [α]D –9.2 (c 0.7, CHCl3).  
N
N3
 
(R)-(+)-2-(1-Azidoethyl)benzo[h]quinoline ((R)-18). e.e. = 80% , [α]D = + 11.6 (c 
0.8, CHCl3) 75% yield from (S)-14. IR (neat) 3051, 2105, 1623, 1594, 1566, 1504 
cm-1. 1H NMR (400 MHz, CDCl3) δ 1.78 (d,  J = 7.0 Hz, 3H, CH3CH), 4.83 (q,  J = 
6.6 Hz, 1H, CH3CH), 7.53 (d,  J = 8.0 Hz), 7.67 (d,  J = 8.8 Hz, 1H), 7.71 (m, 3H), 
7.80 (d,  J = 8.8 Hz, 1H), 7.89 (dd,  J = 1.5, 9.0 Hz, 1H), 8.18 (d,  J = 8.0 Hz, 1H), 9.33 
(dd, J = 1.1, 8.0 Hz, 1H). 13C NMR (100.1 MHz, CDCl3) δ 20.1, 61.7, 118.9, 124.7, 
124.9, 125.5, 127.0, 127.7, 127.8, 128.2, 131.4, 133.8, 135.8, 144.3, 162.0. ESI-MS 
271.1 (M+Na+).  
N
N3
 
(S)-(–)-2-(1-Azidoethyl)benzo[h]quinoline ((S)-18). e.e.= 95%, [α]D –15.3 (c 0.8, 
CHCl3), 75% yield from (R)-14.  
Br N
N3  
(R)-(+)-2-(1-azidoethyl)-6-bromopyridine ((R)-24). e.e. = 95%, [α]D + 15 (c 0.25, 
CHCl3), 70% yield from ((S)-22) (e.e. = 96%).IR (neat) 3357, 2981, 2932, 2106, 
1581, 1557, 1432, 1406 cm-1. 1H NMR (400 MHz, CDCl3) δ 1.59 (d, J = 6.8 Hz, 3H, 
CH3CH), 4.66 (q, J = 6.8 Hz, 1H, CH3CH), 7.33 (d, J = 7.6 Hz, 1H), 7.41 (d, J = 8.0 
Hz, 1H), 7.57 (dd, J = 7.6, 8.0 Hz, 1H). 13C NMR (100.1 MHz, CDCl3) δ 20.3, 61.1, 
119.3, 127.3, 139.4, 141.7, 161.7. ESI-MS 250 (M+Na+). 
 
 
 
Br N
N3  
(S)-(–)-2-(1-azidoethyl)-6-bromopyridine ((S)-24). e.e. = 97%, [α]D  – 15.5 (c0.25, 
CHCl3), 70% yield from ((R)-22) (e.e. = 98%).  
 
Azide reduction: general procedure  
H2O (0.16 g, 9 mmol) and PPh3 (1.4 g, Mw 262.28, 5.4 mmol) were added to a 
solution of the azide  (4.5 mmol) in THF (10 mL). The mixture was refluxed until the 
starting material had disappeared (TLC) and then concentrated in vacuo. The residue 
was partitioned between water and dichloromethane and the organic phase was dried 
over anhydrous Na2SO4. The solvent was evaporated under reduced pressure to give 
the crude amine which was purified by flash chromatography (eluent: CHCl3, then 
EtOAc/CH3OH 8:2). 
N
NH2
 
(R)-(+)-2-(1-Aminoethyl)-6-phenylpyridine ((R)-4) e.e. > 99.9%, 97% yield, [α]D = 
+10.5 (c 0.4, EtOH) [lit.: + 2.0, c 2.0, EtOH). IR (neat) 3363, 3049, 2967, 2925, 1595, 
1564, 846, 736 cm-1. 1H NMR (400 MHz, CDCl3) δ 1.48 (d, J = 7.0 Hz, 3H, CH3CH), 
1.87 (bs, 2H, NH2), 4.19 (q, J = 7.7 Hz, 1H, CH3CH), 7.21 (d, J = 7.7 Hz, 1H) 7.41 (m, 
1H) 7.47 (m, 2H), 7.59 (dd, J  = 0.8, 8.0 Hz, 1H), 7.70 (dd, J  = 7.6, 8.0 Hz, 1H), 8.04 
(dm, 2H); 13C NMR (100.1 MHz, CDCl3) δ 24.5, 52.5, 118.4, 126.9, 128.6, 128.8, 
137.2, 137.5, 156.4, 165.3; ESI-MS 199.1 (M+H+). 
N
NH2
 
(S)-(–)-2-(1-Aminoethyl)-6-phenylpyridine ((S)-4).  e.e. = 97%,  95% yield,  [α]D –
8.6 (c 0.35, EtOH).  
N
NH2
 
(R)-(–)-2-(1-Aminoethyl)benzo[h]quinoline ((R)-5). e.e. = 80% (by 1H NMR 
analysis of the corresponding mandelic acid amide), 95% yield from (R)-14; [α]D –
17.8 (c 0.45, CHCl3). IR (neat) 3363, 3359, 3049, 1623, 1595, 1564, 1502 cm-1. 1H 
NMR (400 MHz, CDCl3) δ 1.57 (d, J = 6.6, 3H, CH3CH), 2.10 (bs, 2H, NH2), 4.40 (q, 
J = 6.6 Hz, 1H, CH3CH), 7.51 (d, J = 8.2 Hz, 1H), 7.65 – 7.78 (m and d, 3H), 7.90 (dd, 
J = 1.9, 8.0 Hz, 1H), 8.12 (d, J = 8.2 Hz, 1H), 9.36 (dd, J = 1.9, 7.4 Hz, 1H). 13C NMR 
(100.1 MHz, CDCl3) δ 24.7, 52.9, 118.7, 124.4, 124.9, 125.1, 126.7, 127.0, 127.7, 
128.0, 131.4, 133.7, 136.3, 145.6, 164.4. ESI-MS 223.1 (M+H+). 
N
NH2
 
(S)-(+)-2-(1-Aminoethyl)benzo[h]quinoline ((S)-5). e.e. = 95% (by 1H NMR analysis 
of the corresponding mandelic acid amide), 94% yield from (S)-14, [α]D + 21.0 (c 
0.45, CHCl3).  
Br N
NH2  
(R)-(+)-1-(6-bromopyridin-2-yl)ethanamine ((R)-21). e.e. = 95%, 90% yield, [α]D + 
15 (c 0.25, CH3OH). 1H NMR (400 MHz, CDCl3) δ 1.42 (d, J = 6.8 Hz, 3H CHCH3), 
1.79 (bs, 2H, NH2), 4.13 (q, J = 6.8 Hz, 1H, CHCH3), 7.28 (d, J = 7.2 Hz, 1H), 7.34 (d, 
J = 8.0 Hz, 1H), 7.50 (t, J = 7.6 Hz, 1H). 13C NMR (100.1 MHz, CDCl3) δ 24.2, 52.2, 
118.8, 126.2, 139.0, 141.7, 179.6; ESI-MS 184, 186 (M–NH2), 201, 203 (M+H+), 223, 
225 (M+Na+).   
N
NH2
Br
 
(S)-(–)-1-(6-bromopyridin-2-yl)ethanamine ((S)-21). e.e. = 97%, 96 % yield, [α]D – 
15.5 (c 0.25, CH3OH). 
 
Mandelic’s amide synthesis: general procedure 
A solution of (R)-(‒)-mandelic acid (31 mg, Mw 152.15, 0.202 mmol) in dry DMF was 
stirred at room temperature and HOBt (27 mg, Mw 135.13, 0.202 mmol), Et3N (37 µL, 
Mw 101.19, δ 0.726 g/mL, 0.270 mmol) and the amine (0.135 mmol) were added, the 
solution’s pH has to be close to 8. The mixture was cooled to 0°C and EDC (38 mg, 
Mw 191.70, 0.20 mmol) was added portion wise. The reaction was run at 0°C for 1h 
then refluxed until the disappearance of the reactants (TLC). The solvent was evapored 
and the crude recovered with brine and extracted with EtOAc, the combined organic 
extracts were washed with a solution of 5% citric acid and then with a solution of 
satured NaHCO3, the organic phase was dried on Na2SO4 and evapored. The 1H NMR 
analysis to get e.e.% value of the amines were done on the crude diasteromeric mixture 
of mandelic’s amides. 
N
NHO
OH
H
H
N
NHO
OH
H
H
(R,R) (R,S)
 
N-(1-(benzo[h]quinolin-2-yl)ethyl)-2-hydroxy-2-phenylacetamide. 1H NMR (400 
MHz, CDCl3) δ 1.55 (d, 3H, CH3CH RS diast.), 1,62 (d, 3H, CH3CH RR diast.), 8.9 
(m, 1H, H10 RR diast.), 9.00 (m, 1H, H10 RS diast.). 
 
Synthesis of CNN pincer ligands 4a-h: general procedure 
CNN pincer ligands characterized by different Ar groups were synthesized by means 
of a Suzuki–Miyaura cross-coupling reaction. Palladium (II) acetate (2.2 mg, Mw 224, 
0.01 mmol,), triphenylphosphine (8 mg, Mw 262.28, 0.03 mmol), 2.0 M aqueous 
K2CO3 (5 mL, 9.78 mmol,) and distilled water (4 ml) were added to a degassed 
solution of (S) or (R)-21 (0.520 g, Mw 201.06, 2.58 mmol) and phenylboronic acid 
(3.26 mmol) in 1-propanol (16.5 mL), and the mixture was refluxed overnight.  
After cooling at room temperature and solvent evaporation, satured NaHCO3 solution 
(10.0 mL) was added and the mixture was extracted with ethyl acetate, (4 x 15 mL). 
The organic layer was dried over anhydrous Na2SO4
 
and the solvent was evaporated to 
give the crude amine which was purified on a SiO2
 
column (150 mL PE/EtOAc 8:2, 
150 mL PE/EtOAc 1:1  then EtOAc/MeOH/NH3 90:10:0.1). 
With this procedure were synthesized:  
N
NH2
 
(R)-(+)-1-(6-p-tolylpyridin-2-yl)ethanamine ((R)-4d). e.e. = 80%, 78 % yield, [α]D + 
2 (c 0.75, CH3OH). IR (neat) 3355, 2966, 2922, 1589, 1586, 1446, 800 cm-1. 1H NMR 
(400 MHz, CDCl3) δ 1.48 (d, J = 6.8 Hz, 3H, CHCH3), 2.21 (bs, 2H, NH2), 2.40 (s, 
3H, p-Tol CH3), 4.19 (q, J = 6.8 Hz, 1H, CHCH3), 7.17 (d, J = 7.6 Hz, 1H), 7.27 (d, J 
= 8.4 Hz, 2H), 7.56 (d, J = 8.8 Hz, 1H), 7.68 (dd, J = 7.6, 8.0 Hz, 1H), 7.93 (d, J = 8.4 
Hz, 2H). 13C NMR (100.1 MHz, CDCl3) δ 21.2, 24.4, 52.4, 118.1, 126.8, 129.4, 
136.7, 137.2, 138.8, 156.5, 165.0. ESI-MS 213 (M+H+), 196 (M‒NH2). 
N
NH2
 
(R)-(–)-1-(6-m-tolylpyridin-2-yl)ethanamine ((R)-4c). e.e. = 80%, 80 % yield, [α]D – 
6.4
 
(c 0.9, CH3OH). IR (neat) 3359, 3051, 2966, 2923, 1572, 1447, 782 cm-1. 1H 
NMR (400 MHz, CDCl3) δ 1.49 (d, J = 6.8 Hz, 3H, CHCH3), 2.11 (bs, 2H, NH2), 2.44 
(s, 3H, m-Tol CH3), 4.21 (q, J = 6.8 Hz, 1H), 7.20 (d, J = 7.6 Hz, 1H), 7.23 (m, 1H), 
7.35 (dd, J = 7.6, 8.0 Hz, 1H), 7.57 (d, J = 7.6 Hz, 1H), 7.69 (dt, J = 0.4, 0,8, 7.6, 1H), 
7.81 (dm, J = 8 Hz, 1H), 7.85 (m, 1H). 13C NMR (100.1 MHz, CDCl3) δ 21.7, 24.6, 
52.6, 118.4, 118.7, 124.1, 127.7, 128.6, 129.7, 137.3, 138.3, 139.6, 156.8, 165.2. ESI-
MS 213 (M+H+), 235 (M+Na+), 196 (M‒NH2). 
N
NH2
 
(S)-(–)-1-(3,5-dimethylphenyl)pyridine-2-yl)ethanamine ((S)-4g). e.e. = 95%, 70 % 
yield, [α]D – 1.1  (c 0.45, CHCl3). 1H NMR (400 MHz, CDCl3) δ 1.50 (d, J = 6.4 Hz, 
3H, CHCH3), 2.40 (s, 6H, 3,5-CH3-Ar), 2.56 (bs, 2H, NH2), 4.23 (q, J = 6.4 Hz, 1H, 
CHCH3), 7.05 (s, 1H), 7.19 (d, J = 7.6 Hz, 1H), 7.56 (d,  J = 7.6 Hz, 1H), 7.62 (s, 2H), 
7.68 (dd, J = 7.6, 8 Hz, 1H). 13C NMR (100.1 MHz, CDCl3) δ 21.4, 24.2, 52.4, 118.3, 
118.8, 124.8, 130.6, 137.2, 138.2, 139.4, 156.9, 164.6. ESI-MS 227 (M+H+), 210 
(M‒NH2). 
H3CO
N
NH2
 
(S)-(–)-1-(6-(4-methoxyphenyl)pyridin-2-yl)ethanamine ((S)-4e). e.e. = 95%, 70 % 
yield, [α]D – 3.3  (c 0.35, CHCl3). 1H NMR (400 MHz, CDCl3) δ 1.48 (d,  J = 6.8 Hz, 
3H, CHCH3), 2.47 (bs, 2H, NH2), 3.86 (s, 3H, OCH3), 4.19 (q,  J = 6.8 Hz, 1H, 
CHCH3), 6.99 (dm, J = 8.8 Hz, 2H), 7.14 (d, J = 7.6 Hz, 1H), 7.52 (d, J = 7.6 Hz, 1H), 
7.66  (dd, J = 7.6, 8 Hz, 1H), 7.99 (dm, J = 8.8 Hz, 2H). 13C NMR (100.1 MHz, 
CDCl3) δ 24.3, 52.4, 55.3, 114.0, 117.7, 117.8, 128.1, 132.1, 137.2, 156.1, 160.4, 
164.7. ESI-MS 229 (M+H+), 212 (M‒NH2). 
F3C
N
NH2
     
(S)-(+)-1-(6-(4-(trifluoromethyl)phenyl)pyridin-2-yl)ethanamine ((S)-4f). e.e. = 
95%, 75 % yield, [α]D + 3.6  (c 0.6, CHCl3).  1H NMR (400 MHz, CDCl3) δ 1.50 (d, J 
= 6.4 Hz, 3H, CHCH3), 1.99 (bs, 2H, NH2), 4.24 (q, J = 6.4 Hz, 1H, CHCH3), 7.29 (d, 
J = 7.6 Hz, 1H), 7.63 (d,  J = 7.2, 1H), 7.72 (d,  J = 8 Hz, 2H), 7.75 (dd, J = 7.6, 8 Hz, 
1H), 8.16 (dm,  J = 8.4 Hz, 2H). 13C NMR (100.1 MHz, CDCl3) δ 24.5, 52.5, 119.0, 
119.6, 125.6, 125.7, 127.3, 130.9 (q, CF3) 137.6, 142.7, 155.0, 165.3. ESI-MS 267 
(M+H+), 250 (M‒NH2). 
N
NH2
F3C
CF3  
(S)-(–)-1-(6-(3,5-bis(trifluoromethyl)phenyl)pyridin-2-yl)ethanamine ((S)-4h). e.e. 
= 95%, 90 % yield, [α]D  – 1.2  (c 0.9, CHCl3).  1H NMR (400 MHz, CDCl3) δ 1.51 (d, 
J = 6.8 Hz, 3H, CHCH3), 1.91 (bs, 2H, NH2), 4.27 (q, J = 6.8 Hz, 1H, CHCH3), 7.36 
(d, J = 8 Hz, 1H), 7.68 (dd, J = 0.8, 7.6 Hz, 1H), 7.80 (dd, J = 7.6, 8 Hz, 1H), 7.91 (s, 
1H), 8.49 (s, 2H). 13C NMR (100.1 MHz, CDCl3) δ  24.6, 52.5, 118.8, 120.3, 122.3, 
122.4, 124.8, 127.0, 132.0 (q, CF3), 138.0, 141.4, 153.3, 165.9. ESI-MS 335 (M+H+), 
318 (M‒NH2). 
N
NH2
 
(S)-(+)-1-(6-(naphthalen-2-yl)pyridin-2-yl)ethanamine ((S)-4a). e.e. = 98%, 95 % 
yield, [α]D  + 1.4  (c 0.6, CHCl3). IR (neat) 3355, 3056, 2967, 2925, 1573, 1475, 1445, 
807, 742 cm-1.  1H NMR (400 MHz, CDCl3) δ 1.53 (d, J = 6.4 Hz, 3H, CHCH3), 1.94 
(bs, 2H, NH2), 4.25 (q, J = 6.4, 1H, CHCH3), 7.25 (d, J = 4.4 Hz, 1H), 7.51 (m, J = 
0.8, 4.0, 4.4 Hz, 2H), 7.75 (m, J = 4.4 Hz, 2H), 7.87 (m, 1H), 7.95 (m, J = 6.8, 8.8 Hz, 
2H), 8.21 (dd, J = 1.6, 8.4 Hz, 1H), 8.50 (s, 1H). 13C NMR (100.1 MHz, CDCl3) δ 
24.6, 52.6, 118.5, 118.7, 124.7, 126.2, 126.4, 127.6, 128.3, 128.7, 133.5, 133.6, 136.8, 
137.3, 156.3, 165.4. ESI-MS 249 (M+H+), 271 (M+Na+) 232 (M‒NH2). 
 
N
NH2
 
(S)-(+)-1-(6-(naphthalen-1-yl)pyridin-2-yl)ethanamine ((S)-4b). e.e. = 98%, 73 % 
yield, [α]D  + 1.5  (c 0.65, CHCl3). 1H NMR (400 MHz, CDCl3) δ 1.52 (d, J = 6.8 Hz, 
3H, CHCH3), 2.37 (bs, 2H, NH2), 4.28 (q, J = 6.8 Hz, 1H, CHCH3), 7.33 (d, J = 8 Hz, 
1H), 7.42-7,61 (m, 4H), 7.78 (dt, J = 0.8, 8 Hz, 1H), 7.90 (d, J = 8 Hz, 2H). 13C NMR 
(100.1 MHz, CDCl3) δ 24.4, 52.5, 128.3, 123.2, 125.3, 125.7, 125.8, 126.3, 127.5, 
128.3, 128.8, 131.2, 134.0, 137.0, 158.5, 165.0. ESI-MS 249 (M+H+), 232 (M‒NH2). 
 
Alcohol  methylation: general procedure 
NaH (0.127 g, Mw 24, 5 mmol, 60% purity) was put in a three necks flask under Ar 
atmosphere and washed 2 times with freshly distilled THF. At 0°C the alcohol (2.5 
mmol) dissolved in THF and CH3I (0.203 mL, Mw 141.94, δ 2.23 g/mL, 5 mmol) were 
added and the mixture stirred at 0°C for 5 hours (TLC CH2Cl2/CH3OH 9:1). The 
reaction was quenched with sat. NH4Cl and the product extracted three times with 
CH2Cl2. The organic phases collected were dried on Na2SO4 and evapored getting pure 
methyl ether in 80-90% yield. 
N
N
OCH3
2
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(±)-6-(1-methoxyethyl)-2,2’-bipyridine (rac-29). 1H NMR (400 MHz, CDCl3) δ 
1.53 (d, J = 6.8 Hz, 3H, CHCH3), 3.36 (s, 3H, OCH3), 4.53 (q, J = 6.8 Hz, 1H, 
CHCH3), 7.29 (m, 1H, H5’), 7.44 (d, J = 7.6 Hz, 1H, H5), 7.8 (td, J = 2, 7.6 Hz, 1H, 
H4’), 7.83 (t, J = 8 Hz, 1H, H4), 8.28 (dd, J = 0.8, 7.6 Hz, 1H, H3’), 8.44 (d, J = 8 Hz, 
1H, H3), 8.63 (dm, J = 4.8 Hz, 1H, H6’). 13C NMR (100.1 MHz, CDCl3) δ 22.2 
(CHCH3), 56.9 (OCH3), 80.9 (CHCH3), 119.6 (C3), 119.8(C5), 121.3 (C3’), 123.7 (C5’), 
136.9 (C4’), 137.7 (C4), 149.2 (C6’), 155.4 (C2’), 156.3 (C2), 162.7 (C6). ESI-MS 215 
(M+H+), 237 (M+Na+). 
(R)-(+)-(6-(1-methoxyethyl)-2,2’-bipyridine ((R)-29): e.e. > 99.9% (by HRGC). [α]D 
+ 106.5 (c 0.6, CHCl3). 
(S)-(‒)-(6-(1-methoxyethyl)-2,2’-bipyridine ((S)-29): e.e. = 99% (by HRGC). [α]D – 
83.5 (c 0.4, CHCl3). 
An alternative synthesis of both racemic and optically pure 6-(1-methoxyethyl)-
2,2’-bipyridine (29) has been developed starting from either racemic or optically 
pure 1-(6-bromopyridin-2-yl)ethanol (22): 
The alcohols were methylated using NaH and CH3I in dry THF (see the general 
procedure for alcohol methylation), (rac)-2-bromo-6-(methoxyethil)pyridine (Br-39) 
and (S)-2-bromo-6-(methoxyethil)pyridine ((S)-39) were obtained in 98% yield and 
used in the next step without further purification. 1H NMR (400 MHz, CDCl3) δ 1.43 
(d, J = 6.6 Hz, CHCH3, 3H), 3.31 (s, OCH3, 3H), 4.39 (q, J = 6.6 Hz, CHCH3, 1H), 
7.37 (t, J = 7.7 Hz, 2H), 7.56 (t, J = 7.7 Hz, 1H).13C NMR (100.1 MHz, CDCl3) δ 
22.32, 57.06, 80.20, 118.43, 126.58, 139.18, 141.27, 165.18. ESI-MS 215, 217 
(M+H+), 237, 239 (M+Na+), 183, 185 (M‒OCH3). 
A solution of the methoxy derivative (0.5 g, Mw 216.8, 2.3 mmol) in freshly distilled 
THF (19 mL) was cooled with a acetone/liquid nitrogen bath (-90°C) under argon 
atmosphere and treated with 1.76 mL of n-butyllithium (1.6 M in n-hexane, 2.7 mmol), 
the reaction temperature was maintained bellow -70°C and the mixture stirred for 45’. 
35 dissolved in dry THF was then added dropwise. The intensely red solution was 
stirred overnight at room temperature. After removal of the solvent under reduce 
pressure the crude was purified by column chromatography (CH2Cl2/EtOAc as eluent).  
This protocol gave  29 in 60% yield.  
N
OCH3
N
N N  
2-(Methoxymethyl)-6-(1-methyl-1H-1,2,3-triazol-4-yl)pyridine 30. white solid, mp 
78-9 °C. IR (Nujol) 3147, 1604, 1578, 1116 cm-1.  1H NMR (400 MHz, CDCl3) δ 
3.42 (s, 3H, CH3O), 4.11 (s, 3H, CH3N), 4.58 (s, 2H, CH2OCH3), 7.32 (d, J = 7.7, 1H, 
H3), 7.72 (t, J = 7.7, 1H, H4), 7.98 (d, J = 7.7, 1H, H5), 8.10 (s, 1H, triazolo). 13C NMR 
(fom CH COSY, 100.1 MHz, CDCl3) δ 36.7 (CH3N), 58.7 (CH3O), 75.5 (CH2OMe), 
118.7 (C5 py), 120.3 (d, C3 py), 123.1 (d, C5 triazole), 137.3 (d, C4 py), 148.6, 149.6, 
158.1. ESI-MS  227.0 (M+Na+). 
N
OH
OBoc
 
N-(tert-butoxycarbony1)-(S)-proline (48). Triethylamine (16.5 mL, Mw 101.19, δ 
0.726 g/mL, 0.12 mmol) was added to an ice-cold suspension of (S)-proline (10.0 g, 
Mw 115.13, 0.09 mol) in dichloromethane (200 mL). Next, di-tert-butyl dicarbonate 
(27.2 g, Mw 218.25, 0.13 mol) in dichloromethane (10 mL) was added over 10 min, 
and the mixture was stirred at 0°C for 2.5 h. The reaction was discontinued by addition 
of saturated aqueous citric acid (50 mL), and the organic phase was washed with brine 
(2 x 50 mL) and water (50 mL). Removal in vacuum of solvent yielded a crude product 
which was dissolved in hot acetyl acetate. Following addition of hexane (500 mL) 
Boc-(S)-Pro (48) crystallized from the cooled solution to yield 17.8 g, 95%. mp 135- 
137°C. IR (nujol) 3430, 1671 cm-1. 1H NMR (400 MHz, CDCl3) δ 1.47 (bs, 9 H, t-
Bu) 2.0-1.8 (m, 4 H), 3.5-3.3 (m, 2 H), 4.4-4.1 (m, 1 H, CHCO), 7.5 (bs, 1 H).  
N
H HN
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(S)-(‒)-N-(pyridine-2-yl)pyrrolidine-2-carboxamide ((S)-46). Compounds 48 (1.000 
g, Mw 215.12, 4.65 mmol) was dissolved in dichloromethane (20 mL). The solution 
was cooled to 0 °C, and EDC (0.908 g, Mw 191.71, 4.74 mmol) was added. The 
solution was stirred at 0 °C for 1/2 h and then 2-aminopyridine (0.439 g, Mw 94.12, 
4.65 mmol) was added in one portion. The mixture was left at room temperature and 
followed with TLC (EtOAc/CH3OH/NH3 8:2:0.1). After removal of the solvent under 
reduced pressure, the residue was purified by column chromatography on silica gel 
(petroleum ether/ethyl acetate 3:7, petroleum ether/ethyl acetate 4:6, then petroleum 
ether/ethyl acetate/ammonia 4:6:0.2) to give Boc-protected-(S)-46 as white solid. [α]D 
– 71 (c 0.25, CH3OH). 1H NMR (400 MHz, CDCl3) δ 1.26-1.42 (bs, 9H, t-Bu), 1.69 
(bs, 1H), 1.91 (m, 2H), 2.24 (bs, 1H), 3.53 (bs, 2H), 4.32 (bs, 1H, CHCO), 7.01 (bs, 
1H), 7.68 (bs, 1H), 8.21 (d,  J = 8 Hz, 1H), 8.28 (dm, 1H), 9.22 (bs, 1H, NH). 13C 
NMR (100.1 MHz, CDCl3) δ 21.4, 24.8, 28.3, 47.2, 62.3, 80.96, 113.8, 119.78, 
138.22, 148.0, 151.8, 155.2, 172.0. ESI-MS 292 (M+H+), 314 (M+Na+). 
Boc-protected-(S)-46 (1.508 g, Mw 291.35, 5.17 mmol) was dissolved in 15 mL of 
trifluoroacetic acid solution (40% in CH2Cl2) at 0°C and the solution was stirred for 2 
h at room temperature. Then trifluoroacetic acid was neutralized by addition of Et3N 
(15 mL, Mw 101.19, δ 0.726 g/mL, 0.10 mmol) at 0°C. The solution was washed with 
H2O, dried over anhydrous Na2SO4, and concentrated under reduce pressure obtaining 
(S)-46 as a yellow oil in 90% yield. [α]D – 56.4 (c 0.5, CH3OH). IR (neat) 3276, 2969, 
2870, 1692, 1589, 1574, 1510, 1434, 1299, 1148, 1095, 779. 1H NMR (400 MHz, 
CDCl3) δ 1.69 (m, 2H), 1.97 (m, 1H), 2.16 (m, 1H), 2.54 (bs, 1H, NH-amine), 3.00 (m, 
2H), 3.84 ( dd, J = 4, 5.2 Hz, 1H, CHCO), 6.97 (ddd, J = 0.8, 2.4, 4.8  Hz, 1H), 7.64 
(td, J =2, 8  Hz, 1H), 8.20 (d, J = 8.4  Hz, 1H), 8.24 (dm, J = 4.8  Hz, 1H), 10.17 (bs, 
1H, NH-amide). 13C NMR (100.1 MHz, CDCl3) δ 26.3, 30.9, 47.4, 61.0, 113.6, 119.7, 
138.3, 148.0, 151.2, 174.4. ESI-MS 192 (M+H+), 214 (M+Na+). 
N
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(S)-(+)-N-(pyrrolidin-2-ylmethyl)pyridin-2-amine ((S)-47). To a cooled (-10°C) and 
stirred solution of the amide (S)-46 (0.304 g, Mw 191.11, 1.05 mmol) in dry THF (42 
mL) was added LiAlH4 (0.470 g, Mw 37.95, 12.4 mmol) portionwise, and the mixture 
was stirred at r.t. until almost all of the starting material was consumed. The mixture 
was concentrated and the residue diluted with CH2C12, in a ice-bath the reaction was 
quenched by the careful addition of NaOH 2 M. Stirring was continued to obtain a 
clear organic layer and the white residue was filtered off. The two-phases mixture was 
separated and the aquous layer was extracted with CH2C12. The combined organic 
phases were dried over anhydrous Na2SO4, and evapored. The product (S)-47 was 
obtained as a yellow oil in 90% yield without further purifications. [α]D + 28.86 (c 
0.35, CH3OH). IR (neat) 3287, 2961, 2870, 1606, 1518, 1488, 1291, 771, 736. 1H 
NMR (400 MHz, CDCl3) δ 1.47 (m, 1H), 1.75 (m, 2H), 1.89 (m, 1H), 2.52 (bs, 1H, 
NH-prolinic amine), 2.93 (td, J = 0.8, 6.4  Hz, 1H ), 3.14 (m, 1H), 3.39 (m, 2H), 4.94 
(bs, 1H, NH-amine), 6.4 (dt, J = 0.8, 8.4  Hz, 1H), 6.53 (ddd, J = 0.8, 2, 5.2  Hz, 1H), 
7.36 (ddd, J = 0.4, 1.6, 6.8  Hz, 1H), 8.04 (dm, J = 5.6  Hz, 1H). 13C NMR (100.1 
MHz, CDCl3) δ 25.5, 29.0, 46.2, 58.3, 107.9, 112.8, 137.3, 147.7, 158.8. ESI-MS 178 
(M+H+). 
 
P-N ligands synthesis: general procedure 
Amide (S)-46 or amine (S)-47 (1.05 mmol) was put in a Schlenk and azeotropically 
dried three times with distilled and degassed toluene. 5 mL of toluene were then added 
and under Ar atmosphere and 0°C bis(diethylamino)-phenylphosphine (244 µL, Mw 
252.34, δ 0.971 g/mL, 0.94  mmol) was added dropwise. The reaction mixture was 
heated to 90°C and stirred overnight. The cooled solution was evapored in vacuo. 
Compound 44 was washed 7 times with distilled and degassed n-pentane obtaining a 
white solid. Compound 45 was used as crude reaction product (viscous orange oil) 
without further purifications. 
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(1R,3aS)-(‒)-1-phenyl-2-(pyridin-2-yl)tetrahydro-1H-pyrrolo[1,2-
c][1,3,2]diazaphosphol-3(2H)-one (44). [α]D ‒128.9 (c 0.35, CH3OH). 1H NMR (500 
MHz, CD2Cl2) δ 1.72 (m, 1H, CH2, H4), 1.87 (m, 1H, CH2, H4), 2.18 (m, 1H, CH2, 
H3), 2.24 (m, 1H, CH2, H3), 3.39 (m, 1H, CH2, H5), 3.46 (m, 1H, CH2, H5), 4.16 (dd, J 
= 3, 9  Hz, 1H, CH, H2), 7.04 (dd, J = 2, 5.5  Hz, 1H, H4’), 7.35 (m, 3H, Ph), 7.57 (m, 
2H, Ph), 7.73 (td, J = 1.5, 8  Hz, 1H, H5’), 8.25 (dm, J = 4  Hz, 1H, CH, H3’), 8.33 (dm, 
J = 8.5  Hz, 1H, CH, H6’). 13C NMR (100.1 MHz, CDCl3) δ 26.5  (C4), 30.9 (C3), 55.4  
(C5), 68.3 (C2), 114.4 (C6’), 120.1 (C4’), 128.6 (CPh-P), 129.8 (Ph), 130.0 (Ph), 138.3 
(C5’), 147.7 (C3’), 152.4 (C2’), 178.1 (CO). 31P NMR (500 MHz, CD2Cl2) δ 106.29. 
ESI-MS 298.1 (M+H+), 320.1 (M+Na+). 
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(1R,3aS)-(‒)-1-phenyl-2-(pyridin-2-yl)hexahydro-1H-pyrrolo[1,2-c][1,3,2] -
diazaphosphole (45). [α]D ‒170.6 (c 0.485, CH3OH). 1H NMR (500 MHz, CD2Cl2) δ 
1.78 (m, 2H, CH2, H4 and 1H, CH2, H3), 2.07 (m, 1H, CH2, H3), 3.08 (m, 1H, CH2, 
H6), 3.31 (m, 1H, CH2, H5), 3.37 (m, 1H, CH2, H5), 3.55 (m, 1H, CH2, H6), 4.00 (q, J = 
2, 18.5 Hz, 1H, CH, H2), 6.61 (d, J = 8 Hz, 1H, H5’), 6.64 (ddd, J = 1, 2, 5  Hz, 1H, 
H3’), 7.30 (m, 3H, Ph), 7.47 (m, 2H, Ph and 1H, H4’), 8.10 (dm, J = 4.5 Hz, 1H, H6’).  
13C NMR (100.1 MHz, CD2Cl2) δ 26.1 (C4), 31.3 (C3), 52.2 (C6), 52.6 (C5), 64.8 (C2), 
108.5 (C5’), 113.7 (C3’), 128.5 (Ph), 129.2 (Ph), 129.9 (CPh-P), 137.9 (C4’), 148.7 (C6’). 
31P NMR (500 MHz, CD2Cl2) δ 99.71. ESI-MS 284.1 (M+H+). 
SYNTHESIS OF THE COMPLEXES 
 
Neutral complexes: general procedure to obtain [Pd(N-N’)(CH3)Cl], 
[Pd(PNCO)(CH3)Cl]2, and [Pd(PN)(CH3)Cl]. 
1.50 mmol of ligand was added to a solution of [Pd(COD)(CH3)Cl] (332 mg, Mw 
265.96, 1.25 mmol) in freshly distilled dicholoromethane and stirred at room 
temperature. 
 Pd-(N-N’) complexes: after 3 h, diethyl ether was added and the product precipitated 
as a yellow solid. Average yield: 90%. 
Pd-(P-N) complexes: after 1.5 h, the reaction mixture was concentrated and n-hexane 
was added to precipitate the products as a yellow-orange solid. Average yield: 80-90%. 
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R = -OCH3 (29a)
= -CH3 (31a)
= -CH2CH3 (32a)
 
[Pd(29)(CH3)Cl] (29a). 1H NMR (500 MHz, CDCl3) δ 1.32 (s, 3H, CH3-Pd), 1.49 (d, 
3H, CH3CH), 3.43 (s, 3H, OCH3), 6.20 (m, 1H, CH3CH), 7.49 (t, 1H, H5’), 7.80 (dd, 
1H, H5), 7.96-8.05 (m, 4H, H3’,4’ and H3,4), 8.63 (d, 1H, H6’).  
 
[Pd(31)(CH3)Cl] (31a). Elementar Anal. Calc. for C14H17ClN2Pd: C 47.34; H 4.79; N 
7.89. Found: C 47.38; H 4.45; N 7.30. 1H NMR (500 MHz, CDCl3) δ  1.32 (s, 3H, 
CH3-Pd), 1.33 (d, 6H, CH(CH3)2), 4.74 (m, 1H, CH(CH3)2), 7.48 (d, 2H, H5,5’), 7.89 
(m, 2H, H3,4), 8.01 (m, 2H, H3’,4’), 8.63 (d, 1H, H6’). 
 
[Pd(32)(CH3)Cl] (32a). 1H NMR (500 MHz, CD2Cl2) δ 0.88 (t, 3H, CH2CH3), 1.18 
(s, 3H, CH3-Pd), 1,27 (d, 3H, CHCH3), 1.60-1.74 (m, 2H, CHCH2CH3), 4,57 (m, 1H, 
CHCH3), 7.48 (m, 2H, H5,5’), 7.91 (m, 2H, H3,4), 8.01-8.04 (m, 2H, H3’,4’), 8.61 (d, 1H, 
H6’). 
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[Pd(30)(CH3)Cl] (30a). 1H NMR (500 MHz, DMSO-d6, 60 °C) δ 1.01 (s, 3H, CH3-
Pd), 3.40 (s, 3H, CH2OCH3), 4.09 (s, 3H, N-CH3), 4.58 (s, 2H, CH2OCH3), 7.38 (s, 
1H, H3), 7.91 (s, 2H, H4,5), 8.52 (s, 1H, H5’). 
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[Pd(PNCO)(CH3)Cl]2 (44a). [α]D ‒7.6 (c 0.29, CH3OH). IR (nujol) 1693 cm-1. 1H 
NMR (500 MHz, CD2Cl2) δ 1.94-2.11 (m, 2H, CH2, H4 and 1H, CH2, H3 ), 2.12 (d, J 
= 13 Hz, 3H, CH3-P), 2.45 (d, J = 11.5 Hz, 3H, CH3-P minority isomer), 2.61 (m, 1H, 
CH2, H3), 3.29 (m, J = 7.5 Hz, 1H, CH2, H5), 3.39 (m, 1H, CH2, H5), 3.81 (m, 1H, CH, 
H2), 6.91 (t, J = 6 Hz, 1H, C5’), 7.55 (tm, J = 2.5, 7 Hz, 2H, m-H-Ph), 7.59 (m, 1H, p-
H-Ph), 7.68 (td, J = 1.5, 8 Hz, 1H, H4’), 7.79 (d, J = 8,5 Hz, 1H, H3’), 7.96 (m, J = 2.5 
Hz, 1H, H6’), 8.06 (dd, J = 5.5, 7.5 Hz, 2H, o-H-Ph ). 13C NMR (100.1 MHz, CD2Cl2) 
δ 15.3 (CH3-P), 25.4 (C4), 29.7 (C3), 49.6 (C5), 65.0 (C2), 115.2 (C3’), 117.9 (C5’), 
128.8 (p-Ph), 129.6 (o-Ph), 132.3 (m-Ph), 133.0 (Ph-P), 140.5 (C4’), 144.7 (C6’), 170.3 
(CO). 31P NMR (500 MHz, CD2Cl2) δ 67.05 (minority isomer), 75.57 (major isomer). 
Isomers ratio 9:1. 
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[Pd(PN)(CH3)Cl] (45a). [α]D ‒ 20.4 (c 0.12, CH3OH). 1H NMR (500 MHz, CD2Cl2) 
δ 0.69 (d, J = 2 Hz, 3H, CH3-Pd, cis isomer), 1.57 (m, 1H, H3, cis isomer), 1.65 (d, J = 
8.8 Hz, 3H, CH3-Pd, trans isomer), 1.94 (m, 2H, H4, cis isomer), 2.18 (m, 1H, H3, cis 
isomer), 2.64-3.00 (m, aliphatic proton of the trans isomer), 3.29 (m, 1H, H6 cis 
isomer), 3.49 (m, 1H, H5, cis isomer), 3.70 (m, 1H, H6 and 1H, H5, cis isomer), 3.86 
(m, aliphatic protons, trans isomer), 4.06 (m, 1H, H2 cis and aliphatic protons of the 
trans isomer), 6.67 (d, J = 8.5 Hz, 1H, H3’), 6.85 (d, J = 8 Hz, 1H, H3’, trans isomer), 
6.95 (m, 1H, H5’ of both cis and trans isomers)  7.07 (t, J = 7.5 Hz, Ph, trans isomer), 
7.46 (m, 3H, Ph, cis isomer and Ph protons of the trans isomer), 7.73 (m, 2H, Ph and 
1H, H4’, cis isomer and  Ph H4’, trans isomer), 8.98 (m, 1H, H6’). 13C NMR (100.1 
MHz, CD2Cl2) 18.5 (CH3-Pd, trans isomer), 26.2 (C4, cis isomer), 32.8 (C3, cis 
isomer), 51.6 (C6, cis isomer), 52,2 (C5, cis isomer), 65.9 (C2, cis isomer), 109.6 (C3’, 
cis isomer), 110.4 (C3’, trans isomer), 116.5 (C5’, cis isomer), 123.4 (C5’, trans 
isomer), 127.0 (Ph, trans isomer), 128.6 (Ph, cis isomer), 130.2 (Ph, cis isomer), 131.5 
(Ph, trans isomer), 137.7 (Ph, cis isomer), 139.9 (C4’, cis isomer and C4’, trans 
isomer), 148.7 (C6’, cis isomer). 31P NMR (500 MHz, CD2Cl2) δ 119.9 (cis isomer), 
133.7 (trans isomer). Ratio cis/trans 2:1. 
 
Cationic complexes: general procedure to obtain: [Pd(N-N’)(CH3)(NCCH3)][PF6] 
All complexes were obtained starting from the corresponding neutral derivatives upon 
addition of AgPF6 in a mixture of CH2Cl2 and CH3CN. [Pd(N-N’)(CH3)Cl](1a-4a) 
(0.40 mmol) was dissolved in the minimal amount of CH2Cl2 under Ar. To the mixture 
obtained a solution of AgPF6 (121 mg, Mw 252.83, 0.48 mmol) in CH3CN (6 mL) was 
added, leading to the precipitation of AgCl. After 3 h, the solution was filtered over 
Celite and concentrated to minimal volume under vacuum. Upon addition of diethyl 
ether the product precipitate as a white solid. Average yield: 80%. 
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[Pd(29)(CH3)(NCCH3)][PF6] (29b). 1H NMR (500 MHz, CD2Cl2) δ  1.35 (s, 3H, 
CH3-Pd), 1.53 (d, 3H, CH3CH), 2.49 (s, 3H, CNCH3), 3.32 (s, 3H, OCH3), 4.68 (m, 
1H, CH3CH), 7.64 (t, 1H, H5’), 7.86 (d, 1H, H5), 8.16-8.24 (m, 4H, H3’,4’ and H3,4), 
8.56 (d, 1H, H6’). 
13C NMR (500 MHz, CD2Cl2) δ -4.44 (CH3-Pd), 22.69 (CH3CH), 56.97 (OCH3), 
79.39 (CH3CH), 121.77-124.03 (C4,4’), 123.94 (C5’), 126.51 (C5), 140.70 (C4,4’), 148.62 
(C6’). 
[Pd(31)(CH3)(NCCH3)][PF6] (31b). Elementar Anal. Calc. for C16H20F6N3Pd: C 
37.99; H 3.96; N 8.31. Found: C 37.52; H 3.26; N 7.55. 1H NMR (500 MHz, CDCl3) 
δ 1.30 (s, 3H, CH3-Pd), 1.38 (d, 6H, CH(CH3)2), 2.46 (s, 3H, NCCH3), 3.42 (m, 1H, 
CH(CH3)2), 7.61 (d, 2H, H5,5’), 8.07-8.17 (m, 4H, H3’,4’ and H3,4), 8.53 (d, 1H, H6’). 13C 
NMR (500 MHz, CD2Cl2) δ 6.67 (CH3-Pd), 22.76 (CH(CH3)2), 36.58 (CH(CH3)2), 
120.47-123.29 (C3,3’), 123.83-126.45 (C5,5’), 140.39 (C4,4’), 148.75 (C6’). 
 
[Pd(32)(CH3)(NCCH3)][PF6] (32b). 1H NMR (500 MHz, CD2Cl2) δ 0.89 (t, 3H, 
CHCH2CH3), 1.32 (s, 3H, CH3-Pd), 1.38 (d, 3H, CH3CH), 1.77 (m, 2H, CHCH2CH3), 
2.46 (s, 3H, NCCH3), 3.22 (m, 1H, CH3CH), 7.56 (dd, 1H, H5), 7.63 (dt, 1H, H5'), 
8.05-8.21 (m, 4H, H3,3',4,4'), 8.56 (d, 1H, H6'). 13C NMR (125.68 MHz, CD2Cl2) δ 3.3 
(NCCH3), 6.44 (CH3-Pd), 11.3 (CHCH2CH3), 20.0 (CH3CH), 29.4 (CHCH2CH3), 43.5 
(CH3CH), 120.8-122.3 (C3,3’), 126.2-126.9 (C5,5’), 140.3 (C4,4’), 148.5 (C6'). 
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[Pd(30)(CH3)(NCCH3)][PF6] (30b). 1H NMR (500 MHz, DMSO-d6, 60°C) δ 0.98 
(s, 3H, CH3-Pd), 2.04 (s, 3H, free NCCH3), 3.38 (s, 3H, OCH3), 4.13 (s, 3H, N-CH3), 
4.53 (s, 2H, CH2OCH3), 7.39 (s, 1H, H3), 7.94 (s, 2H, H4,5),8.59 (s, 1H, H5’). 
 
General procedure to obtain [Pd(CH3)(N-N’)2][PF6] 
To a suspension of 0.20 mmol of [Pd(N-N’)(CH3)(NCCH3)][PF6] (29b-32b) in 20 mL 
of CH2Cl2, 0.26 mmol of the free N-N’ ligand was added (Pd/free ligand=1/1.3), 
yielding an orange/yellow solution. After 10 min the solution was filtered and 
concentrated in vacuo to induce precipitation of the product as a yellow/orange solid. 
The solid was removed by filtration, washed with diethyl ether and dried. Average 
yield: 90%   
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[Pd(29)2(CH3)][PF6] (29c). 1H NMR (500 MHz, CD2Cl2) δ 0.56 (RR or SS, s, 3H, 
CH3-Pd), 0.64 (RS/SR, s, 3H, CH3-Pd), 0.68 (RR or SS, s, 3H, CH3-Pd), 0.99 (RR or SS, 
3H, CH3CH), 1.03 (dd, RS/SR, 3H, CH3CH), 1.08 (RR or SS, 3H, CH3CH), 2.84 (RR or 
SS, 3H, OCH3), 2.85 (RR or SS, 3H, OCH3), 2.89 (s, RS or SR, 3H, OCH3), 3.76 (RR or 
SS, m, 1H, CH3CH), 3.85 (RS or SR, m, 1H, CH3CH), 3.89 (RS or SR, m, 1H, CH3CH), 
4.02 (RR or SS, m, 1H, CH3CH), 7.57-7.67 (RR/SS and RS/SR, m, aromatic protons), 
7.99-8.21 (RR/SS and RS/SR, m, aromatic protons), 8.77 (RR or SS, d, 1H, H6’), 8.81 
(RS or SR, d, 1H, H6’), 8.91 (RS or SR, d, 1H, H6’), 8.96 (RR or SS, d, 1H, H6’). 
 
[Pd(31)2(CH3)][PF6] (31c). 1H NMR (500 MHz, CD2Cl2) δ 0.63 (s, 6H, CH3-Pd), 
0.94 (d, 3H, CH(CH3)2), 0.99 (d, 3H, CH(CH3)2), 2.85 (m, 2H, CH(CH3)2), 7.38 (d, 
2H, H5), 7.53 (t, 2H, H5’), 7.91 (d, 2H, H3), 8.00 (d, 2H, H4), 8.12 (m, 4H, H3’,4’), 8.76 
(d, 2H, H6’). 
 
[Pd(32)2(CH3)][PF6] (32c). 1H NMR (500 MHz, CD2Cl2) δ 0.50-0.41 (m, 4H, CHH-
CH3), 0.60 (s, 3H, CH3-Pd), 0.63 (s, 3H, CH3-Pd), 0.67 (s, 3H, CH3-Pd), 0.83 (d, 3H, 
CH3CH), 0.89 (d, 3H, CH3CH), 0.92 (d, 3H, CH3CH), 0.97 (d, 3H, CH3CH), 1.27-1.53 
(m, 4H, CHH-CH3), 2.45-2.63 (m, 4H, CHCH3), 7.31-7.36 (m, aromatic protons), 
7.53-7.57 (m, aromatic protons), 8.11-8.18 (m, aromatic protons), 8.78 (d, 1H, H6’), 
8.83 (d, 2H, H6’), 8.86 (d, 1H, H6’). 
 
General procedure to obtain: [Pd(CH3PNCO)(Py)]2[PF6]2, [Pd(CH3PNCO)(4-
CH3Py)]2[PF6]2, [Pd(CH3PNCO)(4-CF3Py)]2[PF6]2, [Pd(PN)(CH3)(Py)][PF6], 
[Pd(PN)(CH3)(4-CH3-Py)][PF6]. 
All complexes were obtained starting from the corresponding neutral derivatives upon 
addition of AgPF6 in a mixture of CH2Cl2 and pyridine or pyridine derivatives. Neutral 
catalyst 44a or 45a (0.22 mmol) was dissolved in the minimal amount of CH2Cl2 under 
Argon and kept in the dark. To the obtained solution was added a solution of AgPF6 in 
CH2Cl2 (0.0615 g, Mw 252.83, 0.24 mmol), and then dropwise the pyridine derivatives 
leading to the precipitation of AgCl. After 1.5 h, the solution was filtered over Celite 
and concentrated to minimal volume under vacuum. Upon addition of diethyl ether the 
product precipitate as a white solid. Average yield: 50-70% depending on the pyridine 
derivatives added. 
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[Pd(CH3PNCO)(Py)]2[PF6]2 (49a). [α] = + 90.9 (c = 0.11 in CH3OH). IR (nujol) 
1706, 842, 557 cm-1.1H NMR (500 MHz, CD2Cl2, - 40°C) δ 2.09 (m, 2H, CH2, H5), 
2.32 (m, 1H, CH2, H3), 2.38 (d, J = 11.5 Hz, 3H, CH3-P), 2.92 (m, 1H, CH2, H3 and 
1H, CH2, H4), 3.21 (m, 1H, CH2, H4), 5.03 (m, J = 4.5, 11 Hz, 1H, CH, H2), 6.72 (t, J = 
6 Hz, 1H, H5’), 6.87 (t, J = 6.5 Hz, 1H, m-Py), 7.33 (m, 5H, Ph and 1H, m-Py), 7.56 
(m, 1H, H6’ and 1H, p-Py), 7.62 (d, J = 8 Hz, 1H, H3’), 7.81 (t, J = 7.5 Hz, 1H, H4’), 
8.66 (d, J = 5.5 Hz, 1H, o-Py), 8.85 (d, J = 5.5 Hz, 1H, o-Py) 31P NMR (500 MHz, 
CD2Cl2) δ 50.73. 
 
[Pd(CH3PNCO)(4-CH3Py)]2[PF6]2 (49b).IR (nujol) 1711, 842, 557 cm-1. 1H NMR 
(500 MHz, CD2Cl2, - 35°C) δ 2.09 (m, 2H, CH2, H5), 2.20 (s, 3H, CH3-Py), 2.29 (m, 
1H, CH2, H3), 2.35 (d, J = 11.5 Hz, 3H, CH3-P), 2.89 (m, 1H, CH2, H4), 2.93 (m, 1H, 
CH2, H3), 3.20 (m, 1H, CH2, H4), 5.00 (m, 1H, CH, H2), 6,67 (bs, 1H, m-4-CH3Py), 
6.71 (t, J = 5.5 Hz, 1H, H5’), 7.17 (bs, 1H, m-4-CH3Py), 7.34 (m, 5H, Ph), 7.53 (m, 1H, 
H6’), 7.60 (d, J = 8 Hz, 1H, H3’), 7.80 (dt, J =1.5, 7.5 Hz, 1H, H4’), 8.44 (bs, 1H, o-4-
CH3Py), 8.63 (bs, 1H, o-4-CH3Py). 31P NMR (500 MHz, CD2Cl2) δ 50.73. 
 [Pd(CH3PNCO)(4-CF3Py)]2[PF6]2 (49c).[α] = + 120.5 ( c = 0.22 in CH3OH). 1H 
NMR (500 MHz, CD2Cl2, - 40°C) δ 2.13 (m, 2H, CH2, H5), 2.36 (m, 1H, CH2, H3), 
2.40 (d, J = 11.5 Hz, 3H, CH3-P), 2.95 (m, 1H, CH2, H4 and 1H, CH2, H3), 3.22 (m, 
1H, CH2, H4), 5.06 (m, 1H, CH, H2), 6.77 (t, J = 6 Hz, 1H, H5’), 7.08 (bs, 1H, m-4-
CF3Py), 7.22 (bs, 1H, m-4-CF3Py), 7.31 (m, 3H, Ph), 7.40 (m, 2H, Ph) 7.66 (m, 1H, 
H6’ and 1H, H3’), 7.85 (t, J =6.5 Hz, 1H, H4’), 8.97 (d, J = 6 Hz, 1H, o-4-CF3Py), 9.18 
(d, J = 6 Hz, 1H, o-4-CF3Py). 31P NMR (500 MHz, CD2Cl2) δ 50.73. 
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[Pd(PN)(CH3)(4-CH3Py)] (50b). [α]D ‒ 12.3 (c 0.105, CH3OH). 1H NMR (500 MHz, 
CD2Cl2) δ 0.50 (d, J = 1.5 Hz, 3H, CH3-Pd, cis isomer), 1.00 (m, aliphatic protons 
trans isomer), 1.65 (m, 1H, H3, cis isomer), 1.72 (d, J = 8.5 Hz, 3H, CH3-Pd, trans 
isomer), 1.98 (m, 2H, H4, cis isomer), 2.24 (m, 1H, H3, cis isomer), 2.30 (s, 3H, CH3-
Py, trans isomer), 2.39 (s, 3H, CH3-Py, cis isomer), 2.73 (m, aliphatic proton of the 
trans isomer), 3.05 (m, 1H, H4 cis isomer), 3.31 (m, 1H, H6, cis isomer), 3.54 (m, 1H, 
H5, cis isomer), 3.65 (m, 1H, H6, cis isomer) 3.74 (m, 1H, H5, cis isomer), 4.12 (m, 1H, 
H2, cis isomer), 6.82 (m, 1H, Py), 7.24 (m, Py), 7.46-7.57 (m, Ph and Py ), 7.78-7.86 
(m, Ph and Py), 7.83 (d, 1H, Py), 8.49 (m, 1H,Py). 31P NMR (500 MHz, CD2Cl2) δ 
122.9 (cis isomer), 136.2 (trans isomer). Ratio cis/trans 2:1. 
 
CATALYSIS 
 
General procedure for oligomerization reactions 
All experiments were carried out in a three-necked, 75 mL glass reactor equipped with 
a magnetic stirrer and connected to a temperature controller. After establishment of the 
reaction temperature (30 °C), the pre-catalyst (1.27 x 10-2 mmol), 1,4-benzoquinone 
(54.9 mg, Mw 108.09, 0.508 mmol), styrene (10 mL, Mw 104.15, δ 0.909 g/mL, 87 
mmol), and TFE (20 mL) were placed inside. CO was bubbled through the solution for 
10 min; afterward a 4 L balloon filled with CO was connected to the reactor. The 
system was stirred at the same temperature for 24 h to give a yellow solution. The 
reaction mixture was then poured into methanol (100 mL) and stirred for 1 h at room 
temperature, and the solvent was evaporated until to obtain a yellow/orange oil. The 
product was dried under vacuum. 1H NMR (500 MHz, CDCl3) CO/styrene oligomers: 
δ 1.40 (d, Bl 3H, -(Ph)CH-CH3), 1.48 (d, Au 3H, -(Ph)CH-CH3), 2.57-3.53 (broad, -
(Ph)CH-CH2-CO-), 3.65 (m, Au 1H, CH3-CH(Ph)-), 3.91 (m, Bl 1H, CH3-CH(Ph)-), 
4.03 (m, Al 1H, CH3-CH(Ph)-), 3.81-4.55 (broad, CO-CH(Ph)-), 6.41 (pst, Au 1H, (Ph-
CH=CH-), 6.73 (pst, Al 1H, (Ph-CH=CH-), 6.97 (m, Bl 1H, Ph-CH=CH-), 7.10-8.21 
(aromatic protons). 13C NMR (100 MHz, CDCl3) δ 17.18 (Bl -(Ph)CH-CH3), 17.63 
(Al -(Ph)CH-CH3), 21.29 (Au -(Ph)CH-CH3), 29.47 (-(Ph)CH-CH2-CO-), 30.02, 42.32-
44.26, 42.43 (Au CH3-CH(Ph)-), 52.42 (Al CH3-CH(Ph)-), 53.23 (Bl CH3-CH(Ph)-), 
52.02-53.28 (CO-CH(Ph)-), 116.37 (Al Ph-CH=CH-), 128.47 (Carom), 135.38 (Au Ph-
CH=CH-), 136.19 (Bl Ph-CH=CH-), 208.17-209.10 (broad, CO).   
 
Styrene dimerization reaction 
All experiments were carried out in a three-necked, 75 mL glass reactor equipped with 
a magnetic stirrer and connected to a temperature controller. After establishment of the 
reaction temperature (70 °C), the pre-catalyst (0.0254 mmol), 1,4-benzoquinone (54.9 
mg, Mw 108.09, 0.508 mmol), styrene (10 mL, Mw 104.15, δ 0.909 g/mL, 87 mmol), 
and TFE (20 mL) were placed inside. The system was stirred at the same temperature 
for 24 h. At the end of the reaction time the two layers formed was separed (dimer was 
the least dense phase), the residue of Pd(0) was filtered on a short pad of Celite then 
washed with methylene chloride. The product was dried under vacuum. IR (neat) 
3081, 3059, 3025, 2964, 2928, 2870, 1945, 1873, 1806, 1599, 1492, 1450, 965 cm-1. 
1H NMR (400 MHz, CDCl3) δ 1.47 (d, 3H, J = 7 Hz, CH3CH), 3.65 (m, 1H, CH3CH), 
6.42 (m, 2H, J = 5.16, 16.2 Hz, HC=CH trans), 7.19-7.48 (m, 10H, Ph). 13C NMR 
(100 MHz, CDCl3) δ  21.2, 42.5, 126.1, 126.2, 127.0, 127.3, 128.5, 135.1, 137.5, 
145.6. 
 
 
